activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1475816	CHEMBL829909	Percent inhibition against MAPKAP-K1a at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	97.0	CHEMBL2553	Homo sapiens	Inhibition	%	97.0
	1475816	CHEMBL829909	Percent inhibition against MAPKAP-K1a at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	97.0	CHEMBL2553	Homo sapiens	Inhibition	%	97.0
	1665736	CHEMBL860234	Inhibition of RSK1 at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	Inhibition	%	1.0
	1671489	CHEMBL858542	Inhibition of MAPKAP-K1a at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	-9.0	CHEMBL2553	Homo sapiens	Inhibition	%	-9.0
	1671518	CHEMBL858542	Inhibition of MAPKAP-K1a at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	Inhibition	%	6.0
	1671542	CHEMBL858542	Inhibition of MAPKAP-K1a at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	-8.0	CHEMBL2553	Homo sapiens	Inhibition	%	-8.0
	1671634	CHEMBL858542	Inhibition of MAPKAP-K1a at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	Inhibition	%	3.0
	1727579	CHEMBL859768	Inhibition of human Rsk1 at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	Inhibition	%	3.0
	1734088	CHEMBL862832	Residual activity at human Rsk1 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	104.0	CHEMBL2553	Homo sapiens	Activity	%	104.0
	1751589	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751590	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751591	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751592	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751593	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751594	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1751658	CHEMBL869137	Inhibition of MAPKAP-K1a	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1790023	CHEMBL854691	Percentage activity of human Rsk1 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	93.0	CHEMBL2553	Homo sapiens	Activity	%	93.0
	1790335	CHEMBL873773	Percent residual activity, relative to control, of MAPKAP-K1a/Rsk1 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	0.0	CHEMBL2553	Homo sapiens	Activity	%	0.0
	1790389	CHEMBL873773	Percent residual activity, relative to control, of MAPKAP-K1a/Rsk1 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	28.0	CHEMBL2553	Homo sapiens	Activity	%	28.0
	1800716	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	IC50	nM	3100.0	CHEMBL2553	Homo sapiens	IC50	nM	3100.0
	1800720	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)CC(=O)N1		CHEMBL218654	=	IC50	nM	1410.0	CHEMBL2553	Homo sapiens	IC50	nM	1410.0
	1800754	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	IC50	nM	90.0	CHEMBL2553	Homo sapiens	IC50	nM	90.0
	1800755	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL375312	=	IC50	nM	780.0	CHEMBL2553	Homo sapiens	IC50	nM	780.0
	1800756	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL217910	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	nM	10000.0
	1800757	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	IC50	nM	1950.0	CHEMBL2553	Homo sapiens	IC50	nM	1950.0
	1800758	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	IC50	nM	1100.0	CHEMBL2553	Homo sapiens	IC50	nM	1100.0
	1800759	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	IC50	nM	620.0	CHEMBL2553	Homo sapiens	IC50	nM	620.0
	1800760	CHEMBL911039	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218719	=	IC50	nM	740.0	CHEMBL2553	Homo sapiens	IC50	nM	740.0
	1837914	CHEMBL920455	Inhibition of MAPKAPK1a at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	52.0	CHEMBL2553	Homo sapiens	Inhibition	%	52.0
	1837935	CHEMBL920484	Inhibition of MAPKAPK1a	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	IC50	nM	10280.0	CHEMBL2553	Homo sapiens	IC50	uM	10.28
	1837953	CHEMBL920455	Inhibition of MAPKAPK1a at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	Inhibition	%	90.0
Not Determined	1916304	CHEMBL894120	Inhibition of recombinant MAPKAPKA by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080		IC50			CHEMBL2553	Homo sapiens	IC50		
	1916361	CHEMBL894120	Inhibition of recombinant MAPKAPKA by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	1981770	CHEMBL899287	Inhibition of RSK1 assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	1981771	CHEMBL899288	Inhibition of RSK1 assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	2025193	CHEMBL887021	Inhibition of human Rsk1 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	15.0	CHEMBL2553	Homo sapiens	Inhibition	%	15.0
	2025471	CHEMBL887021	Inhibition of human Rsk1 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	39.0	CHEMBL2553	Homo sapiens	Inhibition	%	39.0
	2025472	CHEMBL887021	Inhibition of human Rsk1 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	85.0	CHEMBL2553	Homo sapiens	Inhibition	%	85.0
	2025473	CHEMBL887021	Inhibition of human Rsk1 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	15.0	CHEMBL2553	Homo sapiens	Inhibition	%	15.0
	2025518	CHEMBL887036	Inhibition of human Rsk1	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	IC50	nM	1900.0	CHEMBL2553	Homo sapiens	IC50	nM	1900.0
	2099515	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	Inhibition	%	1.0
	2099571	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	22.0	CHEMBL2553	Homo sapiens	Inhibition	%	22.0
	2099572	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	64.0	CHEMBL2553	Homo sapiens	Inhibition	%	64.0
	2099573	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	7.0	CHEMBL2553	Homo sapiens	Inhibition	%	7.0
	2099574	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	Inhibition	%	4.0
	2099575	CHEMBL948229	Inhibition of MAPKAP-K1a at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	Inhibition	%	1.0
	2147380	CHEMBL922165	Activity of human Rsk1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	91.0	CHEMBL2553	Homo sapiens	Activity	%	91.0
Not Active	2170332	CHEMBL927891	Activity at MAPKAP-K1a at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL2553	Homo sapiens	Activity		
	2239713	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	2239741	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	46.0	CHEMBL2553	Homo sapiens	INH	%	46.0
	2239769	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	2239797	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	2239825	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	2239853	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	2239908	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
Not Determined	2239929	CHEMBL996942	Inhibition of MAPKAP-K1a at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	2248293	CHEMBL957361	Inhibition of RSK1 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	2248294	CHEMBL957361	Inhibition of RSK1 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	2251075	CHEMBL1011950	Inhibition of RSK1 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	98.0	CHEMBL2553	Homo sapiens	INH	%	98.0
	2279722	CHEMBL960136	Inhibition of MAPKAP-K1a at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	2356976	CHEMBL958272	Inhibition of RSK1 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	2367231	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(-c3ccccc3)ncc(OCCCN)c21		CHEMBL493250	=	IC50	nM	44.0	CHEMBL2553	Homo sapiens	IC50	uM	0.044
	2367260	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	IC50	nM	251.0	CHEMBL2553	Homo sapiens	IC50	uM	0.251
	2367261	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CCCO)ncc(OCCCN)c21		CHEMBL493875	=	IC50	nM	6.0	CHEMBL2553	Homo sapiens	IC50	uM	0.006
	2367262	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CCO)ncc(OCCCN)c21		CHEMBL523523	=	IC50	nM	1.0	CHEMBL2553	Homo sapiens	IC50	uM	0.001
	2367263	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCN)c21		CHEMBL493874	=	IC50	nM	1259.0	CHEMBL2553	Homo sapiens	IC50	uM	1.259
	2367264	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC3CC3)ncc(OCCCN)c21		CHEMBL494882	=	IC50	nM	251.0	CHEMBL2553	Homo sapiens	IC50	uM	0.251
Not Determined	2367265	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(-c3cn[nH]c3)ncc(OCCCN)c21		CHEMBL450487		IC50			CHEMBL2553	Homo sapiens	IC50		
Not Determined	2367266	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(-c3cc[nH]c3)ncc(OCCCN)c21		CHEMBL523057		IC50			CHEMBL2553	Homo sapiens	IC50		
	2367267	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(-c3ccoc3)ncc(OCCCN)c21		CHEMBL445180	=	IC50	nM	71.0	CHEMBL2553	Homo sapiens	IC50	uM	0.071
	2367268	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(-c3ccc[nH]3)ncc(OCCCN)c21		CHEMBL493251	=	IC50	nM	13.0	CHEMBL2553	Homo sapiens	IC50	uM	0.013
	2367273	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC[C@@H](N)Cc3ccccc3)c21		CHEMBL523859	=	IC50	nM	1560.0	CHEMBL2553	Homo sapiens	IC50	uM	1.56
	2367277	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	IC50	nM	2510.0	CHEMBL2553	Homo sapiens	IC50	uM	2.51
	2367365	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCCN)c21		CHEMBL493269	=	IC50	nM	790.0	CHEMBL2553	Homo sapiens	IC50	uM	0.79
	2367366	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCN)c21		CHEMBL453510	=	IC50	nM	500.0	CHEMBL2553	Homo sapiens	IC50	uM	0.5
	2367369	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNC3)c21		CHEMBL494088	=	IC50	nM	1990.0	CHEMBL2553	Homo sapiens	IC50	uM	1.99
	2367371	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	IC50	nM	3980.0	CHEMBL2553	Homo sapiens	IC50	uM	3.98
	2367374	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	IC50	nM	1260.0	CHEMBL2553	Homo sapiens	IC50	uM	1.26
	2367375	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21		CHEMBL521642	=	IC50	nM	1580.0	CHEMBL2553	Homo sapiens	IC50	uM	1.58
	2367376	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNCCc3ccc(OC)cc3)c21		CHEMBL494060	=	IC50	nM	2510.0	CHEMBL2553	Homo sapiens	IC50	uM	2.51
	2367377	CHEMBL1028103	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNC[C@H](O)CO)c21		CHEMBL522351	=	IC50	nM	500.0	CHEMBL2553	Homo sapiens	IC50	uM	0.5
tde	2419460	CHEMBL1009040	Inhibition of p90RSK phosphorylation in human PC3 cells at 0.1 uM by Western blot analysis	B	COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL523122		Activity			CHEMBL2553	Homo sapiens	Activity		
tde	2419462	CHEMBL1009042	Inhibition of p90RSK phosphorylation in human A431 cells at 0.1 uM by Western blot analysis	B	COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL523122		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	2419464	CHEMBL1009044	Inhibition of p90RSK phosphorylation in human PC3 cells at 0.1 uM after 6 hrs by Western blot analysis	B	COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL523122		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	2419466	CHEMBL1009046	Inhibition of p90RSK phosphorylation in human A431 cells at 0.1 uM after 6 hrs by Western blot analysis	B	COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1		CHEMBL523122		Activity			CHEMBL2553	Homo sapiens	Activity		
	2476028	CHEMBL987091	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	IC50	nM	3100.0	CHEMBL2553	Homo sapiens	IC50	nM	3100.0
	2476031	CHEMBL987091	Inhibition of RSK1	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccccc2)N1		CHEMBL519680	=	IC50	nM	5300.0	CHEMBL2553	Homo sapiens	IC50	nM	5300.0
	2476080	CHEMBL987091	Inhibition of RSK1	B	COc1ccc(C2=NC(c3ccc(Cl)cc3F)C(C(=O)Nc3ccc4[nH]ncc4c3)=C(C)N2)cc1		CHEMBL520828	=	IC50	nM	510.0	CHEMBL2553	Homo sapiens	IC50	nM	510.0
	2476095	CHEMBL987091	Inhibition of RSK1	B	CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(Cl)cc2F)N=C(c2ccnc(Cl)c2)N1		CHEMBL521347	=	IC50	nM	398.0	CHEMBL2553	Homo sapiens	IC50	nM	398.0
Not Evaluated	2476697	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2476900	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2478739	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2479594	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2553	Homo sapiens	Activity		
	2479797	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	10.9	CHEMBL2553	Homo sapiens	Activity	%	10.9
Active	2480594	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2553	Homo sapiens	Activity		
	2480796	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	22.4	CHEMBL2553	Homo sapiens	Activity	%	22.4
	2490363	CHEMBL1025531	Inhibition of RSK1 at 1 uM	B	CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL481806	=	Inhibition	%	21.0	CHEMBL2553	Homo sapiens	INH	%	21.0
	2511607	CHEMBL973461	Inhibition of RSK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	0.1	CHEMBL2553	Homo sapiens	IC50	uM	0.0001
	2511621	CHEMBL973461	Inhibition of RSK1	B	COc1ccc(NC(=S)N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL504574	=	IC50	nM	34900.0	CHEMBL2553	Homo sapiens	IC50	uM	34.9
	2511971	CHEMBL973498	Inhibition of RSK1 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	23.0	CHEMBL2553	Homo sapiens	INH	%	23.0
	2559678	CHEMBL982975	Inhibition of RSK1	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	nM	50000.0
	2567280	CHEMBL975467	Inhibition of human Rsk1 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4	Non standard unit for type	CHEMBL223147	=	AC50	%	29.0	CHEMBL2553	Homo sapiens	AC50	%	29.0
Not Evaluated	2577418	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2593623	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2553	Homo sapiens	Activity		
	2593889	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	4.1	CHEMBL2553	Homo sapiens	Activity	%	4.1
Not Evaluated	2594092	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2594832	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2595035	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2596232	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2596435	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2597704	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Evaluated	2597907	CHEMBL982725	Binding affinity to human RSK1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	2613364	CHEMBL1016977	Binding affinity to RSK1 in HEK293 cells assessed as protein labeling at 1 mM preincubated for 1 hr by enhanced chemiluminescence detection	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	2613366	CHEMBL1016979	Binding affinity to RSK1 in HEK293 cells assessed as protein labeling at 1 mM preincubated for 1 hr by immunodepletion method	B	Cc1ccc(-c2c(C(=O)CF)n(CCCOC(=O)NCCCCNC(=O)CCCC[C@@H]3SC[C@H]4NC(=O)N[C@H]43)c3ncnc(N)c23)cc1		CHEMBL446278		Activity			CHEMBL2553	Homo sapiens	Activity		
	2635206	CHEMBL1003311	Inhibition of RSK1 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL2553	Homo sapiens	Residual_activity	%	100.0
	2635949	CHEMBL1003311	Inhibition of RSK1 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL2553	Homo sapiens	Residual_activity	%	75.0
	2636017	CHEMBL1003311	Inhibition of RSK1 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL2553	Homo sapiens	Residual_activity	%	75.0
	2638343	CHEMBL1011437	Inhibition of RSK1	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	=	IC50	nM	810.0	CHEMBL2553	Homo sapiens	IC50	uM	0.81
	2638344	CHEMBL1011437	Inhibition of RSK1	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	=	IC50	nM	780.0	CHEMBL2553	Homo sapiens	IC50	uM	0.78
	2638345	CHEMBL1011437	Inhibition of RSK1	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	=	IC50	nM	290.0	CHEMBL2553	Homo sapiens	IC50	uM	0.29
	2638346	CHEMBL1011437	Inhibition of RSK1	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	2638347	CHEMBL1011437	Inhibition of RSK1	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	2638348	CHEMBL1011437	Inhibition of RSK1	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	2661598	CHEMBL1061349	Inhibition of RSK1 after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	2721714	CHEMBL1055118	Inhibition of Rsk1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	2891725	CHEMBL1063776	Percentage RSK1 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	2891726	CHEMBL1063776	Percentage RSK1 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	78.0	CHEMBL2553	Homo sapiens	Activity	%	78.0
Antagonist	2891727	CHEMBL1063776	Percentage RSK1 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	25.0	CHEMBL2553	Homo sapiens	Activity	%	25.0
Antagonist	2891728	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	1.0	CHEMBL2553	Homo sapiens	Activity	%	1.0
	2891729	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	55.0	CHEMBL2553	Homo sapiens	Activity	%	55.0
Antagonist	2891730	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	32.0	CHEMBL2553	Homo sapiens	Activity	%	32.0
	2891731	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	74.0	CHEMBL2553	Homo sapiens	Activity	%	74.0
Antagonist	2891732	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	11.0	CHEMBL2553	Homo sapiens	Activity	%	11.0
Antagonist	2891733	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	6.0	CHEMBL2553	Homo sapiens	Activity	%	6.0
Antagonist	2891734	CHEMBL1062025	Percentage RSK1 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	10.0	CHEMBL2553	Homo sapiens	Activity	%	10.0
	2891735	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	124.0	CHEMBL2553	Homo sapiens	Activity	%	124.0
	2891736	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	85.0	CHEMBL2553	Homo sapiens	Activity	%	85.0
	2891737	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	79.0	CHEMBL2553	Homo sapiens	Activity	%	79.0
Antagonist	2891738	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	40.0	CHEMBL2553	Homo sapiens	Activity	%	40.0
	2891739	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	81.0	CHEMBL2553	Homo sapiens	Activity	%	81.0
	2891740	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	91.0	CHEMBL2553	Homo sapiens	Activity	%	91.0
	2891741	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	92.0	CHEMBL2553	Homo sapiens	Activity	%	92.0
Antagonist	2891742	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	40.0	CHEMBL2553	Homo sapiens	Activity	%	40.0
	2891743	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	71.0	CHEMBL2553	Homo sapiens	Activity	%	71.0
Antagonist	2891744	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	25.0	CHEMBL2553	Homo sapiens	Activity	%	25.0
Antagonist	2891745	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	31.0	CHEMBL2553	Homo sapiens	Activity	%	31.0
Antagonist	2891746	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	26.0	CHEMBL2553	Homo sapiens	Activity	%	26.0
Antagonist	2891747	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	19.0	CHEMBL2553	Homo sapiens	Activity	%	19.0
Antagonist	2891748	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	21.0	CHEMBL2553	Homo sapiens	Activity	%	21.0
	2891749	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	97.0	CHEMBL2553	Homo sapiens	Activity	%	97.0
	2891750	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	53.0	CHEMBL2553	Homo sapiens	Activity	%	53.0
	2891751	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	56.0	CHEMBL2553	Homo sapiens	Activity	%	56.0
	2891752	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	70.0	CHEMBL2553	Homo sapiens	Activity	%	70.0
Antagonist	2891753	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	41.0	CHEMBL2553	Homo sapiens	Activity	%	41.0
Antagonist	2891754	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	23.0	CHEMBL2553	Homo sapiens	Activity	%	23.0
	2891755	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	66.0	CHEMBL2553	Homo sapiens	Activity	%	66.0
	2891756	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	99.0	CHEMBL2553	Homo sapiens	Activity	%	99.0
	2891757	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	83.0	CHEMBL2553	Homo sapiens	Activity	%	83.0
	2891758	CHEMBL1063777	Percentage RSK1 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	67.0	CHEMBL2553	Homo sapiens	Activity	%	67.0
	2891759	CHEMBL1061103	Percentage RSK1 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	87.0	CHEMBL2553	Homo sapiens	Activity	%	87.0
Antagonist	2891760	CHEMBL1061103	Percentage RSK1 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	48.0	CHEMBL2553	Homo sapiens	Activity	%	48.0
Antagonist	2891761	CHEMBL1061104	Percentage RSK1 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	50.0	CHEMBL2553	Homo sapiens	Activity	%	50.0
	2891762	CHEMBL1062026	Percentage RSK1 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	92.0	CHEMBL2553	Homo sapiens	Activity	%	92.0
Antagonist	2891763	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	35.0	CHEMBL2553	Homo sapiens	Activity	%	35.0
	2891764	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	65.0	CHEMBL2553	Homo sapiens	Activity	%	65.0
	2891765	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	90.0	CHEMBL2553	Homo sapiens	Activity	%	90.0
	2891766	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	90.0	CHEMBL2553	Homo sapiens	Activity	%	90.0
Antagonist	2891767	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	31.0	CHEMBL2553	Homo sapiens	Activity	%	31.0
	2891768	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	55.0	CHEMBL2553	Homo sapiens	Activity	%	55.0
	2891769	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	51.0	CHEMBL2553	Homo sapiens	Activity	%	51.0
	2891770	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	52.0	CHEMBL2553	Homo sapiens	Activity	%	52.0
	2891771	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	78.0	CHEMBL2553	Homo sapiens	Activity	%	78.0
	2891772	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	86.0	CHEMBL2553	Homo sapiens	Activity	%	86.0
	2891773	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	97.0	CHEMBL2553	Homo sapiens	Activity	%	97.0
	2891774	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	67.0	CHEMBL2553	Homo sapiens	Activity	%	67.0
	2891775	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	83.0	CHEMBL2553	Homo sapiens	Activity	%	83.0
	2891776	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	85.0	CHEMBL2553	Homo sapiens	Activity	%	85.0
	2891777	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	55.0	CHEMBL2553	Homo sapiens	Activity	%	55.0
	2891778	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	71.0	CHEMBL2553	Homo sapiens	Activity	%	71.0
	2891779	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	105.0	CHEMBL2553	Homo sapiens	Activity	%	105.0
	2891780	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	2895566	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	2895567	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	110.0	CHEMBL2553	Homo sapiens	Activity	%	110.0
	2895568	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	65.0	CHEMBL2553	Homo sapiens	Activity	%	65.0
Antagonist	2895569	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	36.0	CHEMBL2553	Homo sapiens	Activity	%	36.0
Antagonist	2895570	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	22.0	CHEMBL2553	Homo sapiens	Activity	%	22.0
	2895571	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	62.0	CHEMBL2553	Homo sapiens	Activity	%	62.0
	2895572	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	89.0	CHEMBL2553	Homo sapiens	Activity	%	89.0
	2895573	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	118.0	CHEMBL2553	Homo sapiens	Activity	%	118.0
	2895574	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	84.0	CHEMBL2553	Homo sapiens	Activity	%	84.0
	2895575	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	90.0	CHEMBL2553	Homo sapiens	Activity	%	90.0
	2895576	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	56.0	CHEMBL2553	Homo sapiens	Activity	%	56.0
Antagonist	2895577	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	23.0	CHEMBL2553	Homo sapiens	Activity	%	23.0
	2895578	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	73.0	CHEMBL2553	Homo sapiens	Activity	%	73.0
	2895579	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	2895580	CHEMBL1052116	Percentage RSK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	2897156	CHEMBL1061120	Percent residual MAPKAPK1 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	91.0	CHEMBL2553	Homo sapiens	Activity	%	91.0
	2897157	CHEMBL1061120	Percent residual MAPKAPK1 activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	86.0	CHEMBL2553	Homo sapiens	Activity	%	86.0
	2897158	CHEMBL1061120	Percent residual MAPKAPK1 activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	103.0	CHEMBL2553	Homo sapiens	Activity	%	103.0
	2907589	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907590	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907591	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907592	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907593	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907594	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907595	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	450.0	CHEMBL2553	Homo sapiens	Kd	nM	450.0
	2907596	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907597	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907598	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907599	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907600	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907601	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907602	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907603	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2300.0	CHEMBL2553	Homo sapiens	Kd	nM	2300.0
	2907604	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907605	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907606	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907607	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907608	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	4000.0	CHEMBL2553	Homo sapiens	Kd	nM	4000.0
	2907609	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907610	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	400.0	CHEMBL2553	Homo sapiens	Kd	nM	400.0
	2907611	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907612	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907613	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907614	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	690.0	CHEMBL2553	Homo sapiens	Kd	nM	690.0
	2907615	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907616	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907617	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907618	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907619	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907620	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907621	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	43.0	CHEMBL2553	Homo sapiens	Kd	nM	43.0
	2907622	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	180.0	CHEMBL2553	Homo sapiens	Kd	nM	180.0
	2907623	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	140.0	CHEMBL2553	Homo sapiens	Kd	nM	140.0
	2907624	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907625	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907626	CHEMBL1051351	Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907627	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907628	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907629	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907630	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907631	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907632	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907633	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907634	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907635	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	6200.0	CHEMBL2553	Homo sapiens	Kd	nM	6200.0
	2907636	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907637	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907638	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907639	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907640	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907641	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	720.0	CHEMBL2553	Homo sapiens	Kd	nM	720.0
	2907642	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907643	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907644	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907645	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907646	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907647	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907648	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907649	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907650	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907651	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907652	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907653	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907654	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907655	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	170.0	CHEMBL2553	Homo sapiens	Kd	nM	170.0
	2907656	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	320.0	CHEMBL2553	Homo sapiens	Kd	nM	320.0
	2907657	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Kd	nM	1300.0	CHEMBL2553	Homo sapiens	Kd	nM	1300.0
	2907658	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907659	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1200.0	CHEMBL2553	Homo sapiens	Kd	nM	1200.0
	2907660	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	5800.0	CHEMBL2553	Homo sapiens	Kd	nM	5800.0
	2907661	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5000.0	CHEMBL2553	Homo sapiens	Kd	nM	5000.0
	2907662	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907663	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	2907664	CHEMBL1062785	Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	400.0	CHEMBL2553	Homo sapiens	Kd	nM	400.0
	2921984	CHEMBL1052952	Inhibition of RPS6KA1 kinase domain 1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	2921985	CHEMBL1052953	Inhibition of RPS6KA1 kinase domain 2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	2924705	CHEMBL1047337	Inhibition of RSK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	99.0	CHEMBL2553	Homo sapiens	Activity	%	99.0
	2924706	CHEMBL1047337	Inhibition of RSK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	105.0	CHEMBL2553	Homo sapiens	Activity	%	105.0
	2924707	CHEMBL1047337	Inhibition of RSK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	120.0	CHEMBL2553	Homo sapiens	Activity	%	120.0
	2924708	CHEMBL1047337	Inhibition of RSK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	38.0	CHEMBL2553	Homo sapiens	Activity	%	38.0
	2926197	CHEMBL1049411	Inhibition of RSK1 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	83.0	CHEMBL2553	Homo sapiens	Activity	%	83.0
	2926291	CHEMBL1057675	Inhibition of RSK1 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	88.0	CHEMBL2553	Homo sapiens	Activity	%	88.0
	2938443	CHEMBL1036945	Inhibition of RSK1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
Not Active	2938606	CHEMBL1040619	Inhibition of RSK1 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	2983222	CHEMBL1046259	Inhibition of RSK1	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	2998989	CHEMBL1048079	Inhibition of RSK1 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	79.0	CHEMBL2553	Homo sapiens	Activity	%	79.0
	2999779	CHEMBL1048079	Inhibition of RSK1 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	83.0	CHEMBL2553	Homo sapiens	Activity	%	83.0
	2999856	CHEMBL1048101	Inhibition of RSK1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	78.0	CHEMBL2553	Homo sapiens	Activity	%	78.0
	2999932	CHEMBL1048101	Inhibition of RSK1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	80.0	CHEMBL2553	Homo sapiens	Activity	%	80.0
Active	3005200	CHEMBL1042540	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 50 uM after 3 hrs by Western blotting	B	CCOc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL363555		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005202	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2ccc(F)cc2)C1=O		CHEMBL569743		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005203	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2cccc(F)c2)C1=O		CHEMBL577953		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005204	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2ccc([N+](=O)[O-])cc2)C1=O		CHEMBL576895		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005205	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2cccc([N+](=O)[O-])c2)C1=O		CHEMBL570003		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3005207	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2ccc(-c3ccc(Cl)cc3)cc2)C1=O		CHEMBL570004		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005209	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2ccccc2)C1=O		CHEMBL570390		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005211	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	COc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL570182		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005213	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	CCOc1cccc(/C=C2\SC(=O)N(CCN)C2=O)c1		CHEMBL569778		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005215	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	Cc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL576067		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005216	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	CCOc1ccc(/C=C2\SC(=O)N(CCN(C)C)C2=O)cc1		CHEMBL577105		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3005217	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	CCOc1ccc(/C=C2\SC(=O)N(CCNC(C)=O)C2=O)cc1		CHEMBL570425		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3005219	CHEMBL1042540	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 50 uM after 3 hrs by Western blotting	B	CN(C)CCN1C(=O)S/C(=C\C/C=C/c2ccccc2)C1=O		CHEMBL576088		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3005221	CHEMBL1042540	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2cccc3ccccc23)C1=O		CHEMBL577100		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3005224	CHEMBL1042540	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 50 uM after 3 hrs by Western blotting	B	NCCN1C(=O)S/C(=C\c2ccc3c(c2)OCCO3)C1=O		CHEMBL568808		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3005233	CHEMBL1042542	Inhibition of Rsk1 phosphorylation in PMA-stimulated human U937 cells at 10 to 50 uM after 3 hrs by Western blotting	B	CCOc1ccccc1/C=C1\SC(=O)N(CCN)C1=O		CHEMBL569545		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3006203	CHEMBL1047298	Inhibition of MAPKAPK-1a at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Active	3006204	CHEMBL1047298	Inhibition of MAPKAPK-1a at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Active	3006205	CHEMBL1047298	Inhibition of MAPKAPK-1a at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Active	3006206	CHEMBL1047298	Inhibition of MAPKAPK-1a at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL2553	Homo sapiens	Activity		
	3052471	CHEMBL1072509	Residual activity of RPS6KA1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	86.0	CHEMBL2553	Homo sapiens	Residual activity	%	86.0
	3052723	CHEMBL1043802	Residual activity of RPS6KA1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL2553	Homo sapiens	Residual activity	%	88.0
	3054032	CHEMBL1071362	Residual activity of RPS6KA1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	222.0	CHEMBL2553	Homo sapiens	Residual activity	%	222.0
	3055319	CHEMBL1072509	Residual activity of RPS6KA1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	81.0	CHEMBL2553	Homo sapiens	Residual activity	%	81.0
	3055571	CHEMBL1043802	Residual activity of RPS6KA1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	78.0	CHEMBL2553	Homo sapiens	Residual activity	%	78.0
	3056876	CHEMBL1071362	Residual activity of RPS6KA1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	206.0	CHEMBL2553	Homo sapiens	Residual activity	%	206.0
	3057128	CHEMBL1072509	Residual activity of RPS6KA1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	79.0	CHEMBL2553	Homo sapiens	Residual activity	%	79.0
	3058448	CHEMBL1043802	Residual activity of RPS6KA1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	74.0	CHEMBL2553	Homo sapiens	Residual activity	%	74.0
	3059732	CHEMBL1071362	Residual activity of RPS6KA1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	124.0	CHEMBL2553	Homo sapiens	Residual activity	%	124.0
	3089495	CHEMBL1067367	Inhibition of RSK1	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	11000.0	CHEMBL2553	Homo sapiens	IC50	nM	11000.0
	3094779	CHEMBL1068406	Inhibition of RSK1 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	3094789	CHEMBL1068406	Inhibition of RSK1 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	10.0	CHEMBL2553	Homo sapiens	INH	%	10.0
	3094803	CHEMBL1068406	Inhibition of RSK1 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	21.0	CHEMBL2553	Homo sapiens	INH	%	21.0
	3094814	CHEMBL1068406	Inhibition of RSK1 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	28.0	CHEMBL2553	Homo sapiens	INH	%	28.0
	3130805	CHEMBL1073734	Inhibition of MAPKAPK1A at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3131759	CHEMBL1065763	Inhibition of MAPKAPK1A at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3214037	CHEMBL1103232	Inhibition of RSK1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
	3219707	CHEMBL1114121	Inhibition of RSK1 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	97.0	CHEMBL2553	Homo sapiens	INH	%	97.0
	3219878	CHEMBL1114009	Inhibition of RSk1	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	nM	50000.0
	3219879	CHEMBL1114009	Inhibition of RSk1	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	nM	50000.0
	3220016	CHEMBL1115865	Inhibition of RSk1	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	9710.0	CHEMBL2553	Homo sapiens	IC50	uM	9.71
	3224952	CHEMBL1101756	Inhibition of RSK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3226331	CHEMBL1101756	Inhibition of RSK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3242229	CHEMBL1111615	Inhibition of RSK1	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	3251256	CHEMBL1107911	Inhibition of RSK1	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	45.9	CHEMBL2553	Homo sapiens	IC50	nM	45.9
	3261164	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	3261165	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	15.0	CHEMBL2553	Homo sapiens	INH	%	15.0
	3261166	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	10.0	CHEMBL2553	Homo sapiens	INH	%	10.0
	3261167	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
Not Determined	3261168	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	3261169	CHEMBL1112580	Inhibition of RSK1 at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
	3261345	CHEMBL1105201	Inhibition of RSK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	89.0	CHEMBL2553	Homo sapiens	Activity	%	89.0
	3261439	CHEMBL1105201	Inhibition of RSK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	72.0	CHEMBL2553	Homo sapiens	Activity	%	72.0
	3264382	CHEMBL1104651	Inhibition of RSK1	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
	3271250	CHEMBL1104651	Inhibition of RSK1	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL2553	Homo sapiens	IC50	uM	50.0
Not Active	3272536	CHEMBL1108320	Inhibition of RSK1	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272537	CHEMBL1108320	Inhibition of RSK1	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272538	CHEMBL1108320	Inhibition of RSK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272539	CHEMBL1108320	Inhibition of RSK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272540	CHEMBL1108320	Inhibition of RSK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272541	CHEMBL1108320	Inhibition of RSK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272542	CHEMBL1108320	Inhibition of RSK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272543	CHEMBL1108320	Inhibition of RSK1	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272544	CHEMBL1108320	Inhibition of RSK1	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3272545	CHEMBL1108320	Inhibition of RSK1	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	3272546	CHEMBL1108320	Inhibition of RSK1	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL2553	Homo sapiens	INH	%	20.0
Not Active	3272547	CHEMBL1108320	Inhibition of RSK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	3306915	CHEMBL1117940	Inhibition of MAPKAPK1A at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	31.0	CHEMBL2553	Homo sapiens	INH	%	31.0
	3316812	CHEMBL1120371	Inhibition of RSK1 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	3332138	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3332139	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3333553	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3333554	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3334958	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3334959	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3336378	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3336379	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3337642	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3337643	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3338973	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3338974	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3339227	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3339228	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3340530	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3340531	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3341920	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3341921	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3343367	CHEMBL1166849	Inhibition of RPS6KA1 N-terminal domain1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3343368	CHEMBL1166850	Inhibition of RPS6KA1 C-terminal domain2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	3354262	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	3354307	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	3354308	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	37.0	CHEMBL2553	Homo sapiens	INH	%	37.0
	3354309	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	14.0	CHEMBL2553	Homo sapiens	INH	%	14.0
	3354310	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	31.0	CHEMBL2553	Homo sapiens	INH	%	31.0
	3354311	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	45.0	CHEMBL2553	Homo sapiens	INH	%	45.0
	3354312	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	72.0	CHEMBL2553	Homo sapiens	INH	%	72.0
	3354313	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	39.0	CHEMBL2553	Homo sapiens	INH	%	39.0
	3354314	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	71.0	CHEMBL2553	Homo sapiens	INH	%	71.0
	3354315	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	64.0	CHEMBL2553	Homo sapiens	INH	%	64.0
	3354316	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	3354317	CHEMBL1173980	Inhibition of RSK1 at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	48.0	CHEMBL2553	Homo sapiens	INH	%	48.0
	3358798	CHEMBL1175326	Inhibition of RSK1 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	53.0	CHEMBL2553	Homo sapiens	INH	%	53.0
	3358799	CHEMBL1175327	Inhibition of RSK1 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	7.2	CHEMBL2553	Homo sapiens	INH	%	7.2
	3359240	CHEMBL1175326	Inhibition of RSK1 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	34.0	CHEMBL2553	Homo sapiens	INH	%	34.0
	3359241	CHEMBL1175327	Inhibition of RSK1 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
Active	3376390	CHEMBL1212297	Inhibition of RSK1 phosphorylation in human U937 cells at 3 uM by Western blotting	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	3400039	CHEMBL1217236	Inhibition of human Rsk1 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	95.0	CHEMBL2553	Homo sapiens	INH	%	95.0
Active	3419439	CHEMBL1225087	Binding affinity to RSK1 in HEK293 cells up to 300 nM by TAMRA-N3 reporter gene assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	3419441	CHEMBL1226193	Binding affinity to RSK1 in HEK293 cells at 100 nM by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Activity			CHEMBL2553	Homo sapiens	Activity		
Not Active	3419442	CHEMBL1225089	Inhibition of RSK1 phosphorylation in HEK293 cells at 100 nM by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	3419443	CHEMBL1225090	Inhibition of RSK1 phosphorylation in HEK293 cells at 3 uM after 1 hr by TAMARA-N3 assay in presence of 10% fetal bovine serum	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	3419446	CHEMBL1226196	Inhibition of RSK1 phosphorylation in HEK293 cells at saturating concentration by immunoprecipitation assay	B	Cc1ccc(-c2c(C(=O)CF)n(CCCNCC#N)c3ncnc(N)c23)cc1		CHEMBL1221698		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	3434699	CHEMBL1246568	Inhibition of RPS6KA1 at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	3443515	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	10.0	CHEMBL2553	Homo sapiens	INH	%	10.0
	3443732	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	3444887	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	3445293	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	290.0	CHEMBL2553	Homo sapiens	Kd	nM	290.0
	3445294	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	62.0	CHEMBL2553	Homo sapiens	Kd	nM	62.0
	3445511	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	3445728	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	21.0	CHEMBL2553	Homo sapiens	INH	%	21.0
	3445921	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	3446111	CHEMBL1244281	Inhibition of RSK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	3448044	CHEMBL1249681	Inhibition of human Rsk1 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	3448120	CHEMBL1249681	Inhibition of human Rsk1 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	58.0	CHEMBL2553	Homo sapiens	INH	%	58.0
	3448615	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3448616	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3449043	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	740.0	CHEMBL2553	Homo sapiens	Kd	nM	740.0
	3449044	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	260.0	CHEMBL2553	Homo sapiens	Kd	nM	260.0
	3449335	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL2553	Homo sapiens	Kd	nM	580.0
	3449336	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	96.0	CHEMBL2553	Homo sapiens	Kd	nM	96.0
	3449842	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3449843	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3450234	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3450235	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3451143	CHEMBL1244968	Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3451144	CHEMBL1244969	Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	uM	10.0
	3463348	CHEMBL1251681	Inhibition of RPS6KA1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	96.0	CHEMBL2553	Homo sapiens	INH	%	96.0
	3463892	CHEMBL1251681	Inhibition of RPS6KA1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	63.0	CHEMBL2553	Homo sapiens	INH	%	63.0
	3464111	CHEMBL1251681	Inhibition of RPS6KA1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	42.0	CHEMBL2553	Homo sapiens	INH	%	42.0
	3502344	CHEMBL1259607	Inhibition of Rsk1 at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12		CHEMBL1257283	>	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
	3526794	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	210.0	CHEMBL2553	Homo sapiens	IC50	uM	0.21
	3526802	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL324153	=	IC50	nM	2100.0	CHEMBL2553	Homo sapiens	IC50	uM	2.1
	3526810	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	O=c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)c[nH]1		CHEMBL1271480	=	IC50	nM	2100.0	CHEMBL2553	Homo sapiens	IC50	uM	2.1
	3526818	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	c1cc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)ccc1OCCN1CCOCC1		CHEMBL1271532	=	IC50	nM	220.0	CHEMBL2553	Homo sapiens	IC50	uM	0.22
	3526826	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	Nc1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL1271533	=	IC50	nM	1100.0	CHEMBL2553	Homo sapiens	IC50	uM	1.1
	3526834	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	Oc1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1O		CHEMBL1271641	=	IC50	nM	560.0	CHEMBL2553	Homo sapiens	IC50	uM	0.56
	3526842	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(O)c(O)c3)o2)cc1		CHEMBL1271642	=	IC50	nM	3400.0	CHEMBL2553	Homo sapiens	IC50	uM	3.4
	3527198	CHEMBL1272386	Inhibition of RSK1 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(=O)[nH]c3)o2)cc1		CHEMBL1271692	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	5120373	CHEMBL1646640	Inhibition of human Rsk1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	105.0	CHEMBL2553	Homo sapiens	INH	%	105.0
	5123818	CHEMBL1645762	Inhibition of RPS6KA1 kinase domain1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
	5133691	CHEMBL1648721	Inhibition of RSK1 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	79.0	CHEMBL2553	Homo sapiens	Activity	%	79.0
	5133786	CHEMBL1648721	Inhibition of RSK1 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	84.0	CHEMBL2553	Homo sapiens	Activity	%	84.0
	5133885	CHEMBL1648721	Inhibition of RSK1 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	84.0	CHEMBL2553	Homo sapiens	Activity	%	84.0
	5191347	CHEMBL1663975	Inhibition of RSK1 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	19.0	CHEMBL2553	Homo sapiens	INH	%	19.0
	5191348	CHEMBL1663975	Inhibition of RSK1 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	51.0	CHEMBL2553	Homo sapiens	INH	%	51.0
	5243764	CHEMBL1685868	Inhibition of Rsk1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	97.0	CHEMBL2553	Homo sapiens	INH	%	97.0
	5243872	CHEMBL1686084	Inhibition of Rsk1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	5243985	CHEMBL1685868	Inhibition of Rsk1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	5244093	CHEMBL1686084	Inhibition of Rsk1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	-1.0	CHEMBL2553	Homo sapiens	INH	%	-1.0
	5244966	CHEMBL1685868	Inhibition of Rsk1 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	5245074	CHEMBL1686084	Inhibition of Rsk1 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	5245225	CHEMBL1685868	Inhibition of Rsk1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	5246055	CHEMBL1686084	Inhibition of Rsk1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	104.0	CHEMBL2553	Homo sapiens	INH	%	104.0
	5250091	CHEMBL1685705	Inhibition of Rsk1 at 1 uM	B	CCOc1cc2nnc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL1683030	=	Inhibition	%	44.0	CHEMBL2553	Homo sapiens	INH	%	44.0
	5250092	CHEMBL1685706	Inhibition of Rsk1 at 0.1 uM	B	CCOc1cc2nnc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL1683030	=	Inhibition	%	7.0	CHEMBL2553	Homo sapiens	INH	%	7.0
	6167676	CHEMBL1769217	Inhibition of RSK1	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL2553	Homo sapiens	Ki	uM	1.0
	6169209	CHEMBL1769077	Inhibition of human RSK1 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	46.0	CHEMBL2553	Homo sapiens	Activity	%	46.0
	6220060	CHEMBL1786958	Inhibition of RPS6KA1 at 10 uM	B	CCCc1cnc(N)c(CNC(=S)Nc2ccc(NC(=O)OC(C)(C)C)cc2)n1		CHEMBL1783708	>	Inhibition	%	70.0	CHEMBL2553	Homo sapiens	INH	%	70.0
	6274428	CHEMBL1806009	Inhibition of RSK1 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	75.0	CHEMBL2553	Homo sapiens	Activity	%	75.0
	6314122	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	6314123	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	6314124	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	24.0	CHEMBL2553	Homo sapiens	INH	%	24.0
	6314125	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	22.0	CHEMBL2553	Homo sapiens	INH	%	22.0
	6314126	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	20.0	CHEMBL2553	Homo sapiens	INH	%	20.0
	6314127	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	7.0	CHEMBL2553	Homo sapiens	INH	%	7.0
	6314128	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	26.0	CHEMBL2553	Homo sapiens	INH	%	26.0
	6314129	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6314130	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	22.0	CHEMBL2553	Homo sapiens	INH	%	22.0
	6314131	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	16.0	CHEMBL2553	Homo sapiens	INH	%	16.0
	6314132	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	6314133	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	-9.0	CHEMBL2553	Homo sapiens	INH	%	-9.0
	6314134	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	46.0	CHEMBL2553	Homo sapiens	INH	%	46.0
	6314135	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	6314136	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	6314137	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	6314138	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
	6314139	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	18.0	CHEMBL2553	Homo sapiens	INH	%	18.0
	6314140	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	22.0	CHEMBL2553	Homo sapiens	INH	%	22.0
	6314141	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	14.0	CHEMBL2553	Homo sapiens	INH	%	14.0
	6314142	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	-5.0	CHEMBL2553	Homo sapiens	INH	%	-5.0
	6314143	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	18.0	CHEMBL2553	Homo sapiens	INH	%	18.0
	6314144	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1	Outside typical range	CHEMBL1813630	=	Inhibition	%	-11.0	CHEMBL2553	Homo sapiens	INH	%	-11.0
	6314145	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	6314146	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	-6.0	CHEMBL2553	Homo sapiens	INH	%	-6.0
	6314147	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	-2.0	CHEMBL2553	Homo sapiens	INH	%	-2.0
	6314148	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	16.0	CHEMBL2553	Homo sapiens	INH	%	16.0
	6314149	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	23.0	CHEMBL2553	Homo sapiens	INH	%	23.0
	6314150	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	6314151	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	-5.0	CHEMBL2553	Homo sapiens	INH	%	-5.0
	6314152	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	-4.0	CHEMBL2553	Homo sapiens	INH	%	-4.0
	6314153	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	-3.0	CHEMBL2553	Homo sapiens	INH	%	-3.0
	6314154	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	6314155	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1	Outside typical range	CHEMBL1813788	=	Inhibition	%	-11.0	CHEMBL2553	Homo sapiens	INH	%	-11.0
	6314156	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	6314157	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	38.0	CHEMBL2553	Homo sapiens	INH	%	38.0
	6314158	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	6314159	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	6314160	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	6314161	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	19.0	CHEMBL2553	Homo sapiens	INH	%	19.0
	6314162	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	6314163	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	6314164	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	-2.0	CHEMBL2553	Homo sapiens	INH	%	-2.0
	6314165	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	6314166	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	6314167	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	6314168	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	-3.0	CHEMBL2553	Homo sapiens	INH	%	-3.0
	6314169	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	6314170	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	-3.0	CHEMBL2553	Homo sapiens	INH	%	-3.0
	6314171	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	-4.0	CHEMBL2553	Homo sapiens	INH	%	-4.0
	6314172	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	14.0	CHEMBL2553	Homo sapiens	INH	%	14.0
	6314173	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1	Outside typical range	CHEMBL1813807	=	Inhibition	%	-23.0	CHEMBL2553	Homo sapiens	INH	%	-23.0
	6314174	CHEMBL1815692	Inhibition of RSK1 at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	89.0	CHEMBL2553	Homo sapiens	INH	%	89.0
	6352274	CHEMBL1826251	Inhibition of RSK1 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	93.0	CHEMBL2553	Homo sapiens	Activity	%	93.0
	6360097	CHEMBL1832355	Inhibition of Rsk1 at 5 uM assessed as remaining activity	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	Activity	%	65.0	CHEMBL2553	Homo sapiens	Activity	%	65.0
	6370090	CHEMBL1833746	Inhibition of MAPKAP-K1a at 10 uM	B	Cc1ccc(C(=O)N(CCCN)C(c2nc3snc(C)c3c(=O)n2Cc2ccccc2)C(C)C)cc1		CHEMBL1829433	=	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6385568	CHEMBL1837947	Inhibition of human RSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6385569	CHEMBL1837947	Inhibition of human RSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6385570	CHEMBL1837947	Inhibition of human RSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6385571	CHEMBL1837947	Inhibition of human RSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	6385572	CHEMBL1837947	Inhibition of human RSK1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	7567295	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7567296	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7567754	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7567755	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1400.0	CHEMBL2553	Homo sapiens	Kd	nM	1400.0
	7568225	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7568226	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7568251	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7568252	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7568683	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	180.0	CHEMBL2553	Homo sapiens	Kd	nM	180.0
	7568684	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	5800.0	CHEMBL2553	Homo sapiens	Kd	nM	5800.0
	7569268	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7569269	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7569728	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7569729	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7570221	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7570222	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7570648	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	140.0	CHEMBL2553	Homo sapiens	Kd	nM	140.0
	7570649	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5000.0	CHEMBL2553	Homo sapiens	Kd	nM	5000.0
	7571244	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	5400.0	CHEMBL2553	Homo sapiens	Kd	nM	5400.0
	7571245	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7571735	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7571736	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	120.0	CHEMBL2553	Homo sapiens	Kd	nM	120.0
	7572198	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7572199	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7572614	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	160.0	CHEMBL2553	Homo sapiens	Kd	nM	160.0
	7572615	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	650.0	CHEMBL2553	Homo sapiens	Kd	nM	650.0
	7573225	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	180.0	CHEMBL2553	Homo sapiens	Kd	nM	180.0
	7573226	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7573240	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7573241	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7573716	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2100.0	CHEMBL2553	Homo sapiens	Kd	nM	2100.0
	7573717	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7574185	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	690.0	CHEMBL2553	Homo sapiens	Kd	nM	690.0
	7574186	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7574593	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7574594	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	220.0	CHEMBL2553	Homo sapiens	Kd	nM	220.0
	7575222	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7575223	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7575693	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7575694	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7576158	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7576159	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7576566	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1200.0	CHEMBL2553	Homo sapiens	Kd	nM	1200.0
	7576567	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	420.0	CHEMBL2553	Homo sapiens	Kd	nM	420.0
	7576735	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7576736	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7577194	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7577195	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7577672	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	3400.0	CHEMBL2553	Homo sapiens	Kd	nM	3400.0
	7577673	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7578142	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2100.0	CHEMBL2553	Homo sapiens	Kd	nM	2100.0
	7578143	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7578547	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7578548	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	400.0	CHEMBL2553	Homo sapiens	Kd	nM	400.0
	7578743	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7578744	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7579117	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7579118	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7579567	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2300.0	CHEMBL2553	Homo sapiens	Kd	nM	2300.0
	7579568	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	720.0	CHEMBL2553	Homo sapiens	Kd	nM	720.0
	7580041	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7580042	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7580510	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7580511	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7580913	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	7900.0	CHEMBL2553	Homo sapiens	Kd	nM	7900.0
	7580914	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7581101	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7581102	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7581486	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7581487	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	3300.0	CHEMBL2553	Homo sapiens	Kd	nM	3300.0
	7581931	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7581932	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7582402	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	1600.0	CHEMBL2553	Homo sapiens	Kd	nM	1600.0
	7582403	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7583447	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7583448	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7583844	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7583845	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7584289	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7584290	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7584780	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	490.0	CHEMBL2553	Homo sapiens	Kd	nM	490.0
	7584781	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	3800.0	CHEMBL2553	Homo sapiens	Kd	nM	3800.0
	7585184	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7585185	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7585777	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7585778	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7586185	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7586186	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7586631	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7586632	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7586660	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	400.0	CHEMBL2553	Homo sapiens	Kd	nM	400.0
	7586661	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7587114	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7587115	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7587738	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7587739	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7588157	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	28.0	CHEMBL2553	Homo sapiens	Kd	nM	28.0
	7588158	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2400.0	CHEMBL2553	Homo sapiens	Kd	nM	2400.0
	7588639	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7588640	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7589090	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7589091	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	320.0	CHEMBL2553	Homo sapiens	Kd	nM	320.0
	7589703	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7589704	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7590152	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	410.0	CHEMBL2553	Homo sapiens	Kd	nM	410.0
	7590153	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7590626	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7590627	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7591077	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7591078	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7591656	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	450.0	CHEMBL2553	Homo sapiens	Kd	nM	450.0
	7591657	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7592128	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7592129	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7592601	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	4800.0	CHEMBL2553	Homo sapiens	Kd	nM	4800.0
	7592602	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593054	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593055	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593201	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593202	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593636	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7593637	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7594108	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7594109	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7594581	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7594582	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595033	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595034	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595169	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595170	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595613	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7595614	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	6200.0	CHEMBL2553	Homo sapiens	Kd	nM	6200.0
	7596087	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7596088	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7596558	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7596559	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7597141	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7597142	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7597594	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7597595	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7598067	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	7400.0	CHEMBL2553	Homo sapiens	Kd	nM	7400.0
	7598068	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2553	Homo sapiens	Kd	nM	10000.0
	7598537	CHEMBL1908597	Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	43.0	CHEMBL2553	Homo sapiens	Kd	nM	43.0
	7598538	CHEMBL1908598	Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1200.0	CHEMBL2553	Homo sapiens	Kd	nM	1200.0
	7841901	CHEMBL1913892	Inhibition of RSK1 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	=	IC50	nM	1181.0	CHEMBL2553	Homo sapiens	IC50	nM	1181.0
	7841907	CHEMBL1913892	Inhibition of RSK1 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	131.3	CHEMBL2553	Homo sapiens	IC50	nM	131.3
	7841914	CHEMBL1913892	Inhibition of RSK1 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	20000.0	CHEMBL2553	Homo sapiens	IC50	nM	20000.0
	7841921	CHEMBL1913892	Inhibition of RSK1 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	0.5	CHEMBL2553	Homo sapiens	IC50	nM	0.5
	7922642	CHEMBL1919006	Inhibition of human recombinant RPS6KA1 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	94.0	CHEMBL2553	Homo sapiens	INH	%	94.0
	7931133	CHEMBL1919470	Inhibition of RSK1 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	7939958	CHEMBL1919627	Inhibition of human Rsk1	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	7960789	CHEMBL1932542	Inhibition of RSK1 assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	4.0	CHEMBL2553	Homo sapiens	Activity	%	4.0
	7960790	CHEMBL1932543	Inhibition of RSK1 assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	2.0	CHEMBL2553	Homo sapiens	Activity	%	2.0
	7960998	CHEMBL1932623	Inhibition of RSK1 assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	18.0	CHEMBL2553	Homo sapiens	Activity	%	18.0
	7960999	CHEMBL1932624	Inhibition of RSK1 assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	5.0	CHEMBL2553	Homo sapiens	Activity	%	5.0
	7961155	CHEMBL1931559	Inhibition of RSK1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2553	Homo sapiens	IC50	uM	30.0
	7961156	CHEMBL1931559	Inhibition of RSK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2553	Homo sapiens	IC50	uM	30.0
	7969792	CHEMBL1930364	Inhibition of RSK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	93.0	CHEMBL2553	Homo sapiens	Activity	%	93.0
	7971381	CHEMBL1929903	Inhibition of RSK1 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	7978804	CHEMBL1930057	Inhibition of human RSK1 at 1 uM	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	94.0	CHEMBL2553	Homo sapiens	INH	%	94.0
	7982609	CHEMBL1936991	Inhibition of RPS6KA1 kinase at 10 uM after 1 hr by competitive binding assay	B	CCOC(=O)C[C@@H]1[C@@H](CNC(=O)NC)O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@@H]1O[Si](C)(C)C(C)(C)C		CHEMBL1076310	=	Inhibition	%	40.0	CHEMBL2553	Homo sapiens	INH	%	40.0
	7996720	CHEMBL1944372	Inhibition of RPS6KA1(Kin.Dom.1) at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
	8018906	CHEMBL1949064	Inhibition of Rsk1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	93.0	CHEMBL2553	Homo sapiens	Activity	%	93.0
	8018907	CHEMBL1949064	Inhibition of Rsk1 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	89.0	CHEMBL2553	Homo sapiens	Activity	%	89.0
	8018908	CHEMBL1949064	Inhibition of Rsk1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	74.0	CHEMBL2553	Homo sapiens	Activity	%	74.0
	8047303	CHEMBL1960789	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	IC50	nM	132.0	CHEMBL2553	Homo sapiens	IC50	nM	132.0
	8047304	CHEMBL1960789	Inhibition of RSK1	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21		CHEMBL1956071	=	IC50	nM	35.0	CHEMBL2553	Homo sapiens	IC50	nM	35.0
	8049886	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957497	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049887	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)cn3c2Br)CC1		CHEMBL1957498	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049888	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(C#N)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957499	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049889	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957500	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049890	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957502	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049891	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	O=C(NCCN1CCOCC1)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957504	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049892	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	CN(C)CCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957505	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8049893	CHEMBL1959622	Inhibition of RPS6KA1 at 5 to 10 uM	B	COCCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957508	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	8061245	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.63	CHEMBL2553	Homo sapiens	Inhibition	%	-0.63
	8061422	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.82	CHEMBL2553	Homo sapiens	Inhibition	%	3.82
	8061646	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.97	CHEMBL2553	Homo sapiens	Inhibition	%	1.97
	8061753	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.83	CHEMBL2553	Homo sapiens	Inhibition	%	4.83
	8061944	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.08	CHEMBL2553	Homo sapiens	Inhibition	%	0.08
	8062168	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.16	CHEMBL2553	Homo sapiens	Inhibition	%	5.16
	8062284	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	9.65	CHEMBL2553	Homo sapiens	Inhibition	%	9.65
	8062670	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.06	CHEMBL2553	Homo sapiens	Inhibition	%	2.06
	8062768	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.69	CHEMBL2553	Homo sapiens	Inhibition	%	0.69
	8062992	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.43	CHEMBL2553	Homo sapiens	Inhibition	%	0.43
	8063124	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.3	CHEMBL2553	Homo sapiens	Inhibition	%	1.3
	8063515	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.11	CHEMBL2553	Homo sapiens	Inhibition	%	4.11
	8063623	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.09	CHEMBL2553	Homo sapiens	Inhibition	%	1.09
	8064029	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.14	CHEMBL2553	Homo sapiens	Inhibition	%	1.14
	8064144	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	44.77	CHEMBL2553	Homo sapiens	Inhibition	%	44.77
	8064368	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	26.05	CHEMBL2553	Homo sapiens	Inhibition	%	26.05
	8064578	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.71	CHEMBL2553	Homo sapiens	Inhibition	%	0.71
	8064716	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.28	CHEMBL2553	Homo sapiens	Inhibition	%	0.28
	8065106	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.22	CHEMBL2553	Homo sapiens	Inhibition	%	0.22
	8065222	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.33	CHEMBL2553	Homo sapiens	Inhibition	%	2.33
	8065446	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.44	CHEMBL2553	Homo sapiens	Inhibition	%	1.44
	8065621	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.1	CHEMBL2553	Homo sapiens	Inhibition	%	5.1
	8065960	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	68.3	CHEMBL2553	Homo sapiens	Inhibition	%	68.3
	8066170	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.37	CHEMBL2553	Homo sapiens	Inhibition	%	5.37
	8066306	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.18	CHEMBL2553	Homo sapiens	Inhibition	%	2.18
	8066530	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.35	CHEMBL2553	Homo sapiens	Inhibition	%	1.35
	8066696	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.59	CHEMBL2553	Homo sapiens	Inhibition	%	2.59
	8067044	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.53	CHEMBL2553	Homo sapiens	Inhibition	%	1.53
	8067219	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8067564	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.48	CHEMBL2553	Homo sapiens	Inhibition	%	1.48
	8067774	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	35.24	CHEMBL2553	Homo sapiens	Inhibition	%	35.24
	8068133	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.27	CHEMBL2553	Homo sapiens	Inhibition	%	3.27
	8068297	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.19	CHEMBL2553	Homo sapiens	Inhibition	%	0.19
	8068646	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.41	CHEMBL2553	Homo sapiens	Inhibition	%	1.41
	8068820	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.31	CHEMBL2553	Homo sapiens	Inhibition	%	0.31
	8069044	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.79	CHEMBL2553	Homo sapiens	Inhibition	%	0.79
	8069169	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.42	CHEMBL2553	Homo sapiens	Inhibition	%	4.42
	8069464	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.14	CHEMBL2553	Homo sapiens	Inhibition	%	3.14
	8069625	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.79	CHEMBL2553	Homo sapiens	Inhibition	%	3.79
	8069849	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.28	CHEMBL2553	Homo sapiens	Inhibition	%	2.28
	8069975	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.35	CHEMBL2553	Homo sapiens	Inhibition	%	2.35
	8070371	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.09	CHEMBL2553	Homo sapiens	Inhibition	%	0.09
	8070496	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.37	CHEMBL2553	Homo sapiens	Inhibition	%	-0.37
	8070720	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.19	CHEMBL2553	Homo sapiens	Inhibition	%	1.19
	8070794	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	18.54	CHEMBL2553	Homo sapiens	Inhibition	%	18.54
	8071175	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.19	CHEMBL2553	Homo sapiens	Inhibition	%	4.19
	8071301	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.36	CHEMBL2553	Homo sapiens	Inhibition	%	-0.36
	8071525	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.1	CHEMBL2553	Homo sapiens	Inhibition	%	0.1
	8071698	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.12	CHEMBL2553	Homo sapiens	Inhibition	%	1.12
	8072047	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.59	CHEMBL2553	Homo sapiens	Inhibition	%	1.59
	8072137	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.53	CHEMBL2553	Homo sapiens	Inhibition	%	0.53
	8072361	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.21	CHEMBL2553	Homo sapiens	Inhibition	%	0.21
	8072518	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.66	CHEMBL2553	Homo sapiens	Inhibition	%	1.66
	8072867	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.72	CHEMBL2553	Homo sapiens	Inhibition	%	-0.72
	8073034	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.1	CHEMBL2553	Homo sapiens	Inhibition	%	-0.1
	8073383	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.46	CHEMBL2553	Homo sapiens	Inhibition	%	2.46
	8073502	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.21	CHEMBL2553	Homo sapiens	Inhibition	%	0.21
	8073726	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.22	CHEMBL2553	Homo sapiens	Inhibition	%	0.22
	8073959	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.05	CHEMBL2553	Homo sapiens	Inhibition	%	2.05
	8074111	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.06	CHEMBL2553	Homo sapiens	Inhibition	%	4.06
	8074465	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.84	CHEMBL2553	Homo sapiens	Inhibition	%	0.84
	8074622	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.2	CHEMBL2553	Homo sapiens	Inhibition	%	1.2
	8074846	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.63	CHEMBL2553	Homo sapiens	Inhibition	%	0.63
	8074973	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.19	CHEMBL2553	Homo sapiens	Inhibition	%	0.19
	8075308	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.49	CHEMBL2553	Homo sapiens	Inhibition	%	-1.49
	8075545	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.13	CHEMBL2553	Homo sapiens	Inhibition	%	1.13
	8075686	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.51	CHEMBL2553	Homo sapiens	Inhibition	%	1.51
	8075910	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.92	CHEMBL2553	Homo sapiens	Inhibition	%	2.92
	8076052	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.85	CHEMBL2553	Homo sapiens	Inhibition	%	0.85
	8076424	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.33	CHEMBL2553	Homo sapiens	Inhibition	%	0.33
	8076558	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.05	CHEMBL2553	Homo sapiens	Inhibition	%	3.05
	8076884	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-3.25	CHEMBL2553	Homo sapiens	Inhibition	%	-3.25
	8077131	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	19.05	CHEMBL2553	Homo sapiens	Inhibition	%	19.05
	8077483	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.66	CHEMBL2553	Homo sapiens	Inhibition	%	1.66
	8077634	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	3.85	CHEMBL2553	Homo sapiens	Inhibition	%	3.85
	8078001	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.89	CHEMBL2553	Homo sapiens	Inhibition	%	-0.89
	8078140	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.13	CHEMBL2553	Homo sapiens	Inhibition	%	4.13
	8078364	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	32.57	CHEMBL2553	Homo sapiens	Inhibition	%	32.57
	8078466	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.46	CHEMBL2553	Homo sapiens	Inhibition	%	-1.46
	8078716	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	71.6	CHEMBL2553	Homo sapiens	Inhibition	%	71.6
	8079056	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.77	CHEMBL2553	Homo sapiens	Inhibition	%	3.77
	8079214	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.36	CHEMBL2553	Homo sapiens	Inhibition	%	0.36
	8079438	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.32	CHEMBL2553	Homo sapiens	Inhibition	%	3.32
	8079580	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.15	CHEMBL2553	Homo sapiens	Inhibition	%	-0.15
	8079943	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	37.38	CHEMBL2553	Homo sapiens	Inhibition	%	37.38
	8080048	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.99	CHEMBL2553	Homo sapiens	Inhibition	%	-1.99
	8080272	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.2	CHEMBL2553	Homo sapiens	Inhibition	%	1.2
	8080300	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	6.23	CHEMBL2553	Homo sapiens	Inhibition	%	6.23
	8080524	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	32.42	CHEMBL2553	Homo sapiens	Inhibition	%	32.42
	8080639	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.33	CHEMBL2553	Homo sapiens	Inhibition	%	0.33
	8081027	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.25	CHEMBL2553	Homo sapiens	Inhibition	%	-1.25
	8081162	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.56	CHEMBL2553	Homo sapiens	Inhibition	%	-0.56
	8081530	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	69.66	CHEMBL2553	Homo sapiens	Inhibition	%	69.66
	8081857	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	7.59	CHEMBL2553	Homo sapiens	Inhibition	%	7.59
	8082109	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	52.1	CHEMBL2553	Homo sapiens	Inhibition	%	52.1
	8082222	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.98	CHEMBL2553	Homo sapiens	Inhibition	%	0.98
	8082446	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.08	CHEMBL2553	Homo sapiens	Inhibition	%	1.08
	8082619	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.83	CHEMBL2553	Homo sapiens	Inhibition	%	1.83
	8082742	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.52	CHEMBL2553	Homo sapiens	Inhibition	%	1.52
	8082966	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.45	CHEMBL2553	Homo sapiens	Inhibition	%	1.45
	8083122	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.58	CHEMBL2553	Homo sapiens	Inhibition	%	2.58
	8083445	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.15	CHEMBL2553	Homo sapiens	Inhibition	%	-0.15
	8083699	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	86.39	CHEMBL2553	Homo sapiens	Inhibition	%	86.39
	8084033	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.9	CHEMBL2553	Homo sapiens	Inhibition	%	4.9
	8084218	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	6.2	CHEMBL2553	Homo sapiens	Inhibition	%	6.2
	8084560	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.98	CHEMBL2553	Homo sapiens	Inhibition	%	0.98
	8084721	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	7.85	CHEMBL2553	Homo sapiens	Inhibition	%	7.85
	8085043	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.83	CHEMBL2553	Homo sapiens	Inhibition	%	-0.83
	8085299	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.68	CHEMBL2553	Homo sapiens	Inhibition	%	1.68
	8085631	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.76	CHEMBL2553	Homo sapiens	Inhibition	%	1.76
	8085820	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	30.6	CHEMBL2553	Homo sapiens	Inhibition	%	30.6
	8086159	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.04	CHEMBL2553	Homo sapiens	Inhibition	%	3.04
	8086321	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.66	CHEMBL2553	Homo sapiens	Inhibition	%	2.66
	8086545	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.58	CHEMBL2553	Homo sapiens	Inhibition	%	5.58
	8086644	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.57	CHEMBL2553	Homo sapiens	Inhibition	%	0.57
	8086855	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.04	CHEMBL2553	Homo sapiens	Inhibition	%	1.04
	8087079	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.53	CHEMBL2553	Homo sapiens	Inhibition	%	4.53
	8087237	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.56	CHEMBL2553	Homo sapiens	Inhibition	%	0.56
	8087575	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.8	CHEMBL2553	Homo sapiens	Inhibition	%	0.8
	8087713	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.31	CHEMBL2553	Homo sapiens	Inhibition	%	3.31
	8087937	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.66	CHEMBL2553	Homo sapiens	Inhibition	%	-0.66
	8088079	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.1	CHEMBL2553	Homo sapiens	Inhibition	%	3.1
	8088227	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.14	CHEMBL2553	Homo sapiens	Inhibition	%	-1.14
	8088451	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.41	CHEMBL2553	Homo sapiens	Inhibition	%	0.41
	8088579	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.94	CHEMBL2553	Homo sapiens	Inhibition	%	1.94
	8088896	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	58.29	CHEMBL2553	Homo sapiens	Inhibition	%	58.29
	8089248	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.33	CHEMBL2553	Homo sapiens	Inhibition	%	7.33
	8089396	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.45	CHEMBL2553	Homo sapiens	Inhibition	%	2.45
	8089740	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.95	CHEMBL2553	Homo sapiens	Inhibition	%	1.95
	8089920	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.53	CHEMBL2553	Homo sapiens	Inhibition	%	0.53
	8090309	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	20.14	CHEMBL2553	Homo sapiens	Inhibition	%	20.14
	8090476	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.44	CHEMBL2553	Homo sapiens	Inhibition	%	1.44
	8090839	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.06	CHEMBL2553	Homo sapiens	Inhibition	%	0.06
	8091044	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.15	CHEMBL2553	Homo sapiens	Inhibition	%	2.15
	8091405	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	19.82	CHEMBL2553	Homo sapiens	Inhibition	%	19.82
	8091560	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.53	CHEMBL2553	Homo sapiens	Inhibition	%	0.53
	8091900	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	23.53	CHEMBL2553	Homo sapiens	Inhibition	%	23.53
	8092261	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.32	CHEMBL2553	Homo sapiens	Inhibition	%	-0.32
	8092412	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.03	CHEMBL2553	Homo sapiens	Inhibition	%	-0.03
	8092784	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.29	CHEMBL2553	Homo sapiens	Inhibition	%	-0.29
	8092913	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.51	CHEMBL2553	Homo sapiens	Inhibition	%	4.51
	8093137	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.02	CHEMBL2553	Homo sapiens	Inhibition	%	-0.02
	8093225	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.23	CHEMBL2553	Homo sapiens	Inhibition	%	1.23
	8093589	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.16	CHEMBL2553	Homo sapiens	Inhibition	%	2.16
	8093728	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	12.42	CHEMBL2553	Homo sapiens	Inhibition	%	12.42
	8093952	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.21	CHEMBL2553	Homo sapiens	Inhibition	%	1.21
	8094072	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.76	CHEMBL2553	Homo sapiens	Inhibition	%	5.76
	8094252	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.75	CHEMBL2553	Homo sapiens	Inhibition	%	0.75
	8094476	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.35	CHEMBL2553	Homo sapiens	Inhibition	%	1.35
	8094651	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	21.98	CHEMBL2553	Homo sapiens	Inhibition	%	21.98
	8094807	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.36	CHEMBL2553	Homo sapiens	Inhibition	%	5.36
	8095031	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.08	CHEMBL2553	Homo sapiens	Inhibition	%	2.08
	8095171	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.25	CHEMBL2553	Homo sapiens	Inhibition	%	0.25
	8095374	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.81	CHEMBL2553	Homo sapiens	Inhibition	%	3.81
	8095598	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.57	CHEMBL2553	Homo sapiens	Inhibition	%	0.57
	8095739	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	54.56	CHEMBL2553	Homo sapiens	Inhibition	%	54.56
	8095887	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.76	CHEMBL2553	Homo sapiens	Inhibition	%	0.76
	8096111	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.15	CHEMBL2553	Homo sapiens	Inhibition	%	2.15
	8096228	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.78	CHEMBL2553	Homo sapiens	Inhibition	%	1.78
	8096591	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.27	CHEMBL2553	Homo sapiens	Inhibition	%	-1.27
	8096747	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.94	CHEMBL2553	Homo sapiens	Inhibition	%	1.94
	8096971	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.42	CHEMBL2553	Homo sapiens	Inhibition	%	2.42
	8097118	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.48	CHEMBL2553	Homo sapiens	Inhibition	%	-0.48
	8097425	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.41	CHEMBL2553	Homo sapiens	Inhibition	%	2.41
	8097649	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.76	CHEMBL2553	Homo sapiens	Inhibition	%	2.76
	8097799	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	21.43	CHEMBL2553	Homo sapiens	Inhibition	%	21.43
	8098156	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.55	CHEMBL2553	Homo sapiens	Inhibition	%	2.55
	8098276	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.37	CHEMBL2553	Homo sapiens	Inhibition	%	0.37
	8098500	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.21	CHEMBL2553	Homo sapiens	Inhibition	%	0.21
	8098680	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.1	CHEMBL2553	Homo sapiens	Inhibition	%	-0.1
	8098865	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	65.34	CHEMBL2553	Homo sapiens	Inhibition	%	65.34
	8099233	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.82	CHEMBL2553	Homo sapiens	Inhibition	%	2.82
	8099375	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8099793	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.36	CHEMBL2553	Homo sapiens	Inhibition	%	0.36
	8099940	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.5	CHEMBL2553	Homo sapiens	Inhibition	%	2.5
	8100310	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.32	CHEMBL2553	Homo sapiens	Inhibition	%	-0.32
	8100426	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.59	CHEMBL2553	Homo sapiens	Inhibition	%	5.59
	8100650	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.36	CHEMBL2553	Homo sapiens	Inhibition	%	0.36
	8100790	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.75	CHEMBL2553	Homo sapiens	Inhibition	%	0.75
	8101174	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.51	CHEMBL2553	Homo sapiens	Inhibition	%	4.51
	8101316	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.23	CHEMBL2553	Homo sapiens	Inhibition	%	0.23
	8101725	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.44	CHEMBL2553	Homo sapiens	Inhibition	%	0.44
	8101978	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	7.19	CHEMBL2553	Homo sapiens	Inhibition	%	7.19
	8102133	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.17	CHEMBL2553	Homo sapiens	Inhibition	%	-0.17
	8102488	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.82	CHEMBL2553	Homo sapiens	Inhibition	%	0.82
	8102832	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.5	CHEMBL2553	Homo sapiens	Inhibition	%	-1.5
	8103010	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.39	CHEMBL2553	Homo sapiens	Inhibition	%	1.39
	8103206	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.36	CHEMBL2553	Homo sapiens	Inhibition	%	3.36
	8103568	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.2	CHEMBL2553	Homo sapiens	Inhibition	%	-1.2
	8103718	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.01	CHEMBL2553	Homo sapiens	Inhibition	%	2.01
	8103942	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.1	CHEMBL2553	Homo sapiens	Inhibition	%	1.1
	8104127	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.78	CHEMBL2553	Homo sapiens	Inhibition	%	-0.78
	8104275	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.59	CHEMBL2553	Homo sapiens	Inhibition	%	6.59
	8104499	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.39	CHEMBL2553	Homo sapiens	Inhibition	%	3.39
	8104645	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.8	CHEMBL2553	Homo sapiens	Inhibition	%	3.8
	8104983	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.46	CHEMBL2553	Homo sapiens	Inhibition	%	1.46
	8105123	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.43	CHEMBL2553	Homo sapiens	Inhibition	%	-0.43
	8105347	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.6	CHEMBL2553	Homo sapiens	Inhibition	%	-0.6
	8105513	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.3	CHEMBL2553	Homo sapiens	Inhibition	%	2.3
	8105651	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.07	CHEMBL2553	Homo sapiens	Inhibition	%	3.07
	8105875	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.54	CHEMBL2553	Homo sapiens	Inhibition	%	1.54
	8105931	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.12	CHEMBL2553	Homo sapiens	Inhibition	%	0.12
	8106155	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-1.94	CHEMBL2553	Homo sapiens	Inhibition	%	-1.94
	8106320	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.04	CHEMBL2553	Homo sapiens	Inhibition	%	2.04
	8106476	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.69	CHEMBL2553	Homo sapiens	Inhibition	%	7.69
	8106700	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	20.06	CHEMBL2553	Homo sapiens	Inhibition	%	20.06
	8106829	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.22	CHEMBL2553	Homo sapiens	Inhibition	%	5.22
	8107174	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.29	CHEMBL2553	Homo sapiens	Inhibition	%	1.29
	8107346	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.6	CHEMBL2553	Homo sapiens	Inhibition	%	1.6
	8107547	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	12.81	CHEMBL2553	Homo sapiens	Inhibition	%	12.81
	8107771	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.35	CHEMBL2553	Homo sapiens	Inhibition	%	2.35
	8107906	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.35	CHEMBL2553	Homo sapiens	Inhibition	%	1.35
	8108288	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.58	CHEMBL2553	Homo sapiens	Inhibition	%	2.58
	8108463	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.39	CHEMBL2553	Homo sapiens	Inhibition	%	0.39
	8108834	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	16.79	CHEMBL2553	Homo sapiens	Inhibition	%	16.79
	8108976	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-1.65	CHEMBL2553	Homo sapiens	Inhibition	%	-1.65
	8109314	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.47	CHEMBL2553	Homo sapiens	Inhibition	%	1.47
	8109668	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.45	CHEMBL2553	Homo sapiens	Inhibition	%	-0.45
	8109839	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	12.43	CHEMBL2553	Homo sapiens	Inhibition	%	12.43
	8110195	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.99	CHEMBL2553	Homo sapiens	Inhibition	%	1.99
	8110474	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.59	CHEMBL2553	Homo sapiens	Inhibition	%	1.59
	8110640	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.02	CHEMBL2553	Homo sapiens	Inhibition	%	4.02
	8111022	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	68.26	CHEMBL2553	Homo sapiens	Inhibition	%	68.26
	8111145	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.07	CHEMBL2553	Homo sapiens	Inhibition	%	1.07
	8111496	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.68	CHEMBL2553	Homo sapiens	Inhibition	%	-0.68
	8111662	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.97	CHEMBL2553	Homo sapiens	Inhibition	%	2.97
	8111886	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.63	CHEMBL2553	Homo sapiens	Inhibition	%	0.63
	8112091	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.99	CHEMBL2553	Homo sapiens	Inhibition	%	2.99
	8112228	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.25	CHEMBL2553	Homo sapiens	Inhibition	%	-1.25
	8112452	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.11	CHEMBL2553	Homo sapiens	Inhibition	%	-0.11
	8112620	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.93	CHEMBL2553	Homo sapiens	Inhibition	%	2.93
	8112792	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.19	CHEMBL2553	Homo sapiens	Inhibition	%	0.19
	8113016	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.1	CHEMBL2553	Homo sapiens	Inhibition	%	-0.1
	8113168	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.22	CHEMBL2553	Homo sapiens	Inhibition	%	0.22
	8113304	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.43	CHEMBL2553	Homo sapiens	Inhibition	%	1.43
	8113528	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.36	CHEMBL2553	Homo sapiens	Inhibition	%	0.36
	8113652	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.71	CHEMBL2553	Homo sapiens	Inhibition	%	2.71
	8113992	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.1	CHEMBL2553	Homo sapiens	Inhibition	%	1.1
	8114168	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.96	CHEMBL2553	Homo sapiens	Inhibition	%	0.96
	8114524	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.09	CHEMBL2553	Homo sapiens	Inhibition	%	2.09
	8114800	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.15	CHEMBL2553	Homo sapiens	Inhibition	%	0.15
	8114966	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	9.06	CHEMBL2553	Homo sapiens	Inhibition	%	9.06
	8115190	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	46.62	CHEMBL2553	Homo sapiens	Inhibition	%	46.62
	8115355	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.35	CHEMBL2553	Homo sapiens	Inhibition	%	3.35
	8115475	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.59	CHEMBL2553	Homo sapiens	Inhibition	%	1.59
	8115699	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.4	CHEMBL2553	Homo sapiens	Inhibition	%	1.4
	8115832	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	23.27	CHEMBL2553	Homo sapiens	Inhibition	%	23.27
	8116215	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.49	CHEMBL2553	Homo sapiens	Inhibition	%	3.49
	8116418	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.38	CHEMBL2553	Homo sapiens	Inhibition	%	2.38
	8116776	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.52	CHEMBL2553	Homo sapiens	Inhibition	%	0.52
	8116948	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.15	CHEMBL2553	Homo sapiens	Inhibition	%	6.15
	8117343	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.2	CHEMBL2553	Homo sapiens	Inhibition	%	2.2
	8117501	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.86	CHEMBL2553	Homo sapiens	Inhibition	%	4.86
	8117855	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.7	CHEMBL2553	Homo sapiens	Inhibition	%	2.7
	8117993	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.34	CHEMBL2553	Homo sapiens	Inhibition	%	0.34
	8118217	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.83	CHEMBL2553	Homo sapiens	Inhibition	%	2.83
	8118333	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.96	CHEMBL2553	Homo sapiens	Inhibition	%	1.96
	8118505	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.45	CHEMBL2553	Homo sapiens	Inhibition	%	2.45
	8118729	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.06	CHEMBL2553	Homo sapiens	Inhibition	%	3.06
	8118865	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.91	CHEMBL2553	Homo sapiens	Inhibition	%	2.91
	8119136	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	9.42	CHEMBL2553	Homo sapiens	Inhibition	%	9.42
	8119519	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.65	CHEMBL2553	Homo sapiens	Inhibition	%	1.65
	8119686	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	5.09	CHEMBL2553	Homo sapiens	Inhibition	%	5.09
	8120029	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.63	CHEMBL2553	Homo sapiens	Inhibition	%	3.63
	8120168	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.91	CHEMBL2553	Homo sapiens	Inhibition	%	0.91
	8120392	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.79	CHEMBL2553	Homo sapiens	Inhibition	%	0.79
	8120552	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.77	CHEMBL2553	Homo sapiens	Inhibition	%	-1.77
	8120753	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	12.27	CHEMBL2553	Homo sapiens	Inhibition	%	12.27
	8121105	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.63	CHEMBL2553	Homo sapiens	Inhibition	%	0.63
	8121277	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.51	CHEMBL2553	Homo sapiens	Inhibition	%	1.51
	8121668	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.84	CHEMBL2553	Homo sapiens	Inhibition	%	1.84
	8121831	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.32	CHEMBL2553	Homo sapiens	Inhibition	%	1.32
	8122176	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	4.67	CHEMBL2553	Homo sapiens	Inhibition	%	4.67
	8122538	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.22	CHEMBL2553	Homo sapiens	Inhibition	%	4.22
	8122658	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.12	CHEMBL2553	Homo sapiens	Inhibition	%	2.12
	8123049	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.03	CHEMBL2553	Homo sapiens	Inhibition	%	2.03
	8123191	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.65	CHEMBL2553	Homo sapiens	Inhibition	%	0.65
	8123415	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	9.54	CHEMBL2553	Homo sapiens	Inhibition	%	9.54
	8123469	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	40.74	CHEMBL2553	Homo sapiens	Inhibition	%	40.74
	8123843	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	7.83	CHEMBL2553	Homo sapiens	Inhibition	%	7.83
	8124010	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.62	CHEMBL2553	Homo sapiens	Inhibition	%	2.62
	8124353	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.64	CHEMBL2553	Homo sapiens	Inhibition	%	0.64
	8124716	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.63	CHEMBL2553	Homo sapiens	Inhibition	%	0.63
	8124881	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.14	CHEMBL2553	Homo sapiens	Inhibition	%	-0.14
	8125082	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.14	CHEMBL2553	Homo sapiens	Inhibition	%	2.14
	8125306	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.42	CHEMBL2553	Homo sapiens	Inhibition	%	3.42
	8125436	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.83	CHEMBL2553	Homo sapiens	Inhibition	%	0.83
	8125604	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.3	CHEMBL2553	Homo sapiens	Inhibition	%	1.3
	8125828	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.21	CHEMBL2553	Homo sapiens	Inhibition	%	-0.21
	8125992	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.15	CHEMBL2553	Homo sapiens	Inhibition	%	0.15
	8126156	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.02	CHEMBL2553	Homo sapiens	Inhibition	%	3.02
	8126380	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.21	CHEMBL2553	Homo sapiens	Inhibition	%	0.21
	8126495	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	34.22	CHEMBL2553	Homo sapiens	Inhibition	%	34.22
	8126855	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	31.34	CHEMBL2553	Homo sapiens	Inhibition	%	31.34
	8126977	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.01	CHEMBL2553	Homo sapiens	Inhibition	%	3.01
	8127201	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.7	CHEMBL2553	Homo sapiens	Inhibition	%	2.7
	8127368	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.84	CHEMBL2553	Homo sapiens	Inhibition	%	2.84
	8127734	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.59	CHEMBL2553	Homo sapiens	Inhibition	%	4.59
	8127798	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.56	CHEMBL2553	Homo sapiens	Inhibition	%	1.56
	8128022	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	7.14	CHEMBL2553	Homo sapiens	Inhibition	%	7.14
	8128174	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.88	CHEMBL2553	Homo sapiens	Inhibition	%	1.88
	8128341	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.66	CHEMBL2553	Homo sapiens	Inhibition	%	4.66
	8128565	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.85	CHEMBL2553	Homo sapiens	Inhibition	%	0.85
	8128684	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.33	CHEMBL2553	Homo sapiens	Inhibition	%	4.33
	8129045	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.34	CHEMBL2553	Homo sapiens	Inhibition	%	3.34
	8129216	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.55	CHEMBL2553	Homo sapiens	Inhibition	%	-0.55
	8129629	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.85	CHEMBL2553	Homo sapiens	Inhibition	%	0.85
	8129768	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.39	CHEMBL2553	Homo sapiens	Inhibition	%	0.39
	8130153	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.24	CHEMBL2553	Homo sapiens	Inhibition	%	1.24
	8130325	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.28	CHEMBL2553	Homo sapiens	Inhibition	%	0.28
	8130709	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.52	CHEMBL2553	Homo sapiens	Inhibition	%	2.52
	8130825	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.27	CHEMBL2553	Homo sapiens	Inhibition	%	0.27
	8131049	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.4	CHEMBL2553	Homo sapiens	Inhibition	%	1.4
	8131188	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.31	CHEMBL2553	Homo sapiens	Inhibition	%	1.31
	8131532	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.25	CHEMBL2553	Homo sapiens	Inhibition	%	1.25
	8131699	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	6.08	CHEMBL2553	Homo sapiens	Inhibition	%	6.08
	8132064	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	33.82	CHEMBL2553	Homo sapiens	Inhibition	%	33.82
	8132350	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.17	CHEMBL2553	Homo sapiens	Inhibition	%	1.17
	8132497	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.54	CHEMBL2553	Homo sapiens	Inhibition	%	3.54
	8132889	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.91	CHEMBL2553	Homo sapiens	Inhibition	%	2.91
	8133010	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.41	CHEMBL2553	Homo sapiens	Inhibition	%	1.41
	8133234	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.24	CHEMBL2553	Homo sapiens	Inhibition	%	1.24
	8133372	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.35	CHEMBL2553	Homo sapiens	Inhibition	%	1.35
	8133544	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.02	CHEMBL2553	Homo sapiens	Inhibition	%	-1.02
	8133768	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.59	CHEMBL2553	Homo sapiens	Inhibition	%	0.59
	8133948	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.5	CHEMBL2553	Homo sapiens	Inhibition	%	2.5
	8134096	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.04	CHEMBL2553	Homo sapiens	Inhibition	%	1.04
	8134320	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.11	CHEMBL2553	Homo sapiens	Inhibition	%	0.11
	8134480	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.06	CHEMBL2553	Homo sapiens	Inhibition	%	1.06
	8134664	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.8	CHEMBL2553	Homo sapiens	Inhibition	%	1.8
	8134888	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	9.64	CHEMBL2553	Homo sapiens	Inhibition	%	9.64
	8135048	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-1.27	CHEMBL2553	Homo sapiens	Inhibition	%	-1.27
	8135387	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.89	CHEMBL2553	Homo sapiens	Inhibition	%	0.89
	8135528	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.85	CHEMBL2553	Homo sapiens	Inhibition	%	3.85
	8135873	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.35	CHEMBL2553	Homo sapiens	Inhibition	%	0.35
	8136041	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.05	CHEMBL2553	Homo sapiens	Inhibition	%	1.05
	8136265	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.75	CHEMBL2553	Homo sapiens	Inhibition	%	0.75
	8136409	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.84	CHEMBL2553	Homo sapiens	Inhibition	%	1.84
	8136699	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.02	CHEMBL2553	Homo sapiens	Inhibition	%	3.02
	8136834	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.44	CHEMBL2553	Homo sapiens	Inhibition	%	3.44
	8137058	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	23.61	CHEMBL2553	Homo sapiens	Inhibition	%	23.61
	8137221	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.36	CHEMBL2553	Homo sapiens	Inhibition	%	1.36
	8137565	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.16	CHEMBL2553	Homo sapiens	Inhibition	%	1.16
	8137713	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.11	CHEMBL2553	Homo sapiens	Inhibition	%	2.11
	8138103	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.03	CHEMBL2553	Homo sapiens	Inhibition	%	1.03
	8138282	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-1.01	CHEMBL2553	Homo sapiens	Inhibition	%	-1.01
	8138654	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8138812	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.4	CHEMBL2553	Homo sapiens	Inhibition	%	0.4
	8139221	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.5	CHEMBL2553	Homo sapiens	Inhibition	%	0.5
	8139380	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.85	CHEMBL2553	Homo sapiens	Inhibition	%	1.85
	8139718	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.86	CHEMBL2553	Homo sapiens	Inhibition	%	1.86
	8139859	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.31	CHEMBL2553	Homo sapiens	Inhibition	%	2.31
	8140083	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.99	CHEMBL2553	Homo sapiens	Inhibition	%	3.99
	8140206	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.55	CHEMBL2553	Homo sapiens	Inhibition	%	0.55
	8140589	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.9	CHEMBL2553	Homo sapiens	Inhibition	%	0.9
	8140732	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.67	CHEMBL2553	Homo sapiens	Inhibition	%	3.67
	8141034	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.16	CHEMBL2553	Homo sapiens	Inhibition	%	0.16
	8141388	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.92	CHEMBL2553	Homo sapiens	Inhibition	%	0.92
	8141548	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.72	CHEMBL2553	Homo sapiens	Inhibition	%	4.72
	8141891	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.45	CHEMBL2553	Homo sapiens	Inhibition	%	0.45
	8142052	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.25	CHEMBL2553	Homo sapiens	Inhibition	%	-0.25
	8142276	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.03	CHEMBL2553	Homo sapiens	Inhibition	%	-1.03
	8142444	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	5.1	CHEMBL2553	Homo sapiens	Inhibition	%	5.1
	8142620	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.29	CHEMBL2553	Homo sapiens	Inhibition	%	0.29
	8142844	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.77	CHEMBL2553	Homo sapiens	Inhibition	%	0.77
	8142993	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.32	CHEMBL2553	Homo sapiens	Inhibition	%	-0.32
	8143148	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.19	CHEMBL2553	Homo sapiens	Inhibition	%	1.19
	8143372	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.59	CHEMBL2553	Homo sapiens	Inhibition	%	1.59
	8143559	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.27	CHEMBL2553	Homo sapiens	Inhibition	%	2.27
	8143718	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.52	CHEMBL2553	Homo sapiens	Inhibition	%	0.52
	8143942	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.33	CHEMBL2553	Homo sapiens	Inhibition	%	2.33
	8144056	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.49	CHEMBL2553	Homo sapiens	Inhibition	%	-0.49
	8144419	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.88	CHEMBL2553	Homo sapiens	Inhibition	%	0.88
	8144549	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.46	CHEMBL2553	Homo sapiens	Inhibition	%	1.46
	8144773	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.06	CHEMBL2553	Homo sapiens	Inhibition	%	2.06
	8144926	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.77	CHEMBL2553	Homo sapiens	Inhibition	%	1.77
	8145063	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.26	CHEMBL2553	Homo sapiens	Inhibition	%	2.26
	8145287	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.3	CHEMBL2553	Homo sapiens	Inhibition	%	4.3
	8145376	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.41	CHEMBL2553	Homo sapiens	Inhibition	%	0.41
	8145724	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.86	CHEMBL2553	Homo sapiens	Inhibition	%	0.86
	8145885	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.34	CHEMBL2553	Homo sapiens	Inhibition	%	2.34
	8146109	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.66	CHEMBL2553	Homo sapiens	Inhibition	%	4.66
	8146229	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.4	CHEMBL2553	Homo sapiens	Inhibition	%	-0.4
	8146613	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	7.13	CHEMBL2553	Homo sapiens	Inhibition	%	7.13
	8146780	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	32.68	CHEMBL2553	Homo sapiens	Inhibition	%	32.68
	8147173	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.84	CHEMBL2553	Homo sapiens	Inhibition	%	0.84
	8147315	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.01	CHEMBL2553	Homo sapiens	Inhibition	%	1.01
	8147692	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.07	CHEMBL2553	Homo sapiens	Inhibition	%	1.07
	8147879	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.5	CHEMBL2553	Homo sapiens	Inhibition	%	1.5
	8148261	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.02	CHEMBL2553	Homo sapiens	Inhibition	%	2.02
	8148375	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.36	CHEMBL2553	Homo sapiens	Inhibition	%	0.36
	8148599	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.57	CHEMBL2553	Homo sapiens	Inhibition	%	-0.57
	8148738	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.99	CHEMBL2553	Homo sapiens	Inhibition	%	0.99
	8149100	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.84	CHEMBL2553	Homo sapiens	Inhibition	%	1.84
	8149259	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.47	CHEMBL2553	Homo sapiens	Inhibition	%	-0.47
	8149617	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	62.34	CHEMBL2553	Homo sapiens	Inhibition	%	62.34
	8149715	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.03	CHEMBL2553	Homo sapiens	Inhibition	%	2.03
	8149939	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.8	CHEMBL2553	Homo sapiens	Inhibition	%	4.8
	8150064	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.39	CHEMBL2553	Homo sapiens	Inhibition	%	1.39
	8150448	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.04	CHEMBL2553	Homo sapiens	Inhibition	%	1.04
	8150568	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.24	CHEMBL2553	Homo sapiens	Inhibition	%	0.24
	8150792	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.42	CHEMBL2553	Homo sapiens	Inhibition	%	0.42
	8150957	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	34.82	CHEMBL2553	Homo sapiens	Inhibition	%	34.82
	8151120	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.16	CHEMBL2553	Homo sapiens	Inhibition	%	1.16
	8151344	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.93	CHEMBL2553	Homo sapiens	Inhibition	%	1.93
	8151521	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.29	CHEMBL2553	Homo sapiens	Inhibition	%	1.29
	8151659	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.56	CHEMBL2553	Homo sapiens	Inhibition	%	1.56
	8151883	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.89	CHEMBL2553	Homo sapiens	Inhibition	%	-0.89
	8152037	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.11	CHEMBL2553	Homo sapiens	Inhibition	%	2.11
	8152225	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.51	CHEMBL2553	Homo sapiens	Inhibition	%	6.51
	8152607	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.37	CHEMBL2553	Homo sapiens	Inhibition	%	2.37
	8152945	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.78	CHEMBL2553	Homo sapiens	Inhibition	%	3.78
	8153084	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.86	CHEMBL2553	Homo sapiens	Inhibition	%	0.86
	8153445	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.84	CHEMBL2553	Homo sapiens	Inhibition	%	1.84
	8153602	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.29	CHEMBL2553	Homo sapiens	Inhibition	%	-0.29
	8153959	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	88.32	CHEMBL2553	Homo sapiens	Inhibition	%	88.32
	8154280	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	17.96	CHEMBL2553	Homo sapiens	Inhibition	%	17.96
	8154406	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	10.16	CHEMBL2553	Homo sapiens	Inhibition	%	10.16
	8154630	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.01	CHEMBL2553	Homo sapiens	Inhibition	%	0.01
	8154789	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.83	CHEMBL2553	Homo sapiens	Inhibition	%	1.83
	8155133	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.14	CHEMBL2553	Homo sapiens	Inhibition	%	0.14
	8155309	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.48	CHEMBL2553	Homo sapiens	Inhibition	%	0.48
	8155694	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.37	CHEMBL2553	Homo sapiens	Inhibition	%	4.37
	8155872	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.08	CHEMBL2553	Homo sapiens	Inhibition	%	2.08
	8156234	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.51	CHEMBL2553	Homo sapiens	Inhibition	%	0.51
	8156446	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.52	CHEMBL2553	Homo sapiens	Inhibition	%	2.52
	8156596	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.75	CHEMBL2553	Homo sapiens	Inhibition	%	5.75
	8156820	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.1	CHEMBL2553	Homo sapiens	Inhibition	%	1.1
	8156963	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.42	CHEMBL2553	Homo sapiens	Inhibition	%	6.42
	8157307	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	11.35	CHEMBL2553	Homo sapiens	Inhibition	%	11.35
	8157448	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.19	CHEMBL2553	Homo sapiens	Inhibition	%	5.19
	8157672	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	26.69	CHEMBL2553	Homo sapiens	Inhibition	%	26.69
	8157802	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.67	CHEMBL2553	Homo sapiens	Inhibition	%	1.67
	8157963	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.81	CHEMBL2553	Homo sapiens	Inhibition	%	-1.81
	8158187	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.08	CHEMBL2553	Homo sapiens	Inhibition	%	1.08
	8158437	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	44.62	CHEMBL2553	Homo sapiens	Inhibition	%	44.62
	8158595	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.01	CHEMBL2553	Homo sapiens	Inhibition	%	5.01
	8158988	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.86	CHEMBL2553	Homo sapiens	Inhibition	%	0.86
	8159123	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.45	CHEMBL2553	Homo sapiens	Inhibition	%	1.45
	8159467	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.39	CHEMBL2553	Homo sapiens	Inhibition	%	3.39
	8159822	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	35.11	CHEMBL2553	Homo sapiens	Inhibition	%	35.11
	8159963	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.39	CHEMBL2553	Homo sapiens	Inhibition	%	5.39
	8160324	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.62	CHEMBL2553	Homo sapiens	Inhibition	%	3.62
	8160474	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.24	CHEMBL2553	Homo sapiens	Inhibition	%	-0.24
	8160768	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.28	CHEMBL2553	Homo sapiens	Inhibition	%	4.28
	8161142	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.56	CHEMBL2553	Homo sapiens	Inhibition	%	3.56
	8161285	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.62	CHEMBL2553	Homo sapiens	Inhibition	%	2.62
	8161634	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.82	CHEMBL2553	Homo sapiens	Inhibition	%	1.82
	8161996	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.22	CHEMBL2553	Homo sapiens	Inhibition	%	3.22
	8162126	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.91	CHEMBL2553	Homo sapiens	Inhibition	%	4.91
	8162510	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.68	CHEMBL2553	Homo sapiens	Inhibition	%	-1.68
	8162763	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	75.78	CHEMBL2553	Homo sapiens	Inhibition	%	75.78
	8162911	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	15.06	CHEMBL2553	Homo sapiens	Inhibition	%	15.06
	8163135	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	53.41	CHEMBL2553	Homo sapiens	Inhibition	%	53.41
	8163304	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.91	CHEMBL2553	Homo sapiens	Inhibition	%	1.91
	8163438	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.91	CHEMBL2553	Homo sapiens	Inhibition	%	6.91
	8163662	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.37	CHEMBL2553	Homo sapiens	Inhibition	%	4.37
	8163785	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.17	CHEMBL2553	Homo sapiens	Inhibition	%	6.17
	8164143	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	72.45	CHEMBL2553	Homo sapiens	Inhibition	%	72.45
	8164283	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.07	CHEMBL2553	Homo sapiens	Inhibition	%	1.07
	8164507	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.93	CHEMBL2553	Homo sapiens	Inhibition	%	1.93
	8164662	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.54	CHEMBL2553	Homo sapiens	Inhibition	%	2.54
	8164806	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.78	CHEMBL2553	Homo sapiens	Inhibition	%	2.78
	8165030	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.25	CHEMBL2553	Homo sapiens	Inhibition	%	1.25
	8165100	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.58	CHEMBL2553	Homo sapiens	Inhibition	%	5.58
	8165465	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.93	CHEMBL2553	Homo sapiens	Inhibition	%	0.93
	8165608	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.26	CHEMBL2553	Homo sapiens	Inhibition	%	7.26
	8165832	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.14	CHEMBL2553	Homo sapiens	Inhibition	%	3.14
	8165958	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.3	CHEMBL2553	Homo sapiens	Inhibition	%	4.3
	8166320	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.2	CHEMBL2553	Homo sapiens	Inhibition	%	7.2
	8166450	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.58	CHEMBL2553	Homo sapiens	Inhibition	%	2.58
	8166674	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.62	CHEMBL2553	Homo sapiens	Inhibition	%	3.62
	8166775	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.01	CHEMBL2553	Homo sapiens	Inhibition	%	-0.01
	8167087	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	26.1	CHEMBL2553	Homo sapiens	Inhibition	%	26.1
	8167452	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	23.25	CHEMBL2553	Homo sapiens	Inhibition	%	23.25
	8167616	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.22	CHEMBL2553	Homo sapiens	Inhibition	%	0.22
	8167973	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	21.01	CHEMBL2553	Homo sapiens	Inhibition	%	21.01
	8168097	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.36	CHEMBL2553	Homo sapiens	Inhibition	%	2.36
	8168321	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	15.73	CHEMBL2553	Homo sapiens	Inhibition	%	15.73
	8168462	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.69	CHEMBL2553	Homo sapiens	Inhibition	%	3.69
	8168822	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.46	CHEMBL2553	Homo sapiens	Inhibition	%	0.46
	8168986	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.07	CHEMBL2553	Homo sapiens	Inhibition	%	7.07
	8169352	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.36	CHEMBL2553	Homo sapiens	Inhibition	%	1.36
	8169432	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	25.79	CHEMBL2553	Homo sapiens	Inhibition	%	25.79
	8169656	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.37	CHEMBL2553	Homo sapiens	Inhibition	%	3.37
	8169790	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.76	CHEMBL2553	Homo sapiens	Inhibition	%	3.76
	8170159	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	41.1	CHEMBL2553	Homo sapiens	Inhibition	%	41.1
	8170284	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.09	CHEMBL2553	Homo sapiens	Inhibition	%	1.09
	8170508	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.6	CHEMBL2553	Homo sapiens	Inhibition	%	1.6
	8170648	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.34	CHEMBL2553	Homo sapiens	Inhibition	%	4.34
	8171007	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.96	CHEMBL2553	Homo sapiens	Inhibition	%	0.96
	8171204	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.21	CHEMBL2553	Homo sapiens	Inhibition	%	-0.21
	8171421	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	70.57	CHEMBL2553	Homo sapiens	Inhibition	%	70.57
	8171786	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	65.96	CHEMBL2553	Homo sapiens	Inhibition	%	65.96
	8171939	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.59	CHEMBL2553	Homo sapiens	Inhibition	%	1.59
	8172295	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.61	CHEMBL2553	Homo sapiens	Inhibition	%	3.61
	8172647	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.66	CHEMBL2553	Homo sapiens	Inhibition	%	0.66
	8172789	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.7	CHEMBL2553	Homo sapiens	Inhibition	%	1.7
	8173149	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.07	CHEMBL2553	Homo sapiens	Inhibition	%	3.07
	8173314	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.51	CHEMBL2553	Homo sapiens	Inhibition	%	3.51
	8173679	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.15	CHEMBL2553	Homo sapiens	Inhibition	%	2.15
	8173990	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.02	CHEMBL2553	Homo sapiens	Inhibition	%	12.02
	8174122	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.26	CHEMBL2553	Homo sapiens	Inhibition	%	2.26
	8174346	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.95	CHEMBL2553	Homo sapiens	Inhibition	%	4.95
	8174494	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.06	CHEMBL2553	Homo sapiens	Inhibition	%	-0.06
	8174840	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.32	CHEMBL2553	Homo sapiens	Inhibition	%	1.32
	8174983	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	19.93	CHEMBL2553	Homo sapiens	Inhibition	%	19.93
	8175343	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.69	CHEMBL2553	Homo sapiens	Inhibition	%	3.69
	8175599	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	10.88	CHEMBL2553	Homo sapiens	Inhibition	%	10.88
	8175762	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.77	CHEMBL2553	Homo sapiens	Inhibition	%	1.77
	8175986	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.73	CHEMBL2553	Homo sapiens	Inhibition	%	3.73
	8176139	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	56.25	CHEMBL2553	Homo sapiens	Inhibition	%	56.25
	8176288	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.07	CHEMBL2553	Homo sapiens	Inhibition	%	1.07
	8176512	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.57	CHEMBL2553	Homo sapiens	Inhibition	%	1.57
	8176644	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	20.9	CHEMBL2553	Homo sapiens	Inhibition	%	20.9
	8176998	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.31	CHEMBL2553	Homo sapiens	Inhibition	%	4.31
	8177140	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.97	CHEMBL2553	Homo sapiens	Inhibition	%	2.97
	8177364	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	Inhibition	%	1.0
	8177502	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	53.9	CHEMBL2553	Homo sapiens	Inhibition	%	53.9
	8177666	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.17	CHEMBL2553	Homo sapiens	Inhibition	%	7.17
	8177890	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.54	CHEMBL2553	Homo sapiens	Inhibition	%	3.54
	8178030	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.73	CHEMBL2553	Homo sapiens	Inhibition	%	2.73
	8178342	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.95	CHEMBL2553	Homo sapiens	Inhibition	%	1.95
	8178693	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.21	CHEMBL2553	Homo sapiens	Inhibition	%	2.21
	8178842	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.15	CHEMBL2553	Homo sapiens	Inhibition	%	0.15
	8179189	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.05	CHEMBL2553	Homo sapiens	Inhibition	%	0.05
	8179333	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.77	CHEMBL2553	Homo sapiens	Inhibition	%	1.77
	8179557	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	7.98	CHEMBL2553	Homo sapiens	Inhibition	%	7.98
	8179694	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.36	CHEMBL2553	Homo sapiens	Inhibition	%	1.36
	8179951	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.04	CHEMBL2553	Homo sapiens	Inhibition	%	2.04
	8180329	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.06	CHEMBL2553	Homo sapiens	Inhibition	%	2.06
	8180485	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	87.9	CHEMBL2553	Homo sapiens	Inhibition	%	87.9
	8180857	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	11.64	CHEMBL2553	Homo sapiens	Inhibition	%	11.64
	8180990	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.4	CHEMBL2553	Homo sapiens	Inhibition	%	2.4
	8181214	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	0.29	CHEMBL2553	Homo sapiens	Inhibition	%	0.29
	8181345	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.62	CHEMBL2553	Homo sapiens	Inhibition	%	1.62
	8181709	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.84	CHEMBL2553	Homo sapiens	Inhibition	%	0.84
	8181848	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	81.97	CHEMBL2553	Homo sapiens	Inhibition	%	81.97
	8182235	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.04	CHEMBL2553	Homo sapiens	Inhibition	%	7.04
	8182375	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.24	CHEMBL2553	Homo sapiens	Inhibition	%	0.24
	8182599	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.46	CHEMBL2553	Homo sapiens	Inhibition	%	-0.46
	8182691	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.1	CHEMBL2553	Homo sapiens	Inhibition	%	2.1
	8183037	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.62	CHEMBL2553	Homo sapiens	Inhibition	%	4.62
	8183186	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.6	CHEMBL2553	Homo sapiens	Inhibition	%	0.6
	8183410	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.04	CHEMBL2553	Homo sapiens	Inhibition	%	4.04
	8183539	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.49	CHEMBL2553	Homo sapiens	Inhibition	%	1.49
	8183905	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.95	CHEMBL2553	Homo sapiens	Inhibition	%	1.95
	8184041	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.68	CHEMBL2553	Homo sapiens	Inhibition	%	0.68
	8184307	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.41	CHEMBL2553	Homo sapiens	Inhibition	%	3.41
	8184678	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.75	CHEMBL2553	Homo sapiens	Inhibition	%	0.75
	8184835	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.15	CHEMBL2553	Homo sapiens	Inhibition	%	1.15
	8185059	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.94	CHEMBL2553	Homo sapiens	Inhibition	%	4.94
	8185208	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.02	CHEMBL2553	Homo sapiens	Inhibition	%	0.02
	8185563	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.85	CHEMBL2553	Homo sapiens	Inhibition	%	3.85
	8185694	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	14.46	CHEMBL2553	Homo sapiens	Inhibition	%	14.46
	8186057	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.81	CHEMBL2553	Homo sapiens	Inhibition	%	1.81
	8186198	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.22	CHEMBL2553	Homo sapiens	Inhibition	%	4.22
	8186422	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.89	CHEMBL2553	Homo sapiens	Inhibition	%	7.89
	8186586	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.46	CHEMBL2553	Homo sapiens	Inhibition	%	2.46
	8186949	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.03	CHEMBL2553	Homo sapiens	Inhibition	%	2.03
	8187047	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.33	CHEMBL2553	Homo sapiens	Inhibition	%	0.33
	8187271	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.09	CHEMBL2553	Homo sapiens	Inhibition	%	-0.09
	8187395	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.26	CHEMBL2553	Homo sapiens	Inhibition	%	2.26
	8187767	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.4	CHEMBL2553	Homo sapiens	Inhibition	%	1.4
	8187896	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.18	CHEMBL2553	Homo sapiens	Inhibition	%	3.18
	8188263	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.81	CHEMBL2553	Homo sapiens	Inhibition	%	4.81
	8188398	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.45	CHEMBL2553	Homo sapiens	Inhibition	%	1.45
	8188622	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.53	CHEMBL2553	Homo sapiens	Inhibition	%	0.53
	8188672	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.44	CHEMBL2553	Homo sapiens	Inhibition	%	2.44
	8188896	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.74	CHEMBL2553	Homo sapiens	Inhibition	%	6.74
	8189044	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	10.37	CHEMBL2553	Homo sapiens	Inhibition	%	10.37
	8189424	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.72	CHEMBL2553	Homo sapiens	Inhibition	%	3.72
	8189573	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.7	CHEMBL2553	Homo sapiens	Inhibition	%	0.7
	8189929	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.51	CHEMBL2553	Homo sapiens	Inhibition	%	5.51
	8190061	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.44	CHEMBL2553	Homo sapiens	Inhibition	%	0.44
	8190285	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.08	CHEMBL2553	Homo sapiens	Inhibition	%	0.08
	8190425	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.01	CHEMBL2553	Homo sapiens	Inhibition	%	1.01
	8190786	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.81	CHEMBL2553	Homo sapiens	Inhibition	%	1.81
	8190950	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.09	CHEMBL2553	Homo sapiens	Inhibition	%	4.09
	8191312	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.41	CHEMBL2553	Homo sapiens	Inhibition	%	2.41
	8191632	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.61	CHEMBL2553	Homo sapiens	Inhibition	%	0.61
	8191754	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.67	CHEMBL2553	Homo sapiens	Inhibition	%	3.67
	8191978	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.52	CHEMBL2553	Homo sapiens	Inhibition	%	2.52
	8192127	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.95	CHEMBL2553	Homo sapiens	Inhibition	%	0.95
	8192256	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.72	CHEMBL2553	Homo sapiens	Inhibition	%	3.72
	8192480	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	8.08	CHEMBL2553	Homo sapiens	Inhibition	%	8.08
	8192624	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.39	CHEMBL2553	Homo sapiens	Inhibition	%	2.39
	8192984	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.43	CHEMBL2553	Homo sapiens	Inhibition	%	-0.43
	8193256	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.16	CHEMBL2553	Homo sapiens	Inhibition	%	1.16
	8193401	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.08	CHEMBL2553	Homo sapiens	Inhibition	%	1.08
	8193625	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.91	CHEMBL2553	Homo sapiens	Inhibition	%	0.91
	8193782	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	17.63	CHEMBL2553	Homo sapiens	Inhibition	%	17.63
	8193931	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.29	CHEMBL2553	Homo sapiens	Inhibition	%	0.29
	8194155	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	7.82	CHEMBL2553	Homo sapiens	Inhibition	%	7.82
	8194286	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.8	CHEMBL2553	Homo sapiens	Inhibition	%	1.8
	8194641	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.94	CHEMBL2553	Homo sapiens	Inhibition	%	1.94
	8194784	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-1.21	CHEMBL2553	Homo sapiens	Inhibition	%	-1.21
	8195008	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.97	CHEMBL2553	Homo sapiens	Inhibition	%	2.97
	8195141	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.04	CHEMBL2553	Homo sapiens	Inhibition	%	6.04
	8195305	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.17	CHEMBL2553	Homo sapiens	Inhibition	%	3.17
	8195529	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	11.9	CHEMBL2553	Homo sapiens	Inhibition	%	11.9
	8195668	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8195990	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.49	CHEMBL2553	Homo sapiens	Inhibition	%	4.49
	8196331	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.1	CHEMBL2553	Homo sapiens	Inhibition	%	4.1
	8196481	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.84	CHEMBL2553	Homo sapiens	Inhibition	%	1.84
	8196833	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.14	CHEMBL2553	Homo sapiens	Inhibition	%	4.14
	8196974	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.99	CHEMBL2553	Homo sapiens	Inhibition	%	4.99
	8197198	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.11	CHEMBL2553	Homo sapiens	Inhibition	%	1.11
	8197335	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.47	CHEMBL2553	Homo sapiens	Inhibition	%	-1.47
	8197610	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.59	CHEMBL2553	Homo sapiens	Inhibition	%	2.59
	8197974	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.5	CHEMBL2553	Homo sapiens	Inhibition	%	3.5
	8198131	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.03	CHEMBL2553	Homo sapiens	Inhibition	%	3.03
	8198493	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.71	CHEMBL2553	Homo sapiens	Inhibition	%	1.71
	8198623	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.05	CHEMBL2553	Homo sapiens	Inhibition	%	6.05
	8198847	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.28	CHEMBL2553	Homo sapiens	Inhibition	%	3.28
	8198978	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.4	CHEMBL2553	Homo sapiens	Inhibition	%	0.4
	8199350	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.02	CHEMBL2553	Homo sapiens	Inhibition	%	4.02
	8199484	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.37	CHEMBL2553	Homo sapiens	Inhibition	%	3.37
	8199871	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.74	CHEMBL2553	Homo sapiens	Inhibition	%	0.74
	8200009	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.67	CHEMBL2553	Homo sapiens	Inhibition	%	0.67
	8200337	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.56	CHEMBL2553	Homo sapiens	Inhibition	%	1.56
	8200676	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.89	CHEMBL2553	Homo sapiens	Inhibition	%	1.89
	8200826	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.63	CHEMBL2553	Homo sapiens	Inhibition	%	4.63
	8201050	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.23	CHEMBL2553	Homo sapiens	Inhibition	%	2.23
	8201180	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.59	CHEMBL2553	Homo sapiens	Inhibition	%	12.59
	8201539	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.06	CHEMBL2553	Homo sapiens	Inhibition	%	3.06
	8201672	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.66	CHEMBL2553	Homo sapiens	Inhibition	%	-0.66
	8201951	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.12	CHEMBL2553	Homo sapiens	Inhibition	%	2.12
	8202315	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.32	CHEMBL2553	Homo sapiens	Inhibition	%	-0.32
	8202482	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.88	CHEMBL2553	Homo sapiens	Inhibition	%	2.88
	8202831	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.2	CHEMBL2553	Homo sapiens	Inhibition	%	5.2
	8203185	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.21	CHEMBL2553	Homo sapiens	Inhibition	%	10.21
	8203316	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	Inhibition	%	2.0
	8203686	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.74	CHEMBL2553	Homo sapiens	Inhibition	%	1.74
	8203820	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.51	CHEMBL2553	Homo sapiens	Inhibition	%	6.51
	8204044	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.73	CHEMBL2553	Homo sapiens	Inhibition	%	2.73
	8204210	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.77	CHEMBL2553	Homo sapiens	Inhibition	%	1.77
	8204347	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.44	CHEMBL2553	Homo sapiens	Inhibition	%	1.44
	8204571	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.51	CHEMBL2553	Homo sapiens	Inhibition	%	0.51
	8204676	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.48	CHEMBL2553	Homo sapiens	Inhibition	%	2.48
	8205015	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	11.33	CHEMBL2553	Homo sapiens	Inhibition	%	11.33
	8205388	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.38	CHEMBL2553	Homo sapiens	Inhibition	%	8.38
	8205524	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.34	CHEMBL2553	Homo sapiens	Inhibition	%	5.34
	8205887	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.91	CHEMBL2553	Homo sapiens	Inhibition	%	1.91
	8206019	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.48	CHEMBL2553	Homo sapiens	Inhibition	%	-1.48
	8206243	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.31	CHEMBL2553	Homo sapiens	Inhibition	%	-1.31
	8206295	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.08	CHEMBL2553	Homo sapiens	Inhibition	%	2.08
	8206519	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.78	CHEMBL2553	Homo sapiens	Inhibition	%	2.78
	8206662	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	4.1	CHEMBL2553	Homo sapiens	Inhibition	%	4.1
	8206842	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.28	CHEMBL2553	Homo sapiens	Inhibition	%	2.28
	8207066	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	11.82	CHEMBL2553	Homo sapiens	Inhibition	%	11.82
	8207192	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.03	CHEMBL2553	Homo sapiens	Inhibition	%	3.03
	8207546	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.28	CHEMBL2553	Homo sapiens	Inhibition	%	7.28
	8207678	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.33	CHEMBL2553	Homo sapiens	Inhibition	%	3.33
	8207902	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.02	CHEMBL2553	Homo sapiens	Inhibition	%	1.02
	8208047	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.45	CHEMBL2553	Homo sapiens	Inhibition	%	4.45
	8208403	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.34	CHEMBL2553	Homo sapiens	Inhibition	%	6.34
	8208569	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.94	CHEMBL2553	Homo sapiens	Inhibition	%	3.94
	8208926	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	66.3	CHEMBL2553	Homo sapiens	Inhibition	%	66.3
	8209031	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.18	CHEMBL2553	Homo sapiens	Inhibition	%	0.18
	8209255	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8209371	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.17	CHEMBL2553	Homo sapiens	Inhibition	%	1.17
	8209745	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.47	CHEMBL2553	Homo sapiens	Inhibition	%	1.47
	8209881	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	30.01	CHEMBL2553	Homo sapiens	Inhibition	%	30.01
	8210105	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.9	CHEMBL2553	Homo sapiens	Inhibition	%	3.9
	8210246	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.35	CHEMBL2553	Homo sapiens	Inhibition	%	2.35
	8210606	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.49	CHEMBL2553	Homo sapiens	Inhibition	%	-0.49
	8210865	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.72	CHEMBL2553	Homo sapiens	Inhibition	%	2.72
	8211009	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.68	CHEMBL2553	Homo sapiens	Inhibition	%	0.68
	8211403	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.53	CHEMBL2553	Homo sapiens	Inhibition	%	1.53
	8211526	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.16	CHEMBL2553	Homo sapiens	Inhibition	%	9.16
	8211750	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.27	CHEMBL2553	Homo sapiens	Inhibition	%	3.27
	8211879	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	32.95	CHEMBL2553	Homo sapiens	Inhibition	%	32.95
	8212235	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.9	CHEMBL2553	Homo sapiens	Inhibition	%	2.9
	8212376	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.62	CHEMBL2553	Homo sapiens	Inhibition	%	6.62
	8212733	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.8	CHEMBL2553	Homo sapiens	Inhibition	%	2.8
	8212903	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	26.45	CHEMBL2553	Homo sapiens	Inhibition	%	26.45
	8213127	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.98	CHEMBL2553	Homo sapiens	Inhibition	%	1.98
	8213256	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	84.2	CHEMBL2553	Homo sapiens	Inhibition	%	84.2
	8213584	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.77	CHEMBL2553	Homo sapiens	Inhibition	%	-0.77
	8213697	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.4	CHEMBL2553	Homo sapiens	Inhibition	%	3.4
	8213921	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.14	CHEMBL2553	Homo sapiens	Inhibition	%	2.14
	8214068	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.59	CHEMBL2553	Homo sapiens	Inhibition	%	0.59
	8214429	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	18.69	CHEMBL2553	Homo sapiens	Inhibition	%	18.69
	8214563	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.41	CHEMBL2553	Homo sapiens	Inhibition	%	2.41
	8214939	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.42	CHEMBL2553	Homo sapiens	Inhibition	%	0.42
	8215190	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.16	CHEMBL2553	Homo sapiens	Inhibition	%	2.16
	8215343	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.38	CHEMBL2553	Homo sapiens	Inhibition	%	1.38
	8215567	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.72	CHEMBL2553	Homo sapiens	Inhibition	%	1.72
	8215731	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.62	CHEMBL2553	Homo sapiens	Inhibition	%	1.62
	8216074	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	12.12	CHEMBL2553	Homo sapiens	Inhibition	%	12.12
	8216193	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.63	CHEMBL2553	Homo sapiens	Inhibition	%	2.63
	8216553	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.76	CHEMBL2553	Homo sapiens	Inhibition	%	5.76
	8216691	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.5	CHEMBL2553	Homo sapiens	Inhibition	%	9.5
	8216915	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	63.63	CHEMBL2553	Homo sapiens	Inhibition	%	63.63
	8217049	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.92	CHEMBL2553	Homo sapiens	Inhibition	%	4.92
	8217447	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.12	CHEMBL2553	Homo sapiens	Inhibition	%	3.12
	8217578	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.57	CHEMBL2553	Homo sapiens	Inhibition	%	5.57
	8217903	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.61	CHEMBL2553	Homo sapiens	Inhibition	%	-0.61
	8218242	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.08	CHEMBL2553	Homo sapiens	Inhibition	%	5.08
	8218369	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.48	CHEMBL2553	Homo sapiens	Inhibition	%	1.48
	8218736	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	10.52	CHEMBL2553	Homo sapiens	Inhibition	%	10.52
	8218867	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.62	CHEMBL2553	Homo sapiens	Inhibition	%	3.62
	8219091	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.17	CHEMBL2553	Homo sapiens	Inhibition	%	1.17
	8219251	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.3	CHEMBL2553	Homo sapiens	Inhibition	%	-1.3
	8219501	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.6	CHEMBL2553	Homo sapiens	Inhibition	%	4.6
	8219886	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.94	CHEMBL2553	Homo sapiens	Inhibition	%	0.94
	8220055	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.94	CHEMBL2553	Homo sapiens	Inhibition	%	1.94
	8220408	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.49	CHEMBL2553	Homo sapiens	Inhibition	%	1.49
	8220522	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.25	CHEMBL2553	Homo sapiens	Inhibition	%	4.25
	8220746	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	27.8	CHEMBL2553	Homo sapiens	Inhibition	%	27.8
	8220884	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	28.44	CHEMBL2553	Homo sapiens	Inhibition	%	28.44
	8221244	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	79.44	CHEMBL2553	Homo sapiens	Inhibition	%	79.44
	8221377	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.06	CHEMBL2553	Homo sapiens	Inhibition	%	4.06
	8221601	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	15.96	CHEMBL2553	Homo sapiens	Inhibition	%	15.96
	8221766	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.52	CHEMBL2553	Homo sapiens	Inhibition	%	0.52
	8221897	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	14.01	CHEMBL2553	Homo sapiens	Inhibition	%	14.01
	8222121	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.3	CHEMBL2553	Homo sapiens	Inhibition	%	1.3
	8222219	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.43	CHEMBL2553	Homo sapiens	Inhibition	%	2.43
	8222577	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.44	CHEMBL2553	Homo sapiens	Inhibition	%	2.44
	8222695	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.32	CHEMBL2553	Homo sapiens	Inhibition	%	6.32
	8222919	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.72	CHEMBL2553	Homo sapiens	Inhibition	%	2.72
	8223063	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	61.26	CHEMBL2553	Homo sapiens	Inhibition	%	61.26
	8223416	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.03	CHEMBL2553	Homo sapiens	Inhibition	%	5.03
	8223577	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.36	CHEMBL2553	Homo sapiens	Inhibition	%	1.36
	8223827	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.01	CHEMBL2553	Homo sapiens	Inhibition	%	6.01
	8224051	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	9.72	CHEMBL2553	Homo sapiens	Inhibition	%	9.72
	8224213	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.15	CHEMBL2553	Homo sapiens	Inhibition	%	3.15
	8224383	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.4	CHEMBL2553	Homo sapiens	Inhibition	%	2.4
	8224607	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.64	CHEMBL2553	Homo sapiens	Inhibition	%	0.64
	8224742	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.31	CHEMBL2553	Homo sapiens	Inhibition	%	5.31
	8225080	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	68.74	CHEMBL2553	Homo sapiens	Inhibition	%	68.74
	8225214	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.5	CHEMBL2553	Homo sapiens	Inhibition	%	2.5
	8225438	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.11	CHEMBL2553	Homo sapiens	Inhibition	%	6.11
	8225576	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.98	CHEMBL2553	Homo sapiens	Inhibition	%	4.98
	8225935	CHEMBL1961928	GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.13	CHEMBL2553	Homo sapiens	Inhibition	%	2.13
	8226093	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.8	CHEMBL2553	Homo sapiens	Inhibition	%	2.8
	8226442	CHEMBL1961929	GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.85	CHEMBL2553	Homo sapiens	Inhibition	%	2.85
	10839478	CHEMBL2015509	Inhibition of RSK1 N-terminal at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	27.0	CHEMBL2553	Homo sapiens	INH	%	27.0
	10839582	CHEMBL2015806	Inhibition of RSK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	8.0	CHEMBL2553	Homo sapiens	Activity	%	8.0
	10839619	CHEMBL2014656	Inhibition of RSK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	14.0	CHEMBL2553	Homo sapiens	Activity	%	14.0
	10921400	CHEMBL2044782	Inhibition of RPS6KA1 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
	10921401	CHEMBL2044783	Inhibition of RPS6KA1 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	68.0	CHEMBL2553	Homo sapiens	INH	%	68.0
	10923965	CHEMBL2044159	Inhibition of RSK1 at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	29.0	CHEMBL2553	Homo sapiens	INH	%	29.0
	10926146	CHEMBL2046222	Inhibition of human Rsk1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	104.0	CHEMBL2553	Homo sapiens	Activity	%	104.0
	10926147	CHEMBL2046222	Inhibition of human Rsk1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	104.0	CHEMBL2553	Homo sapiens	Activity	%	104.0
	10981535	CHEMBL2066385	Inhibition of human Rsk1 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
	10981550	CHEMBL2067596	Inhibition of human Rsk1	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	61.0	CHEMBL2553	Homo sapiens	IC50	nM	61.0
Not Active	10986948	CHEMBL2072252	Inhibition of MAPKAP-K1A at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	11016509	CHEMBL2092412	Inhibition of RPS6KA1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11016510	CHEMBL2092412	Inhibition of RPS6KA1 at 1 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11016511	CHEMBL2092412	Inhibition of RPS6KA1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11016512	CHEMBL2092412	Inhibition of RPS6KA1 at 1 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11016513	CHEMBL2092412	Inhibition of RPS6KA1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11017058	CHEMBL2092436	Inhibition of RPS6KA1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11017059	CHEMBL2092436	Inhibition of RPS6KA1 at 5 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11017060	CHEMBL2092436	Inhibition of RPS6KA1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11017061	CHEMBL2092436	Inhibition of RPS6KA1 at 5 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	11017062	CHEMBL2092436	Inhibition of RPS6KA1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL2553	Homo sapiens	INH	%	30.0
	12047342	CHEMBL2157695	Inhibition of Rsk1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	3.3	CHEMBL2553	Homo sapiens	INH	%	3.3
	12060557	CHEMBL2154988	Binding affinity to C-terminal kinase domain 2 of RPS6KA1	B	Nc1nc2c(-c3ccccn3)nccc2[nH]1		CHEMBL2153264	=	Kd	nM	530.0	CHEMBL2553	Homo sapiens	Kd	nM	530.0
	12074701	CHEMBL2161422	Inhibition of Rsk1 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	12145291	CHEMBL2186670	Inhibition of RSK1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	12145292	CHEMBL2186670	Inhibition of RSK1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	12170737	CHEMBL2214645	Inhibition of S6K1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL2553	Homo sapiens	Activity	%	101.0
	12170739	CHEMBL2214647	Inhibition of RSK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	69.0	CHEMBL2553	Homo sapiens	Activity	%	69.0
	12170868	CHEMBL2213187	Inhibition of S6K1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	12170870	CHEMBL2213189	Inhibition of RSK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	82.0	CHEMBL2553	Homo sapiens	Activity	%	82.0
	12172218	CHEMBL2211998	Inhibition of RSK1 C-terminal domain 2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	12172219	CHEMBL2211999	Inhibition of RSK1 N-terminal domain 1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	88.0	CHEMBL2553	Homo sapiens	Activity	%	88.0
	12183818	CHEMBL2214443	Inhibition of RPS6KA1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	pIC50		5.0
	12187329	CHEMBL2216720	Inhibition of human RSK1 at 1 uM by radiometric assay in presence of ATP	B	COc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1		CHEMBL2203843	>	Inhibition	%	80.0	CHEMBL2553	Homo sapiens	INH	%	80.0
	12188408	CHEMBL2211129	Binding affinity to RSK1 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL2553	Homo sapiens	Activity	%	50.0
	12253001	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	111.0	CHEMBL2553	Homo sapiens	Residual Activity	%	111.0
	12253002	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	22.0	CHEMBL2553	Homo sapiens	Residual Activity	%	22.0
	12253003	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12253004	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	125.0	CHEMBL2553	Homo sapiens	Residual Activity	%	125.0
	12253005	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12253006	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12253007	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	9.0	CHEMBL2553	Homo sapiens	Residual Activity	%	9.0
	12253008	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	90.0	CHEMBL2553	Homo sapiens	Residual Activity	%	90.0
	12253009	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12253010	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12253011	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12253012	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	120.0	CHEMBL2553	Homo sapiens	Residual Activity	%	120.0
	12253013	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	119.0	CHEMBL2553	Homo sapiens	Residual Activity	%	119.0
	12253014	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	107.0	CHEMBL2553	Homo sapiens	Residual Activity	%	107.0
	12253015	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	116.0	CHEMBL2553	Homo sapiens	Residual Activity	%	116.0
	12253016	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12253017	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	114.0	CHEMBL2553	Homo sapiens	Residual Activity	%	114.0
	12253018	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL2553	Homo sapiens	Residual Activity	%	108.0
	12253019	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL2553	Homo sapiens	Residual Activity	%	99.0
	12253020	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	65.0	CHEMBL2553	Homo sapiens	Residual Activity	%	65.0
	12253021	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	129.0	CHEMBL2553	Homo sapiens	Residual Activity	%	129.0
	12253022	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	87.0	CHEMBL2553	Homo sapiens	Residual Activity	%	87.0
	12253023	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	137.0	CHEMBL2553	Homo sapiens	Residual Activity	%	137.0
	12253024	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	129.0	CHEMBL2553	Homo sapiens	Residual Activity	%	129.0
	12253025	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	110.0	CHEMBL2553	Homo sapiens	Residual Activity	%	110.0
	12253026	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	100.0	CHEMBL2553	Homo sapiens	Residual Activity	%	100.0
	12253027	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	40.0	CHEMBL2553	Homo sapiens	Residual Activity	%	40.0
	12253028	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	92.0	CHEMBL2553	Homo sapiens	Residual Activity	%	92.0
	12253029	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	93.0	CHEMBL2553	Homo sapiens	Residual Activity	%	93.0
	12253030	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	8.0	CHEMBL2553	Homo sapiens	Residual Activity	%	8.0
	12253031	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12253032	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12253033	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12253034	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	108.0	CHEMBL2553	Homo sapiens	Residual Activity	%	108.0
	12253035	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	131.0	CHEMBL2553	Homo sapiens	Residual Activity	%	131.0
	12253036	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254446	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	112.0	CHEMBL2553	Homo sapiens	Residual Activity	%	112.0
	12254447	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	110.0	CHEMBL2553	Homo sapiens	Residual Activity	%	110.0
	12254448	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254449	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254450	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	110.0	CHEMBL2553	Homo sapiens	Residual Activity	%	110.0
	12254451	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL2553	Homo sapiens	Residual Activity	%	121.0
	12254452	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	7.0	CHEMBL2553	Homo sapiens	Residual Activity	%	7.0
	12254453	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL2553	Homo sapiens	Residual Activity	%	10.0
	12254454	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	96.0	CHEMBL2553	Homo sapiens	Residual Activity	%	96.0
	12254455	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12254456	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	135.0	CHEMBL2553	Homo sapiens	Residual Activity	%	135.0
	12254457	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	51.0	CHEMBL2553	Homo sapiens	Residual Activity	%	51.0
	12254458	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	109.0	CHEMBL2553	Homo sapiens	Residual Activity	%	109.0
	12254459	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	141.0	CHEMBL2553	Homo sapiens	Residual Activity	%	141.0
	12254460	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	6.0	CHEMBL2553	Homo sapiens	Residual Activity	%	6.0
	12254461	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	123.0	CHEMBL2553	Homo sapiens	Residual Activity	%	123.0
	12254462	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	28.0	CHEMBL2553	Homo sapiens	Residual Activity	%	28.0
	12254463	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	116.0	CHEMBL2553	Homo sapiens	Residual Activity	%	116.0
	12254464	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12254465	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	120.0	CHEMBL2553	Homo sapiens	Residual Activity	%	120.0
	12254466	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12254467	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254468	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254469	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	138.0	CHEMBL2553	Homo sapiens	Residual Activity	%	138.0
	12254470	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12254471	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL2553	Homo sapiens	Residual Activity	%	0.0
	12254472	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12254473	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL2553	Homo sapiens	Residual Activity	%	96.0
	12254474	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	130.0	CHEMBL2553	Homo sapiens	Residual Activity	%	130.0
	12254475	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	66.0	CHEMBL2553	Homo sapiens	Residual Activity	%	66.0
	12254476	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12254477	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	124.0	CHEMBL2553	Homo sapiens	Residual Activity	%	124.0
	12254478	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	112.0	CHEMBL2553	Homo sapiens	Residual Activity	%	112.0
	12254479	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	122.0	CHEMBL2553	Homo sapiens	Residual Activity	%	122.0
	12254480	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	95.0	CHEMBL2553	Homo sapiens	Residual Activity	%	95.0
	12254481	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	78.0	CHEMBL2553	Homo sapiens	Residual Activity	%	78.0
	12254482	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	15.0	CHEMBL2553	Homo sapiens	Residual Activity	%	15.0
	12254483	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254484	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	121.0	CHEMBL2553	Homo sapiens	Residual Activity	%	121.0
	12254485	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	93.0	CHEMBL2553	Homo sapiens	Residual Activity	%	93.0
	12254486	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	125.0	CHEMBL2553	Homo sapiens	Residual Activity	%	125.0
	12254487	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	11.0	CHEMBL2553	Homo sapiens	Residual Activity	%	11.0
	12254488	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	107.0	CHEMBL2553	Homo sapiens	Residual Activity	%	107.0
	12254489	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12254490	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254491	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	28.0	CHEMBL2553	Homo sapiens	Residual Activity	%	28.0
	12254492	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	63.0	CHEMBL2553	Homo sapiens	Residual Activity	%	63.0
	12254493	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	90.0	CHEMBL2553	Homo sapiens	Residual Activity	%	90.0
	12254494	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	95.0	CHEMBL2553	Homo sapiens	Residual Activity	%	95.0
	12254495	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	90.0	CHEMBL2553	Homo sapiens	Residual Activity	%	90.0
	12254496	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	82.0	CHEMBL2553	Homo sapiens	Residual Activity	%	82.0
	12254497	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	86.0	CHEMBL2553	Homo sapiens	Residual Activity	%	86.0
	12254498	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	87.0	CHEMBL2553	Homo sapiens	Residual Activity	%	87.0
	12254499	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	40.0	CHEMBL2553	Homo sapiens	Residual Activity	%	40.0
	12254500	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	116.0	CHEMBL2553	Homo sapiens	Residual Activity	%	116.0
	12254501	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	108.0	CHEMBL2553	Homo sapiens	Residual Activity	%	108.0
	12254502	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	51.0	CHEMBL2553	Homo sapiens	Residual Activity	%	51.0
	12254503	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12254504	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12254505	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254506	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254507	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12254508	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12254509	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	114.0	CHEMBL2553	Homo sapiens	Residual Activity	%	114.0
	12254510	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	58.0	CHEMBL2553	Homo sapiens	Residual Activity	%	58.0
	12254511	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12254512	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	91.0	CHEMBL2553	Homo sapiens	Residual Activity	%	91.0
	12254513	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	13.0	CHEMBL2553	Homo sapiens	Residual Activity	%	13.0
	12254514	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254515	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL2553	Homo sapiens	Residual Activity	%	102.0
	12254516	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	98.0	CHEMBL2553	Homo sapiens	Residual Activity	%	98.0
	12254517	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254518	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL2553	Homo sapiens	Residual Activity	%	102.0
	12254519	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	78.0	CHEMBL2553	Homo sapiens	Residual Activity	%	78.0
	12254520	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	101.0	CHEMBL2553	Homo sapiens	Residual Activity	%	101.0
	12254521	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	88.0	CHEMBL2553	Homo sapiens	Residual Activity	%	88.0
	12254522	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	45.0	CHEMBL2553	Homo sapiens	Residual Activity	%	45.0
	12254523	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254524	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	91.0	CHEMBL2553	Homo sapiens	Residual Activity	%	91.0
	12254525	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	118.0	CHEMBL2553	Homo sapiens	Residual Activity	%	118.0
	12254526	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	85.0	CHEMBL2553	Homo sapiens	Residual Activity	%	85.0
	12254527	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	119.0	CHEMBL2553	Homo sapiens	Residual Activity	%	119.0
	12254528	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12254529	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	73.0	CHEMBL2553	Homo sapiens	Residual Activity	%	73.0
	12254530	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	89.0	CHEMBL2553	Homo sapiens	Residual Activity	%	89.0
	12254531	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	67.0	CHEMBL2553	Homo sapiens	Residual Activity	%	67.0
	12254532	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	50.0	CHEMBL2553	Homo sapiens	Residual Activity	%	50.0
	12254533	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	55.0	CHEMBL2553	Homo sapiens	Residual Activity	%	55.0
	12254534	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	18.0	CHEMBL2553	Homo sapiens	Residual Activity	%	18.0
	12254535	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12254536	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	77.0	CHEMBL2553	Homo sapiens	Residual Activity	%	77.0
	12254537	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254538	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	122.0	CHEMBL2553	Homo sapiens	Residual Activity	%	122.0
	12254539	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL2553	Homo sapiens	Residual Activity	%	4.0
	12254540	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	90.0	CHEMBL2553	Homo sapiens	Residual Activity	%	90.0
	12254541	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	136.0	CHEMBL2553	Homo sapiens	Residual Activity	%	136.0
	12254542	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	86.0	CHEMBL2553	Homo sapiens	Residual Activity	%	86.0
	12254543	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	120.0	CHEMBL2553	Homo sapiens	Residual Activity	%	120.0
	12254544	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254545	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	32.0	CHEMBL2553	Homo sapiens	Residual Activity	%	32.0
	12254546	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	118.0	CHEMBL2553	Homo sapiens	Residual Activity	%	118.0
	12254547	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	58.0	CHEMBL2553	Homo sapiens	Residual Activity	%	58.0
	12254548	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	72.0	CHEMBL2553	Homo sapiens	Residual Activity	%	72.0
	12254549	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	114.0	CHEMBL2553	Homo sapiens	Residual Activity	%	114.0
	12254550	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	40.0	CHEMBL2553	Homo sapiens	Residual Activity	%	40.0
	12254551	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	53.0	CHEMBL2553	Homo sapiens	Residual Activity	%	53.0
	12254552	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12254553	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	95.0	CHEMBL2553	Homo sapiens	Residual Activity	%	95.0
	12254554	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	126.0	CHEMBL2553	Homo sapiens	Residual Activity	%	126.0
	12254555	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12254556	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12254557	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	102.0	CHEMBL2553	Homo sapiens	Residual Activity	%	102.0
	12254558	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254559	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL2553	Homo sapiens	Residual Activity	%	105.0
	12254560	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	60.0	CHEMBL2553	Homo sapiens	Residual Activity	%	60.0
	12254561	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	110.0	CHEMBL2553	Homo sapiens	Residual Activity	%	110.0
	12254562	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	125.0	CHEMBL2553	Homo sapiens	Residual Activity	%	125.0
	12254563	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	98.0	CHEMBL2553	Homo sapiens	Residual Activity	%	98.0
	12254564	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL2553	Homo sapiens	Residual Activity	%	113.0
	12254565	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	58.0	CHEMBL2553	Homo sapiens	Residual Activity	%	58.0
	12254566	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12254567	CHEMBL2219163	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	2.0	CHEMBL2553	Homo sapiens	Residual Activity	%	2.0
	12254568	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	87.0	CHEMBL2553	Homo sapiens	Residual Activity	%	87.0
	12254569	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	3.0	CHEMBL2553	Homo sapiens	Residual Activity	%	3.0
	12254570	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	79.0	CHEMBL2553	Homo sapiens	Residual Activity	%	79.0
	12254571	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	116.0	CHEMBL2553	Homo sapiens	Residual Activity	%	116.0
	12254572	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	59.0	CHEMBL2553	Homo sapiens	Residual Activity	%	59.0
	12254573	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	88.0	CHEMBL2553	Homo sapiens	Residual Activity	%	88.0
	12254574	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	6.0	CHEMBL2553	Homo sapiens	Residual Activity	%	6.0
	12254575	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	69.0	CHEMBL2553	Homo sapiens	Residual Activity	%	69.0
	12254576	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	89.0	CHEMBL2553	Homo sapiens	Residual Activity	%	89.0
	12254577	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	92.0	CHEMBL2553	Homo sapiens	Residual Activity	%	92.0
	12254578	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	101.0	CHEMBL2553	Homo sapiens	Residual Activity	%	101.0
	12254579	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	76.0	CHEMBL2553	Homo sapiens	Residual Activity	%	76.0
	12254580	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254581	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	65.0	CHEMBL2553	Homo sapiens	Residual Activity	%	65.0
	12254582	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	59.0	CHEMBL2553	Homo sapiens	Residual Activity	%	59.0
	12254583	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	82.0	CHEMBL2553	Homo sapiens	Residual Activity	%	82.0
	12254584	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254585	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL2553	Homo sapiens	Residual Activity	%	92.0
	12254586	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12254587	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	55.0	CHEMBL2553	Homo sapiens	Residual Activity	%	55.0
	12254588	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL2553	Homo sapiens	Residual Activity	%	99.0
	12254589	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	91.0	CHEMBL2553	Homo sapiens	Residual Activity	%	91.0
	12254590	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254591	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	85.0	CHEMBL2553	Homo sapiens	Residual Activity	%	85.0
	12254592	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	109.0	CHEMBL2553	Homo sapiens	Residual Activity	%	109.0
	12254593	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	72.0	CHEMBL2553	Homo sapiens	Residual Activity	%	72.0
	12254594	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	9.0	CHEMBL2553	Homo sapiens	Residual Activity	%	9.0
	12254595	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	45.0	CHEMBL2553	Homo sapiens	Residual Activity	%	45.0
	12254596	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	118.0	CHEMBL2553	Homo sapiens	Residual Activity	%	118.0
	12254597	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12254598	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	108.0	CHEMBL2553	Homo sapiens	Residual Activity	%	108.0
	12254599	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	77.0	CHEMBL2553	Homo sapiens	Residual Activity	%	77.0
	12254600	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254601	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254602	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	109.0	CHEMBL2553	Homo sapiens	Residual Activity	%	109.0
	12254603	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	118.0	CHEMBL2553	Homo sapiens	Residual Activity	%	118.0
	12254604	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	79.0	CHEMBL2553	Homo sapiens	Residual Activity	%	79.0
	12254605	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL2553	Homo sapiens	Residual Activity	%	112.0
	12254606	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254607	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL2553	Homo sapiens	Residual Activity	%	81.0
	12254608	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	117.0	CHEMBL2553	Homo sapiens	Residual Activity	%	117.0
	12254609	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL2553	Homo sapiens	Residual Activity	%	110.0
	12254610	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL2553	Homo sapiens	Residual Activity	%	4.0
	12254611	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL2553	Homo sapiens	Residual Activity	%	2.0
	12254612	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	81.0	CHEMBL2553	Homo sapiens	Residual Activity	%	81.0
	12254613	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	67.0	CHEMBL2553	Homo sapiens	Residual Activity	%	67.0
	12254614	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12254615	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	11.0	CHEMBL2553	Homo sapiens	Residual Activity	%	11.0
	12254616	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12254617	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL2553	Homo sapiens	Residual Activity	%	98.0
	12254618	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12254619	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	39.0	CHEMBL2553	Homo sapiens	Residual Activity	%	39.0
	12254620	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL2553	Homo sapiens	Residual Activity	%	4.0
	12254621	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	63.0	CHEMBL2553	Homo sapiens	Residual Activity	%	63.0
	12254622	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	102.0	CHEMBL2553	Homo sapiens	Residual Activity	%	102.0
	12254623	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL2553	Homo sapiens	Residual Activity	%	95.0
	12254624	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	75.0	CHEMBL2553	Homo sapiens	Residual Activity	%	75.0
	12254625	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	61.0	CHEMBL2553	Homo sapiens	Residual Activity	%	61.0
	12254626	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	58.0	CHEMBL2553	Homo sapiens	Residual Activity	%	58.0
	12254627	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	99.0	CHEMBL2553	Homo sapiens	Residual Activity	%	99.0
	12254628	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	29.0	CHEMBL2553	Homo sapiens	Residual Activity	%	29.0
	12254629	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12254630	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	78.0	CHEMBL2553	Homo sapiens	Residual Activity	%	78.0
	12254631	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	85.0	CHEMBL2553	Homo sapiens	Residual Activity	%	85.0
	12254632	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12254633	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	34.0	CHEMBL2553	Homo sapiens	Residual Activity	%	34.0
	12254634	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	84.0	CHEMBL2553	Homo sapiens	Residual Activity	%	84.0
	12254635	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	96.0	CHEMBL2553	Homo sapiens	Residual Activity	%	96.0
	12254636	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	83.0	CHEMBL2553	Homo sapiens	Residual Activity	%	83.0
	12254637	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	78.0	CHEMBL2553	Homo sapiens	Residual Activity	%	78.0
	12254638	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	86.0	CHEMBL2553	Homo sapiens	Residual Activity	%	86.0
	12254639	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	36.0	CHEMBL2553	Homo sapiens	Residual Activity	%	36.0
	12254640	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	2.0	CHEMBL2553	Homo sapiens	Residual Activity	%	2.0
	12254641	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	83.0	CHEMBL2553	Homo sapiens	Residual Activity	%	83.0
	12254642	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	66.0	CHEMBL2553	Homo sapiens	Residual Activity	%	66.0
	12254643	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	51.0	CHEMBL2553	Homo sapiens	Residual Activity	%	51.0
	12254644	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	65.0	CHEMBL2553	Homo sapiens	Residual Activity	%	65.0
	12254645	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL2553	Homo sapiens	Residual Activity	%	2.0
	12254646	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	57.0	CHEMBL2553	Homo sapiens	Residual Activity	%	57.0
	12254647	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2553	Homo sapiens	Residual Activity	%	0.0
	12254648	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL2553	Homo sapiens	Residual Activity	%	87.0
	12254649	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	8.0	CHEMBL2553	Homo sapiens	Residual Activity	%	8.0
	12254650	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	49.0	CHEMBL2553	Homo sapiens	Residual Activity	%	49.0
	12254651	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	48.0	CHEMBL2553	Homo sapiens	Residual Activity	%	48.0
	12254652	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	95.0	CHEMBL2553	Homo sapiens	Residual Activity	%	95.0
	12254653	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	89.0	CHEMBL2553	Homo sapiens	Residual Activity	%	89.0
	12254654	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	74.0	CHEMBL2553	Homo sapiens	Residual Activity	%	74.0
	12254655	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	80.0	CHEMBL2553	Homo sapiens	Residual Activity	%	80.0
	12254656	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12254657	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	6.0	CHEMBL2553	Homo sapiens	Residual Activity	%	6.0
	12254658	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254659	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL2553	Homo sapiens	Residual Activity	%	93.0
	12254660	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	15.0	CHEMBL2553	Homo sapiens	Residual Activity	%	15.0
	12254661	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL2553	Homo sapiens	Residual Activity	%	100.0
	12254662	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	76.0	CHEMBL2553	Homo sapiens	Residual Activity	%	76.0
	12254663	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	47.0	CHEMBL2553	Homo sapiens	Residual Activity	%	47.0
	12254664	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	81.0	CHEMBL2553	Homo sapiens	Residual Activity	%	81.0
	12254665	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	121.0	CHEMBL2553	Homo sapiens	Residual Activity	%	121.0
	12254666	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	78.0	CHEMBL2553	Homo sapiens	Residual Activity	%	78.0
	12254667	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	111.0	CHEMBL2553	Homo sapiens	Residual Activity	%	111.0
	12254668	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	43.0	CHEMBL2553	Homo sapiens	Residual Activity	%	43.0
	12254669	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL2553	Homo sapiens	Residual Activity	%	2.0
	12254670	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	81.0	CHEMBL2553	Homo sapiens	Residual Activity	%	81.0
	12254671	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	7.0	CHEMBL2553	Homo sapiens	Residual Activity	%	7.0
	12254672	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL2553	Homo sapiens	Residual Activity	%	91.0
	12254673	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	82.0	CHEMBL2553	Homo sapiens	Residual Activity	%	82.0
	12254674	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	106.0	CHEMBL2553	Homo sapiens	Residual Activity	%	106.0
	12254675	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	116.0	CHEMBL2553	Homo sapiens	Residual Activity	%	116.0
	12254676	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	101.0	CHEMBL2553	Homo sapiens	Residual Activity	%	101.0
	12254677	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	77.0	CHEMBL2553	Homo sapiens	Residual Activity	%	77.0
	12254678	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12254679	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	97.0	CHEMBL2553	Homo sapiens	Residual Activity	%	97.0
	12254680	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	24.0	CHEMBL2553	Homo sapiens	Residual Activity	%	24.0
	12256085	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	42.0	CHEMBL2553	Homo sapiens	Residual Activity	%	42.0
	12256086	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	67.0	CHEMBL2553	Homo sapiens	Residual Activity	%	67.0
	12256087	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	125.0	CHEMBL2553	Homo sapiens	Residual Activity	%	125.0
	12256088	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	33.0	CHEMBL2553	Homo sapiens	Residual Activity	%	33.0
	12256089	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12256090	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	91.0	CHEMBL2553	Homo sapiens	Residual Activity	%	91.0
	12256091	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	81.0	CHEMBL2553	Homo sapiens	Residual Activity	%	81.0
	12256092	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12256093	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	16.0	CHEMBL2553	Homo sapiens	Residual Activity	%	16.0
	12256094	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	22.0	CHEMBL2553	Homo sapiens	Residual Activity	%	22.0
	12256095	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	46.0	CHEMBL2553	Homo sapiens	Residual Activity	%	46.0
	12256096	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	12.0	CHEMBL2553	Homo sapiens	Residual Activity	%	12.0
	12256097	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	115.0	CHEMBL2553	Homo sapiens	Residual Activity	%	115.0
	12256098	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	19.0	CHEMBL2553	Homo sapiens	Residual Activity	%	19.0
	12256099	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	103.0	CHEMBL2553	Homo sapiens	Residual Activity	%	103.0
	12256100	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	109.0	CHEMBL2553	Homo sapiens	Residual Activity	%	109.0
	12256101	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL2553	Homo sapiens	Residual Activity	%	3.0
	12256102	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	59.0	CHEMBL2553	Homo sapiens	Residual Activity	%	59.0
	12256103	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	109.0	CHEMBL2553	Homo sapiens	Residual Activity	%	109.0
	12256104	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	64.0	CHEMBL2553	Homo sapiens	Residual Activity	%	64.0
	12256105	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	131.0	CHEMBL2553	Homo sapiens	Residual Activity	%	131.0
	12256106	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	68.0	CHEMBL2553	Homo sapiens	Residual Activity	%	68.0
	12256107	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	6.0	CHEMBL2553	Homo sapiens	Residual Activity	%	6.0
	12256108	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL2553	Homo sapiens	Residual Activity	%	87.0
	12256109	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL2553	Homo sapiens	Residual Activity	%	7.0
	12256110	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	73.0	CHEMBL2553	Homo sapiens	Residual Activity	%	73.0
	12256111	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL2553	Homo sapiens	Residual Activity	%	93.0
	12256112	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	42.0	CHEMBL2553	Homo sapiens	Residual Activity	%	42.0
	12256113	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	24.0	CHEMBL2553	Homo sapiens	Residual Activity	%	24.0
	12256114	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	79.0	CHEMBL2553	Homo sapiens	Residual Activity	%	79.0
	12256115	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	74.0	CHEMBL2553	Homo sapiens	Residual Activity	%	74.0
	12256116	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL2553	Homo sapiens	Residual Activity	%	102.0
	12256117	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	56.0	CHEMBL2553	Homo sapiens	Residual Activity	%	56.0
	12256118	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	59.0	CHEMBL2553	Homo sapiens	Residual Activity	%	59.0
	12256119	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	53.0	CHEMBL2553	Homo sapiens	Residual Activity	%	53.0
	12256120	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	64.0	CHEMBL2553	Homo sapiens	Residual Activity	%	64.0
	12256121	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL2553	Homo sapiens	Residual Activity	%	104.0
	12256122	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	17.0	CHEMBL2553	Homo sapiens	Residual Activity	%	17.0
	12256123	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	89.0	CHEMBL2553	Homo sapiens	Residual Activity	%	89.0
	12256124	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	107.0	CHEMBL2553	Homo sapiens	Residual Activity	%	107.0
	12256125	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL2553	Homo sapiens	Residual Activity	%	99.0
	12256126	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	94.0	CHEMBL2553	Homo sapiens	Residual Activity	%	94.0
	12256127	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	41.0	CHEMBL2553	Homo sapiens	Residual Activity	%	41.0
	12256128	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	83.0	CHEMBL2553	Homo sapiens	Residual Activity	%	83.0
	12256129	CHEMBL2219164	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	1.0	CHEMBL2553	Homo sapiens	Residual Activity	%	1.0
	12647859	CHEMBL2329057	Inhibition of RSK1 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	12647860	CHEMBL2329057	Inhibition of RSK1 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	12647861	CHEMBL2329057	Inhibition of RSK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	12647862	CHEMBL2329057	Inhibition of RSK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	42.0	CHEMBL2553	Homo sapiens	INH	%	42.0
	12649555	CHEMBL2329520	Inhibition of RSK1 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	80.0	CHEMBL2553	Homo sapiens	INH	%	80.0
	12649556	CHEMBL2329520	Inhibition of RSK1 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	84.0	CHEMBL2553	Homo sapiens	INH	%	84.0
	12649557	CHEMBL2329520	Inhibition of RSK1 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	95.0	CHEMBL2553	Homo sapiens	INH	%	95.0
	12672903	CHEMBL2341619	Inhibition of recombinant RSK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	12.0	CHEMBL2553	Homo sapiens	Activity	%	12.0
	12672904	CHEMBL2341619	Inhibition of recombinant RSK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	18.0	CHEMBL2553	Homo sapiens	Activity	%	18.0
	12693170	CHEMBL2345771	Inhibition of RSK1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	nM	10000.0
	12727656	CHEMBL2351120	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	85.0	CHEMBL2553	Homo sapiens	Activity	%	85.0
	12728942	CHEMBL2352841	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL2553	Homo sapiens	Activity	%	97.0
	12729829	CHEMBL2352161	Inhibition of RSK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	12730085	CHEMBL2351120	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL2553	Homo sapiens	Activity	%	105.0
	13281269	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	31.0	CHEMBL2553	Homo sapiens	INH	%	31.0
	13281270	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	72.0	CHEMBL2553	Homo sapiens	INH	%	72.0
	13281271	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	40.0	CHEMBL2553	Homo sapiens	INH	%	40.0
	13281272	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	13281273	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	13281274	CHEMBL2378203	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	73.0	CHEMBL2553	Homo sapiens	INH	%	73.0
Active	13300204	CHEMBL2384451	Inhibition of human RSK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(N4CCC(N)CC4)nn23)cn1		CHEMBL2380696		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	13300205	CHEMBL2384451	Inhibition of human RSK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)C4)nn23)cn1		CHEMBL2380692		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	13300206	CHEMBL2384451	Inhibition of human RSK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	13301913	CHEMBL2383373	Inhibition of human RPS6KA1 at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2n[nH]c3cc(-c4cnn(C)c4)c(NC4CCCCC4)cc23)c1		CHEMBL2380587	>	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	13374357	CHEMBL2406300	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	13416805	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	13416806	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	27.0	CHEMBL2553	Homo sapiens	INH	%	27.0
	13416807	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	28.0	CHEMBL2553	Homo sapiens	INH	%	28.0
	13416808	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	42.0	CHEMBL2553	Homo sapiens	INH	%	42.0
	13416809	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	74.0	CHEMBL2553	Homo sapiens	INH	%	74.0
	13416810	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	97.0	CHEMBL2553	Homo sapiens	INH	%	97.0
	13416811	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	13416812	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	64.0	CHEMBL2553	Homo sapiens	INH	%	64.0
	13416813	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	48.0	CHEMBL2553	Homo sapiens	INH	%	48.0
	13416814	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
	13416815	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	85.0	CHEMBL2553	Homo sapiens	INH	%	85.0
	13416816	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	74.0	CHEMBL2553	Homo sapiens	INH	%	74.0
	13416817	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	40.0	CHEMBL2553	Homo sapiens	INH	%	40.0
	13416818	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	95.0	CHEMBL2553	Homo sapiens	INH	%	95.0
	13416819	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	67.0	CHEMBL2553	Homo sapiens	INH	%	67.0
	13416820	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	46.0	CHEMBL2553	Homo sapiens	INH	%	46.0
	13416821	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	64.0	CHEMBL2553	Homo sapiens	INH	%	64.0
	13416822	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	45.0	CHEMBL2553	Homo sapiens	INH	%	45.0
	13416823	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	16.0	CHEMBL2553	Homo sapiens	INH	%	16.0
	13416824	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	20.0	CHEMBL2553	Homo sapiens	INH	%	20.0
	13416825	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	29.0	CHEMBL2553	Homo sapiens	INH	%	29.0
	13416826	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	33.0	CHEMBL2553	Homo sapiens	INH	%	33.0
	13416827	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	29.0	CHEMBL2553	Homo sapiens	INH	%	29.0
	13416828	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	82.0	CHEMBL2553	Homo sapiens	INH	%	82.0
	13416829	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	66.0	CHEMBL2553	Homo sapiens	INH	%	66.0
	13416830	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	42.0	CHEMBL2553	Homo sapiens	INH	%	42.0
	13416831	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
	13416832	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	39.0	CHEMBL2553	Homo sapiens	INH	%	39.0
	13416833	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	71.0	CHEMBL2553	Homo sapiens	INH	%	71.0
	13416834	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	77.0	CHEMBL2553	Homo sapiens	INH	%	77.0
	13416835	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	81.0	CHEMBL2553	Homo sapiens	INH	%	81.0
	13416836	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	72.0	CHEMBL2553	Homo sapiens	INH	%	72.0
	13416837	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	60.0	CHEMBL2553	Homo sapiens	INH	%	60.0
	13416838	CHEMBL2424334	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	94.0	CHEMBL2553	Homo sapiens	INH	%	94.0
	13420997	CHEMBL2424127	Inhibition of RSK1 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	13000.0	CHEMBL2553	Homo sapiens	IC50	uM	13.0
	13420998	CHEMBL2424127	Inhibition of RSK1 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	IC50	nM	63000.0	CHEMBL2553	Homo sapiens	IC50	uM	63.0
	13439759	CHEMBL2429000	Competitive binding affinity to RPS6KA1 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	95.0	CHEMBL2553	Homo sapiens	INH	%	95.0
	13439760	CHEMBL2429001	Competitive binding affinity to RPS6KA1 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	66.0	CHEMBL2553	Homo sapiens	INH	%	66.0
	13442413	CHEMBL2429001	Competitive binding affinity to RPS6KA1 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL2553	Homo sapiens	INH	%	85.0
	13442477	CHEMBL2429170	Binding affinity to RPS6KA1 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	2100.0	CHEMBL2553	Homo sapiens	Kd	uM	2.1
	13445592	CHEMBL2429000	Competitive binding affinity to RPS6KA1 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
	13445593	CHEMBL2429001	Competitive binding affinity to RPS6KA1 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	13451579	CHEMBL2429000	Competitive binding affinity to RPS6KA1 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
	13451580	CHEMBL2429001	Competitive binding affinity to RPS6KA1 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
Active	13475277	CHEMBL2438988	Inhibition of human wild type RSK1 at 1 uM by qPCR analysis	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	13475278	CHEMBL2438988	Inhibition of human wild type RSK1 at 1 uM by qPCR analysis	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	13488408	CHEMBL2439421	Inhibition of human RSK1 at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	13488409	CHEMBL2439421	Inhibition of human RSK1 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	13863528	CHEMBL3101997	Inhibition of RPS6KA1 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	13863529	CHEMBL3101997	Inhibition of RPS6KA1 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	13871753	CHEMBL3100918	Inhibition of human Rsk1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	114.0	CHEMBL2553	Homo sapiens	Activity	%	114.0
	13954741	CHEMBL3130946	Inhibition of human RSK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	76.0	CHEMBL2553	Homo sapiens	Activity	%	76.0
	13954746	CHEMBL3130946	Inhibition of human RSK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	73.0	CHEMBL2553	Homo sapiens	Activity	%	73.0
	13954760	CHEMBL3130946	Inhibition of human RSK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	63.0	CHEMBL2553	Homo sapiens	Activity	%	63.0
	13966050	CHEMBL3136666	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	60.5	CHEMBL2553	Homo sapiens	INH	%	60.5
	13973325	CHEMBL3135063	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	48.5	CHEMBL2553	Homo sapiens	INH	%	48.5
	13974043	CHEMBL3136635	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	37.0	CHEMBL2553	Homo sapiens	INH	%	37.0
	13974134	CHEMBL3136348	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	13974225	CHEMBL3135450	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	98.5	CHEMBL2553	Homo sapiens	INH	%	98.5
	13974963	CHEMBL3136985	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	87.0	CHEMBL2553	Homo sapiens	INH	%	87.0
	13975054	CHEMBL3136132	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	11.5	CHEMBL2553	Homo sapiens	INH	%	11.5
	13975145	CHEMBL3134750	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	19.5	CHEMBL2553	Homo sapiens	INH	%	19.5
	13975236	CHEMBL3136517	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	7.5	CHEMBL2553	Homo sapiens	INH	%	7.5
	13975879	CHEMBL3135650	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	11.5	CHEMBL2553	Homo sapiens	INH	%	11.5
	13975972	CHEMBL3136169	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	38.0	CHEMBL2553	Homo sapiens	INH	%	38.0
	13976063	CHEMBL3136047	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	83.5	CHEMBL2553	Homo sapiens	INH	%	83.5
	13976154	CHEMBL3135091	Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	48.0	CHEMBL2553	Homo sapiens	INH	%	48.0
	14545802	CHEMBL3224472	Inhibition of RSK1 (unknown origin) assessed as residual activity at 1 uM	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	Activity	%	64.3	CHEMBL2553	Homo sapiens	Activity	%	64.3
	14545826	CHEMBL3224499	Inhibition of RSK1 (unknown origin)	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	<	IC50	nM	1.0	CHEMBL2553	Homo sapiens	IC50	nM	1.0
	14585324	CHEMBL3241840	Inhibition of human Rsk1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	145.0	CHEMBL2553	Homo sapiens	Activity	%	145.0
	14648054	CHEMBL3265837	Inhibition of human RSK1 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	14648055	CHEMBL3265837	Inhibition of human RSK1 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	=	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	14664317	CHEMBL3271265	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	98.0	CHEMBL2553	Homo sapiens	INH	%	98.0
	14664318	CHEMBL3271265	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	92.0	CHEMBL2553	Homo sapiens	INH	%	92.0
	14664319	CHEMBL3271265	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	67.0	CHEMBL2553	Homo sapiens	INH	%	67.0
Active	14982887	CHEMBL3378508	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as increase in phosphorylation of eEF2 at 100 uM by immunoblotting analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	14982888	CHEMBL3378507	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as increase in phosphorylation of eEF2 at 50 uM by immunoblotting analysis	B	CC(=O)O[C@H]1[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(C)=O)[C@@H]1O		CHEMBL3356439		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	14982889	CHEMBL3378507	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as increase in phosphorylation of eEF2 at 50 uM by immunoblotting analysis	B	CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H]1O		CHEMBL3356435		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	14982911	CHEMBL3378517	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as decrease in intensity of band at 65 and 27 kDa at 100 uM by immunoblotting analysis	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	14982912	CHEMBL3378516	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as decrease in intensity of band at 65 and 27 kDa at 50 uM by immunoblotting analysis	B	CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@@H]1O		CHEMBL3356435		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	14982913	CHEMBL3378516	Inhibition of RSK in PMA-stimulated human MCF7 cells assessed as decrease in intensity of band at 65 and 27 kDa at 50 uM by immunoblotting analysis	B	CC(=O)O[C@H]1[C@H](C)C[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](OC(C)=O)[C@@H]1O		CHEMBL3356439		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	14999390	CHEMBL3368686	Inhibition of human RSK1 at 10 uM relative to control	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(F)c(O)c2)C1		CHEMBL3323358	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	15018690	CHEMBL3369190	Inhibition of RSK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	1.8	CHEMBL2553	Homo sapiens	INH	%	1.8
	15019202	CHEMBL3364395	Inhibition of RSK1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	15058848	CHEMBL3371402	Inhibition of RPS6KA1 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	42.0	CHEMBL2553	Homo sapiens	Activity	%	42.0
	15072483	CHEMBL3379512	Inhibition of RSK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	108.0	CHEMBL2553	Homo sapiens	Activity	%	108.0
	15075125	CHEMBL3376337	Inhibition of RSK1 (unknown origin) at 1 uM	B	CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1		CHEMBL3326802	=	Inhibition	%	78.0	CHEMBL2553	Homo sapiens	INH	%	78.0
	15104857	CHEMBL3386815	Inhibition of RSK1 (KD 1-N-terminal domain) (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	27.0	CHEMBL2553	Homo sapiens	Activity	%	27.0
	15190979	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	15190980	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	15190981	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	15190982	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	15190983	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	43.0	CHEMBL2553	Homo sapiens	INH	%	43.0
	15190984	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	21.0	CHEMBL2553	Homo sapiens	INH	%	21.0
	15190985	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	23.0	CHEMBL2553	Homo sapiens	INH	%	23.0
	15190986	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	12.0	CHEMBL2553	Homo sapiens	INH	%	12.0
	15190987	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	15190988	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
	15190989	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	15190990	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	15190991	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	5.0	CHEMBL2553	Homo sapiens	INH	%	5.0
	15190992	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	15190993	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	15190994	CHEMBL3412791	Inhibition of RSK1 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	15251845	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	47.0	CHEMBL2553	Homo sapiens	Activity	%	47.0
	15251952	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	29.0	CHEMBL2553	Homo sapiens	Activity	%	29.0
	15252054	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	62.0	CHEMBL2553	Homo sapiens	Activity	%	62.0
	15252699	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	69.0	CHEMBL2553	Homo sapiens	Activity	%	69.0
	15252801	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	92.0	CHEMBL2553	Homo sapiens	Activity	%	92.0
	15252903	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	87.0	CHEMBL2553	Homo sapiens	Activity	%	87.0
	15253577	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	92.0	CHEMBL2553	Homo sapiens	Activity	%	92.0
	15253679	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	90.0	CHEMBL2553	Homo sapiens	Activity	%	90.0
	15253781	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	87.0	CHEMBL2553	Homo sapiens	Activity	%	87.0
	15254447	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	62.0	CHEMBL2553	Homo sapiens	Activity	%	62.0
	15254549	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	74.0	CHEMBL2553	Homo sapiens	Activity	%	74.0
	15254651	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	44.0	CHEMBL2553	Homo sapiens	Activity	%	44.0
	15255342	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	80.0	CHEMBL2553	Homo sapiens	Activity	%	80.0
	15255444	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	15256176	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	115.0	CHEMBL2553	Homo sapiens	Activity	%	115.0
	15256278	CHEMBL3428236	Inhibition of RSK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	112.0	CHEMBL2553	Homo sapiens	Activity	%	112.0
	15684364	CHEMBL3607886	Binding affinity to DNA-tagged RSK1 N-terminal kinase domain (unknown origin) assessed as level of protein captured on solid support at 10 uM by qPCR analysis relative to control	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	Activity	%	0.0	CHEMBL2553	Homo sapiens	Activity	%	0.0
	15686142	CHEMBL3606974	Inhibition of RSK1 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL2553	Homo sapiens	INH	%	80.0
	15686161	CHEMBL3606883	Inhibition of RSK1 (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL2553	Homo sapiens	INH	%	80.0
	15735982	CHEMBL3624366	Inhibition of human recombinant Rsk1	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	15756823	CHEMBL3631327	Inhibition of RSK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	51.97	CHEMBL2553	Homo sapiens	INH	%	51.97
	15757900	CHEMBL3631327	Inhibition of RSK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	72.98	CHEMBL2553	Homo sapiens	INH	%	72.98
	15758879	CHEMBL3631327	Inhibition of RSK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.6	CHEMBL2553	Homo sapiens	INH	%	11.6
273871	16258064	CHEMBL3707977	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	0.19	CHEMBL2553	Homo sapiens	IC50	nM	0.19
273838	16326324	CHEMBL3707977	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	=	IC50	nM	4253.0	CHEMBL2553	Homo sapiens	IC50	nM	4253.0
	16376480	CHEMBL3734504	Inhibition of recombinant human RSK1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	16388326	CHEMBL3737501	Inhibition of RSK1 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	44.0	CHEMBL2553	Homo sapiens	INH	%	44.0
	16397349	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	23.0	CHEMBL2553	Homo sapiens	INH	%	23.0
	16397350	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
	16397351	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	12.0	CHEMBL2553	Homo sapiens	INH	%	12.0
	16397352	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	38.0	CHEMBL2553	Homo sapiens	INH	%	38.0
	16397353	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	16397354	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	33.0	CHEMBL2553	Homo sapiens	INH	%	33.0
	16397355	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	16397356	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	16397357	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	35.0	CHEMBL2553	Homo sapiens	INH	%	35.0
	16397358	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	16397359	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	16397360	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	14.0	CHEMBL2553	Homo sapiens	INH	%	14.0
	16397361	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	16.0	CHEMBL2553	Homo sapiens	INH	%	16.0
	16397362	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	36.0	CHEMBL2553	Homo sapiens	INH	%	36.0
	16397363	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
	16397364	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	16397365	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	34.0	CHEMBL2553	Homo sapiens	INH	%	34.0
	16397366	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	16397367	CHEMBL3743113	Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	16425276	CHEMBL3751108	Inhibition of Rsk1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.4	CHEMBL2553	Homo sapiens	INH	%	-0.4
	16431995	CHEMBL3750034	Inhibition of human RSK1 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL2553	Homo sapiens	IC50	uM	5.0
	16446727	CHEMBL3757132	Inhibition of recombinant human RSK1 assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	14.9	CHEMBL2553	Homo sapiens	Activity	%	14.9
	16446736	CHEMBL3756065	Inhibition of recombinant human RSK1 by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	311.0	CHEMBL2553	Homo sapiens	IC50	nM	311.0
	16451599	CHEMBL3761180	Inhibition of RSK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	13.9	CHEMBL2553	Homo sapiens	INH	%	13.9
	16451750	CHEMBL3761180	Inhibition of RSK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	19.5	CHEMBL2553	Homo sapiens	INH	%	19.5
	16495215	CHEMBL3777757	Inhibition of N-terminal His6-tagged recombinant human RSK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-20.0	CHEMBL2553	Homo sapiens	Activity	%	-20.0
	16496134	CHEMBL3777757	Inhibition of N-terminal His6-tagged recombinant human RSK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL2553	Homo sapiens	Activity	%	-6.0
Not Active	16496867	CHEMBL3776415	Inhibition of human RSK1 (1 to 735 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	16507365	CHEMBL3777419	Inhibition of recombinant RSK1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	77.0	CHEMBL2553	Homo sapiens	Activity	%	77.0
	16508924	CHEMBL3777757	Inhibition of N-terminal His6-tagged recombinant human RSK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL2553	Homo sapiens	Activity	%	5.0
	16534418	CHEMBL3789282	Inhibition of human RSK1 at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	100.0	CHEMBL2553	Homo sapiens	INH	%	100.0
	16578362	CHEMBL3804621	Inhibition of partial length wild type human RSK1(Kin.Dom.1-N-terminal) expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	16589171	CHEMBL3807599	Inhibition of RSK1 (unknown origin) at 0.5 uM by Z-LYTE kinase assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	88.5	CHEMBL2553	Homo sapiens	INH	%	88.5
	16589705	CHEMBL3807893	Inhibition of RSK1 (unknown origin) by Z-LYTE kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.2	CHEMBL2553	Homo sapiens	IC50	nM	1.2
Active	16595030	CHEMBL3812739	Inhibition of RSK1 (unknown origin) at 10 uM	B	Cc1nn(-c2ccccc2)c2nc(CNc3ccc(O)cc3)n(C)c(=O)c12		CHEMBL3808883		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	16611961	CHEMBL3815435	Inhibition of human MAPKAPK1alpha (1 to 735 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-82.0	CHEMBL2553	Homo sapiens	Activity	%	-82.0
	16611962	CHEMBL3815435	Inhibition of human MAPKAPK1alpha (1 to 735 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-56.0	CHEMBL2553	Homo sapiens	Activity	%	-56.0
	16611963	CHEMBL3815435	Inhibition of human MAPKAPK1alpha (1 to 735 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-86.0	CHEMBL2553	Homo sapiens	Activity	%	-86.0
	16611964	CHEMBL3815435	Inhibition of human MAPKAPK1alpha (1 to 735 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-88.0	CHEMBL2553	Homo sapiens	Activity	%	-88.0
	16612700	CHEMBL3815728	Inhibition of human RSK1 (1 to 735 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-69.0	CHEMBL2553	Homo sapiens	Activity	%	-69.0
	16614622	CHEMBL3816768	Inhibition of human RSK1 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	16618648	CHEMBL3816525	Inhibition of full length recombinant human His-tagged RSK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	16642019	CHEMBL3826430	Inhibition of His-tagged full-length recombinant human RSK1 expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	2.0	CHEMBL2553	Homo sapiens	INH	%	2.0
	16654176	CHEMBL3830959	Inhibition of human RSK1 (1 to 735 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	31.0	CHEMBL2553	Homo sapiens	Activity	%	31.0
412653	17777368	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	COc1ccc([C@H](NC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c2cnn(C)c2)cc1F		CHEMBL3920757	=	IC50	nM	18.7	CHEMBL2553	Homo sapiens	IC50	nM	18.7
412654	17777369	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	COc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H](C)CO)cc3n2)c2cnn(C)c2)cc1F		CHEMBL3953138	=	IC50	nM	37.8	CHEMBL2553	Homo sapiens	IC50	nM	37.8
412655	17777370	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)c1ccc2cnc(NC3CCOCC3)cc2n1		CHEMBL4112022	=	IC50	nM	16.3	CHEMBL2553	Homo sapiens	IC50	nM	16.3
412656	17777371	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	CC[C@@H](NC(=O)c1ccc2cnc(NC3CCOCC3)cc2n1)c1ccc(OC)c(F)c1		CHEMBL4112587	=	IC50	nM	5.96	CHEMBL2553	Homo sapiens	IC50	nM	5.96
412657	17777372	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	Cn1nccc1Nc1cc2nc(C(=O)N[C@H](CO)c3ccc(Cl)c(F)c3)ccc2cn1		CHEMBL4108790	=	IC50	nM	9.84	CHEMBL2553	Homo sapiens	IC50	nM	9.84
412658	17777373	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	O=C(NCc1ccc(Cl)c(F)c1)c1ccc2cnc(NC3CCOCC3)cc2n1		CHEMBL3963644	=	IC50	nM	98.9	CHEMBL2553	Homo sapiens	IC50	nM	98.9
412659	17777374	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	O=C(NCCc1ccc(Cl)c(F)c1)c1ccc2cnc(NC3CCOCC3)cc2n1		CHEMBL3903344	=	IC50	nM	476.0	CHEMBL2553	Homo sapiens	IC50	nM	476.0
412660	17777375	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	CC[C@@H](NC(=O)c1ccc2cnc(NC3CCOCC3)cc2c1)c1ccc(Cl)c(F)c1		CHEMBL4115564	=	IC50	nM	8.5	CHEMBL2553	Homo sapiens	IC50	nM	8.5
412661	17777376	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	Cn1cc([C@@H](NC(=O)c2ccc3cnc(Nc4ccnn4C)cc3c2)c2ccc(Cl)c(F)c2)cn1		CHEMBL3976074	=	IC50	nM	9.97	CHEMBL2553	Homo sapiens	IC50	nM	9.97
412662	17777377	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)c1ccc2cnc(NC3CCOCC3)cc2c1		CHEMBL4113272	=	IC50	nM	14.8	CHEMBL2553	Homo sapiens	IC50	nM	14.8
412663	17777378	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	C[C@@H](CO)Nc1cc2cc(C(=O)NCc3cc4c(F)cccc4[nH]3)ccc2cn1		CHEMBL3925797	=	IC50	nM	65.1	CHEMBL2553	Homo sapiens	IC50	nM	65.1
412664	17777379	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	COc1ccc([C@H](NC(=O)c2ccc3cnc(Nc4cc(C)nn4C)cc3c2)c2cnn(C)c2)cc1F		CHEMBL3969698	=	IC50	nM	30.4	CHEMBL2553	Homo sapiens	IC50	nM	30.4
412665	17777380	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	CC[C@@H](NC(=O)c1ccc2cnc(Nc3cc(C)nn3C)cc2c1)c1ccc(Cl)c(F)c1		CHEMBL4108819	=	IC50	nM	15.7	CHEMBL2553	Homo sapiens	IC50	nM	15.7
412666	17777381	CHEMBL3888723	Phosphorylation Assay: HepG2 cells were obtained from ATCC and grown in DMEM supplemented with 10% fetal bovine serum. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach overnight at 37° C./5% CO2. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 1.5 hour compound incubation, cells were stimulated with the addition of PMA (phorbol 12-myristate 13-acetate) at a final concentration of 100 ng/mL; the PMA stimulation was a 30-minute incubation at 37° C./5% CO2. After the 30-minute PMA stimulation, cells were washed with PBS and fixed in 3.7% formaldehyde in PBS at room temperature for 15-20 minutes. This was followed by another wash in PBS and then permeabilization in 100% MeOH at room temperature for 10-15 minutes. Following the permeabilization incubation, cells were washed in PBS/0.05% Tween-20, followed by a block in Odyssey blocking buffer (LI-COR Biosciences) for at least 1 hour. Antibodies to phosphorylated P90RSK(Ser380) (Cell Signaling #9335, rabbit monoclonal) and GAPDH (Fitzgerald 10R-G109a, mouse monoclonal) were added to the cells and incubated overnight at 4° C. pP90RSK(Ser380) antibody was used at a 1:250 dilution; GAPDH was used at a 1:10,000 dilution. After washing with PBS/0.05% Tween-20, the cells were incubated with fluorescently-labeled secondary antibodies (Anti-rabbit-Alexa Flour680, Invitrogen Cat#A21109; Anti-mouse-IRDye800CW, Rockland Inc. Cat#610-131-121) for 1 hour. Both secondary antibodies were used at a 1:1000 dilution. Cells were then washed and analyzed for fluorescence at both wavelengths using the Odyssey Infrared Imaging System (LI-COR Biosciences). Phosphorylated P90RSK(Ser380) signal was normalized to GAPDH signal.	B	COc1ccc([C@@H]2CN(C)C[C@H]2NC(=O)c2ccc3cnc(Nc4cc(C)nn4C)cc3c2)cc1		CHEMBL3964006	=	IC50	nM	5.47	CHEMBL2553	Homo sapiens	IC50	nM	5.47
Inactive	17936224	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936225	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936226	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936227	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	820.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	820.0
Inactive	17936228	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936229	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936230	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936231	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936232	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2398.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2398.0
Inactive	17936233	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936234	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936235	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936236	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936237	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936238	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936239	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936240	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936241	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936242	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936243	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2994.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2994.0
Inactive	17936244	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936245	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	2406.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2406.0
Inactive	17936246	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936247	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936248	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936249	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936250	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936251	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936252	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936253	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936254	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936255	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936256	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936257	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936258	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936259	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936260	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936261	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936262	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936263	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936264	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936265	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936266	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936267	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936268	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936269	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936270	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936271	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936272	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936273	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17936274	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2339.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2339.0
Inactive	17936275	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936276	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936277	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	5920.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	5920.0
Inactive	17936278	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936279	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936280	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936281	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936282	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936283	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936284	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936285	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936286	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936287	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936288	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936289	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936290	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936291	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936292	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936293	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936294	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936295	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936296	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936297	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	3416.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	3416.0
Inactive	17936298	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936299	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936300	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936301	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936302	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936303	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936304	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936305	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936306	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936307	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936308	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936309	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936310	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936311	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936312	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936313	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936314	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936315	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936316	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936317	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936318	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936319	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936320	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936321	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936322	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936323	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936324	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936325	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936326	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936327	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936328	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936329	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936330	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936331	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936332	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936333	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936334	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2675.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2675.0
Inactive	17936335	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936336	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936337	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936338	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936339	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936340	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936341	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936342	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936343	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936344	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936345	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936346	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936347	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936348	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936349	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	4135.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	4135.0
Inactive	17936350	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936351	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936352	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936353	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936354	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936355	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	471.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	471.0
Inactive	17936356	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936357	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936358	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936359	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936360	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936361	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	8560.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	8560.0
Inactive	17936362	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936363	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17936364	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	16936.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	16936.0
Inactive	17936365	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936366	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936367	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936368	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936369	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936370	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936371	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936372	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936373	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936374	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936375	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936376	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936377	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936378	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936379	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936380	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936381	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936382	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936383	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936384	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936385	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936386	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936387	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936388	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936389	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936390	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936391	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936392	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936393	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17936394	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	5202.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	5202.0
Inactive	17936395	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936396	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936397	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936398	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936399	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936400	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936401	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936402	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	22726.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	22726.0
Inactive	17936403	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936404	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936405	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	799.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	799.0
Inactive	17936406	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936407	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936408	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936409	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936410	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936411	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936412	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936413	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936414	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936415	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936416	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	2647.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2647.0
Inactive	17936417	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936418	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936419	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936420	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	3438.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	3438.0
Inactive	17936421	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936422	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936423	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936424	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936425	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936426	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936427	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2022.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2022.0
Inactive	17936428	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936429	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936430	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	21402.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	21402.0
Inactive	17936431	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936432	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936433	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936434	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936435	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936436	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936437	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936438	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936439	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936440	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936441	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936442	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936443	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936444	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936445	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936446	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936447	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936448	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936449	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936450	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936451	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936452	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936453	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936454	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	251.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	251.0
Inactive	17936455	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Active	17936456	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2477.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	2477.0
Inactive	17936457	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936458	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936459	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936460	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936461	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936462	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936463	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936464	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936465	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936466	CHEMBL3991872	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2553	Homo sapiens	Kd apparent	nM	30000.0
	17964950	CHEMBL3995061	Inhibition of human RSK1 kinase domain 1-N-terminal (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	38.0	CHEMBL2553	Homo sapiens	Activity	%	38.0
	18008349	CHEMBL4003702	Inhibition of RSK1 (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	=	IC50	nM	5.4	CHEMBL2553	Homo sapiens	IC50	nM	5.4
	18083261	CHEMBL4018031	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
Not Active	18083262	CHEMBL4018031	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	18083263	CHEMBL4018031	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	18083264	CHEMBL4018031	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	18114842	CHEMBL4025372	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL2553	Homo sapiens	Activity	%	87.0
	18114843	CHEMBL4025373	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18153035	CHEMBL4034482	Inhibition of RSK1 domain 2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.3	CHEMBL2553	Homo sapiens	INH	%	9.3
	18153036	CHEMBL4034481	Inhibition of RSK1 domain 1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	3.5	CHEMBL2553	Homo sapiens	INH	%	3.5
	18153227	CHEMBL4034480	Inhibition of RSK1 domain 1 activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	0.1	CHEMBL2553	Homo sapiens	INH	%	0.1
	18203896	CHEMBL4044183	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	78.0	CHEMBL2553	Homo sapiens	Activity	%	78.0
	18203897	CHEMBL4044184	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	18211722	CHEMBL4045818	Inhibition of RSK1 domain1 activation Loop (LTDFGLSKEAIDHEKK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	14.3	CHEMBL2553	Homo sapiens	INH	%	14.3
	18211723	CHEMBL4045819	Inhibition of RSK1 domain1 conserved Lys2 (DLKPENILLDEEGHIKLTDFGLSKEAIDHEK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	11.0	CHEMBL2553	Homo sapiens	INH	%	11.0
	18211724	CHEMBL4045820	Inhibition of RSK1 domain2 conserved Lys2 (DLKPSNILYVDESGNPECLR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-6.0	CHEMBL2553	Homo sapiens	INH	%	-6.0
	18211725	CHEMBL4045821	Inhibition of RSK1 conserved Lys2 (DLKPENILLDEEGHIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.2	CHEMBL2553	Homo sapiens	INH	%	10.2
	18211963	CHEMBL4046059	Inhibition of RSK1 domain1 activation Loop (LTDFGLSKEAIDHEKK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	17.2	CHEMBL2553	Homo sapiens	INH	%	17.2
	18211964	CHEMBL4046060	Inhibition of RSK1 domain1 conserved Lys2 (DLKPENILLDEEGHIKLTDFGLSKEAIDHEK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	5.3	CHEMBL2553	Homo sapiens	INH	%	5.3
	18211965	CHEMBL4046061	Inhibition of RSK1 domain2 conserved Lys2 (DLKPSNILYVDESGNPECLR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	8.3	CHEMBL2553	Homo sapiens	INH	%	8.3
	18211966	CHEMBL4046062	Inhibition of RSK1 conserved Lys2 (DLKPENILLDEEGHIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	11.8	CHEMBL2553	Homo sapiens	INH	%	11.8
	18212129	CHEMBL4046147	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL2553	Homo sapiens	INH	%	20.0
	18225286	CHEMBL4048667	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	18232196	CHEMBL4050310	Inhibition of human RSK1 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	50.0	CHEMBL2553	Homo sapiens	Activity	%	50.0
	18253393	CHEMBL4054980	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	67.0	CHEMBL2553	Homo sapiens	Activity	%	67.0
	18253394	CHEMBL4054980	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18253481	CHEMBL4055024	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 1 (P360 to L681 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	81.0	CHEMBL2553	Homo sapiens	Activity	%	81.0
	18253482	CHEMBL4055024	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 1 (P360 to L681 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18265797	CHEMBL4057247	Inhibition of RSK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	27.3	CHEMBL2553	Homo sapiens	INH	%	27.3
	18265995	CHEMBL4057445	Inhibition of RSK1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.3	CHEMBL2553	Homo sapiens	INH	%	2.3
	18266178	CHEMBL4057628	Inhibition of RSK1 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	0.3	CHEMBL2553	Homo sapiens	INH	%	0.3
	18269015	CHEMBL4058145	Inhibition of RSK1 (unknown origin) preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	nM	10000.0
	18275259	CHEMBL4118465	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LTDFGLSKEAIDHEKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	56.2	CHEMBL2553	Homo sapiens	INH	%	56.2
	18275260	CHEMBL4118465	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LTDFGLSKEAIDHEKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	33.5	CHEMBL2553	Homo sapiens	INH	%	33.5
	18275261	CHEMBL4118465	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LTDFGLSKEAIDHEKK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	54.5	CHEMBL2553	Homo sapiens	INH	%	54.5
	18275262	CHEMBL4118466	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	42.5	CHEMBL2553	Homo sapiens	INH	%	42.5
	18275263	CHEMBL4118466	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	13.0	CHEMBL2553	Homo sapiens	INH	%	13.0
	18275264	CHEMBL4118466	Inhibition of RSK1 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENILLDEEGHIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	65.4	CHEMBL2553	Homo sapiens	INH	%	65.4
	18275271	CHEMBL4118469	Inhibition of RSK1 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPECLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-32.9	CHEMBL2553	Homo sapiens	INH	%	-32.9
	18275272	CHEMBL4118469	Inhibition of RSK1 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPECLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	12.8	CHEMBL2553	Homo sapiens	INH	%	12.8
	18275273	CHEMBL4118469	Inhibition of RSK1 domain2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNILYVDESGNPECLR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	6.4	CHEMBL2553	Homo sapiens	INH	%	6.4
Active	18275725	CHEMBL4118685	Binding affinity to RPS6KA1 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18275903	CHEMBL4118863	Binding affinity to RPS6KA1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2553	Homo sapiens	Activity		
	18282201	CHEMBL4120156	Inhibition of recombinant full length His-tagged human RSK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	5.5	CHEMBL2553	Homo sapiens	INH	%	5.5
	18282520	CHEMBL4120156	Inhibition of recombinant full length His-tagged human RSK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.1	CHEMBL2553	Homo sapiens	INH	%	2.1
	18282637	CHEMBL4120251	Inhibition of RSK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	27.3	CHEMBL2553	Homo sapiens	INH	%	27.3
	18282882	CHEMBL4120467	Inhibition of RSK1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	4.7	CHEMBL2553	Homo sapiens	INH	%	4.7
	18283096	CHEMBL4120681	Inhibition of RSK1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	18288071	CHEMBL4121778	Inhibition of human RSK1 measured at apparent ATP Km level	B	C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(-c5ccc(F)c(C(F)(F)F)c5)cn4CCN4CCCC4)CC3)c21		CHEMBL4128457	=	IC50	nM	20.0	CHEMBL2553	Homo sapiens	IC50	uM	0.02
	18288072	CHEMBL4121778	Inhibition of human RSK1 measured at apparent ATP Km level	B	C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C(F)(F)F)cn4CCN4CCCC4)CC3)c21		CHEMBL4129817	=	IC50	nM	272.0	CHEMBL2553	Homo sapiens	IC50	uM	0.272
	18288073	CHEMBL4121778	Inhibition of human RSK1 measured at apparent ATP Km level	B	C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C5CCOCC5)cn4CCN4CCCC4)CC3)c21		CHEMBL4126067	=	IC50	nM	699.0	CHEMBL2553	Homo sapiens	IC50	uM	0.699
	18288074	CHEMBL4121778	Inhibition of human RSK1 measured at apparent ATP Km level	B	C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(CCC(F)(F)F)cn4CCN4CCCC4)CC3)c21		CHEMBL4129379	=	IC50	nM	568.0	CHEMBL2553	Homo sapiens	IC50	uM	0.568
	18379944	CHEMBL4145845	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-2.9	CHEMBL2553	Homo sapiens	INH	%	-2.9
	18379996	CHEMBL4145897	Inhibition of RSK1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.09	CHEMBL2553	Homo sapiens	IC50	nM	0.09
	18440438	CHEMBL4157262	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	95.0	CHEMBL2553	Homo sapiens	Activity	%	95.0
	18440439	CHEMBL4157263	Binding affinity to wild-type human partial length C-termianl RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18443278	CHEMBL4157935	Inhibition of human RSK1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	101.0	CHEMBL2553	Homo sapiens	Activity	%	101.0
	18449810	CHEMBL4178047	Inhibition of human RSK1 (1 to 735 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	128.0	CHEMBL2553	Homo sapiens	Activity	%	128.0
	18457610	CHEMBL4179658	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	18457611	CHEMBL4179658	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	18457612	CHEMBL4179658	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	18457613	CHEMBL4179658	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	18462196	CHEMBL4180883	Inhibition of recombinant human full length His6-tagged RSK1 expressed in Sf21 insect cells assessed as residual activity at 1 uM using KKLNRTLSVA as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	65.0	CHEMBL2553	Homo sapiens	Activity	%	65.0
	18463803	CHEMBL4181219	Inhibition of recombinant human full length N-terminal His6-tagged RSK1 expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
Active	18476845	CHEMBL4183721	Induction of RPS6KA1 degradation in human NCI-H3122 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476846	CHEMBL4183721	Induction of RPS6KA1 degradation in human NCI-H3122 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476851	CHEMBL4183723	Induction of RPS6KA1 degradation in human KARPAS299 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476852	CHEMBL4183723	Induction of RPS6KA1 degradation in human KARPAS299 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476857	CHEMBL4183726	Induction of RPS6KA1 degradation in human Kelly cells at 10 to 160 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476858	CHEMBL4183726	Induction of RPS6KA1 degradation in human Kelly cells at 10 to 160 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476863	CHEMBL4183729	Induction of RPS6KA1 degradation in human NCI-H3122 cells at 250 nM measured over 2 to 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476864	CHEMBL4183729	Induction of RPS6KA1 degradation in human NCI-H3122 cells at 250 nM measured over 2 to 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476871	CHEMBL4183733	Induction of RPS6KA1 degradation in human Kelly cells at 100 nM measured over 2 to 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL2553	Homo sapiens	Activity		
Active	18476872	CHEMBL4183733	Induction of RPS6KA1 degradation in human Kelly cells at 100 nM measured over 2 to 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL2553	Homo sapiens	Activity		
	18484394	CHEMBL4186041	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18484395	CHEMBL4186042	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	18484878	CHEMBL4186041	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	18484879	CHEMBL4186042	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL2553	Homo sapiens	Activity	%	99.0
	18507617	CHEMBL4191175	Inhibition of recombinant full-length human Rsk1 at 1 uM using KKKNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-17.0	CHEMBL2553	Homo sapiens	INH	%	-17.0
	18653379	CHEMBL4230216	Inhibition of RSK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
	18653380	CHEMBL4230216	Inhibition of RSK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	18655293	CHEMBL4230942	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18655294	CHEMBL4230941	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	99.0	CHEMBL2553	Homo sapiens	Activity	%	99.0
	18665527	CHEMBL4233403	Inhibition of RSK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2553	Homo sapiens	IC50	nM	1000.0
	18674886	CHEMBL4235431	Inhibition of RSK1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2553	Homo sapiens	Ki	nM	2000.0
	18674887	CHEMBL4235431	Inhibition of RSK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2553	Homo sapiens	Ki	nM	2000.0
Not Determined	18674888	CHEMBL4235431	Inhibition of RSK1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2553	Homo sapiens	Ki		
	18697685	CHEMBL4254358	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	64.0	CHEMBL2553	Homo sapiens	Activity	%	64.0
	18708929	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	19.0	CHEMBL2553	Homo sapiens	INH	%	19.0
	18708958	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	89.0	CHEMBL2553	Homo sapiens	INH	%	89.0
	18708984	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	27.0	CHEMBL2553	Homo sapiens	INH	%	27.0
	18709019	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	23.0	CHEMBL2553	Homo sapiens	INH	%	23.0
	18709048	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	10.0	CHEMBL2553	Homo sapiens	INH	%	10.0
	18709077	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	91.0	CHEMBL2553	Homo sapiens	INH	%	91.0
	18709106	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	89.0	CHEMBL2553	Homo sapiens	INH	%	89.0
	18709153	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	17.0	CHEMBL2553	Homo sapiens	INH	%	17.0
	18709183	CHEMBL4256675	Inhibition of RSK1 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	19.0	CHEMBL2553	Homo sapiens	INH	%	19.0
	18709212	CHEMBL4256649	Inhibition of RSK1 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	38.0	CHEMBL2553	Homo sapiens	INH	%	38.0
	18709254	CHEMBL4256675	Inhibition of RSK1 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	41.0	CHEMBL2553	Homo sapiens	INH	%	41.0
	18709287	CHEMBL4256675	Inhibition of RSK1 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	98.0	CHEMBL2553	Homo sapiens	INH	%	98.0
	18728869	CHEMBL4259699	Inhibition of RSK1 (unknown origin) at 1 uM after 40 mins by scintillation counting method relative to control	B	O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1		CHEMBL4285143	=	Inhibition	%	83.0	CHEMBL2553	Homo sapiens	INH	%	83.0
	18751230	CHEMBL4263939	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	10.0	CHEMBL2553	Homo sapiens	INH	%	10.0
	18752193	CHEMBL4264530	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	94.0	CHEMBL2553	Homo sapiens	Activity	%	94.0
	18752194	CHEMBL4264531	Binding affinity to wild-type human partial length C-termianl RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18761580	CHEMBL4266631	Inhibition of human RSK1 at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	51.0	CHEMBL2553	Homo sapiens	INH	%	51.0
	18761851	CHEMBL4266631	Inhibition of human RSK1 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	12.0	CHEMBL2553	Homo sapiens	INH	%	12.0
	18762014	CHEMBL4266631	Inhibition of human RSK1 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	9.0	CHEMBL2553	Homo sapiens	INH	%	9.0
	18764400	CHEMBL4267052	Inhibition of human RSK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2553	Homo sapiens	INH	%	70.0
	18764401	CHEMBL4267052	Inhibition of human RSK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2553	Homo sapiens	INH	%	70.0
	18764402	CHEMBL4267052	Inhibition of human RSK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2553	Homo sapiens	INH	%	70.0
	18782827	CHEMBL4270693	Inhibition of RSK1 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	60.0	CHEMBL2553	Homo sapiens	Activity	%	60.0
	18858193	CHEMBL4308039	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	18858194	CHEMBL4308040	Binding affinity to wild-type human partial length C- terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	18892704	CHEMBL4314545	Inhibition of recombinant full-length human Rsk1 assessed as residual activity at 10 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	111.5	CHEMBL2553	Homo sapiens	Activity	%	111.5
	18919403	CHEMBL4322763	Binding affinity to recombinant full length human N-terminal GST-tagged RPS6KA1 expressed in baculovirus expression system using S6K peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	16.0	CHEMBL2553	Homo sapiens	Kd	nM	16.0
	18919591	CHEMBL4322763	Binding affinity to recombinant full length human N-terminal GST-tagged RPS6KA1 expressed in baculovirus expression system using S6K peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	36.0	CHEMBL2553	Homo sapiens	Kd	nM	36.0
	18938281	CHEMBL4327867	Inhibition of human RSK1 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	92.41	CHEMBL2553	Homo sapiens	Activity	%	92.41
	18938282	CHEMBL4327867	Inhibition of human RSK1 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.72	CHEMBL2553	Homo sapiens	Activity	%	96.72
	18938712	CHEMBL4328231	Inhibition of human RSK1 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2553	Homo sapiens	Activity	%	65.0
	18939098	CHEMBL4328595	Inhibition of human RSK1 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.126	CHEMBL2553	Homo sapiens	IC50	10'-10M	1.26
	18953728	CHEMBL4331955	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	61.0	CHEMBL2553	Homo sapiens	INH	%	61.0
	18953790	CHEMBL4331955	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	59.0	CHEMBL2553	Homo sapiens	INH	%	59.0
	18953869	CHEMBL4331955	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	84.0	CHEMBL2553	Homo sapiens	INH	%	84.0
	18953961	CHEMBL4332014	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	62.0	CHEMBL2553	Homo sapiens	INH	%	62.0
	18954025	CHEMBL4332014	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	3.0	CHEMBL2553	Homo sapiens	INH	%	3.0
	18954092	CHEMBL4331955	Inhibition of RSK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	84.0	CHEMBL2553	Homo sapiens	INH	%	84.0
	18958566	CHEMBL4333625	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	85.0	CHEMBL2553	Homo sapiens	Activity	%	85.0
	18958567	CHEMBL4333624	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL2553	Homo sapiens	Activity	%	84.0
	18964666	CHEMBL4335274	Inhibition of recombinant full length human Rsk1 assessed as residual activity at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	105.0	CHEMBL2553	Homo sapiens	Activity	%	105.0
	18964667	CHEMBL4335274	Inhibition of recombinant full length human Rsk1 assessed as residual activity at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL2553	Homo sapiens	Activity	%	90.0
	18972088	CHEMBL4337098	Inhibition of recombinant full length human Rsk1 assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	46.0	CHEMBL2553	Homo sapiens	Activity	%	46.0
	18989965	CHEMBL4340958	Inhibition of RPS6KA1 (unknown origin) at 1 uM relative to control	B	COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21		CHEMBL4556293	<	Inhibition	%	25.0	CHEMBL2553	Homo sapiens	INH	%	25.0
	19021564	CHEMBL4347787	Inhibition of recombinant human RSK1 at 20 nM using CREBtide as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	1.0	CHEMBL2553	Homo sapiens	INH	%	1.0
	19021565	CHEMBL4347788	Inhibition of recombinant human RSK1 at 200 nM using CREBtide as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	26.0	CHEMBL2553	Homo sapiens	INH	%	26.0
	19032213	CHEMBL4349806	Inhibition of RPS6KA1 (unknown origin) at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	7.0	CHEMBL2553	Homo sapiens	INH	%	7.0
Not Active	19040146	CHEMBL4352047	Inhibition of recombinant full-length human Rsk1 at 10 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Active	19041273	CHEMBL4352534	Inhibition of human RSK1 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	19059818	CHEMBL4358119	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	19059819	CHEMBL4358120	Binding affinity to wild-type human partial length C- terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	19090382	CHEMBL4365956	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	19090383	CHEMBL4365957	Inhibition of wild-type human partial length N-terminal RSK1 kinase domain 1 (P360 to L681 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	19092106	CHEMBL4366580	Inhibition of human RSK1 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.83	CHEMBL2553	Homo sapiens	INH	%	10.83
	19114483	CHEMBL4371437	Binding affinity to RPS6KA1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	3152.0	CHEMBL2553	Homo sapiens	Kd(free)	uM	3.152
	19114707	CHEMBL4371437	Binding affinity to RPS6KA1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	5474.0	CHEMBL2553	Homo sapiens	Kd(free)	uM	5.474
	19118533	CHEMBL4372377	Inhibition of RSK1 (unknown origin) at 1 uM in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	14.0	CHEMBL2553	Homo sapiens	INH	%	14.0
	19144834	CHEMBL4377850	Inhibition of recombinant full-length human Rsk1 at 1 uM using KKKNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	21.0	CHEMBL2553	Homo sapiens	INH	%	21.0
	19146969	CHEMBL4378823	Inhibition of full length recombinant human Rsk1 at 10 uM using KKKNRTLSVA as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	22.0	CHEMBL2553	Homo sapiens	INH	%	22.0
	19148027	CHEMBL4379423	Inhibition of recombinant full length human Rsk1 using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	uM	10.0
	19159646	CHEMBL4382750	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	4.3	CHEMBL2553	Homo sapiens	Activity	%	4.3
	19159647	CHEMBL4382751	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	44.0	CHEMBL2553	Homo sapiens	Activity	%	44.0
	19181134	CHEMBL4387345	Inhibition of recombinant full length human His-tagged RSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	19181359	CHEMBL4387345	Inhibition of recombinant full length human His-tagged RSK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	19.5	CHEMBL2553	Homo sapiens	INH	%	19.5
	19191360	CHEMBL4389470	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	60.0	CHEMBL2553	Homo sapiens	INH	%	60.0
	19191361	CHEMBL4389469	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	42.0	CHEMBL2553	Homo sapiens	INH	%	42.0
	19192132	CHEMBL4389946	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
	19192133	CHEMBL4389947	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	88.0	CHEMBL2553	Homo sapiens	INH	%	88.0
	19200388	CHEMBL4391572	Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	3.9	CHEMBL2553	Homo sapiens	Activity	%	3.9
	19200389	CHEMBL4391573	Binding affinity to wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	53.0	CHEMBL2553	Homo sapiens	Activity	%	53.0
	19242752	CHEMBL4400087	Inhibition of recombinant full length human RSK1 assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	45.0	CHEMBL2553	Homo sapiens	Activity	%	45.0
	19266601	CHEMBL4405551	Inhibition of wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	19266602	CHEMBL4405552	Inhibition of wild-type human partial length C-terminal RSK1 kinase domain 2 (P360 to L681 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2553	Homo sapiens	INH	%	50.0
	19273854	CHEMBL4407369	Inhibition of RSK1 (unknown origin) by mobility shift assay	B	CNC(=O)C[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1		CHEMBL4440965	=	IC50	nM	131.0	CHEMBL2553	Homo sapiens	IC50	nM	131.0
	19273855	CHEMBL4407369	Inhibition of RSK1 (unknown origin) by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl		CHEMBL4441825	=	IC50	nM	32.0	CHEMBL2553	Homo sapiens	IC50	nM	32.0
	19273856	CHEMBL4407369	Inhibition of RSK1 (unknown origin) by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O		CHEMBL4457064	=	IC50	nM	48.0	CHEMBL2553	Homo sapiens	IC50	nM	48.0
	19273857	CHEMBL4407369	Inhibition of RSK1 (unknown origin) by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	IC50	nM	339.0	CHEMBL2553	Homo sapiens	IC50	nM	339.0
	19276119	CHEMBL4408122	Inhibition of recombinant human full length RSK1 at 1 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	19296352	CHEMBL4412528	Inhibition of RPS6KA1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	4.0	CHEMBL2553	Homo sapiens	INH	%	4.0
	19303787	CHEMBL4414239	Inhibition of RSK1 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	99.0	CHEMBL2553	Homo sapiens	Activity	%	99.0
	20600662	CHEMBL4603614	Inhibition of recombinant full length human His-tagged RPS6KA1 expressed in baculovirus expression system using tyrosine-06 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2553	Homo sapiens	IC50	uM	100.0
	20680691	CHEMBL4623010	Inhibition of RSK1 (unknown origin) using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK a substrate by [32P] gammaATP assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	31.0	CHEMBL2553	Homo sapiens	IC50	nM	31.0
	20680695	CHEMBL4623001	Inhibition of RSK1 (unknown origin)	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	3.0	CHEMBL2553	Homo sapiens	IC50	nM	3.0
	20680696	CHEMBL4623001	Inhibition of RSK1 (unknown origin)	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	6.0	CHEMBL2553	Homo sapiens	IC50	nM	6.0
	22392155	CHEMBL4667250	Inhibition of recombinant human His-tagged full length RSK1 expressed in baculovirus expression system using Ser/Thr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	8.0	CHEMBL2553	Homo sapiens	INH	%	8.0
	22423265	CHEMBL4674208	Inhibition of human RSK1 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	90.99	CHEMBL2553	Homo sapiens	Activity	%	90.99
	22423266	CHEMBL4674208	Inhibition of human RSK1 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	68.03	CHEMBL2553	Homo sapiens	Activity	%	68.03
Not Determined	22752709	CHEMBL4700177	Inhibition of human RSK1 by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL2553	Homo sapiens	IC50		
	22752710	CHEMBL4700177	Inhibition of human RSK1 by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	22800.0	CHEMBL2553	Homo sapiens	IC50	uM	22.8
	22768268	CHEMBL4703627	Inhibition of RSK1 (unknown origin)	B	COc1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4742990	=	IC50	nM	483.0	CHEMBL2553	Homo sapiens	IC50	nM	483.0
	22768269	CHEMBL4703627	Inhibition of RSK1 (unknown origin)	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	IC50	nM	3151.0	CHEMBL2553	Homo sapiens	IC50	nM	3151.0
	22770394	CHEMBL4704291	Inhibition of RSK1 (unknown origin) at 1 uM relative to control	B	Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12		CHEMBL4778578	=	Inhibition	%	55.0	CHEMBL2553	Homo sapiens	INH	%	55.0
	22809798	CHEMBL4713333	Inhibition of recombinant full length human Rsk1 assessed as residual activity at 1 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	62.0	CHEMBL2553	Homo sapiens	Activity	%	62.0
	22820578	CHEMBL4716291	Inhibition of recombinant full length N-terminal His6-tagged human RSK1 expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	55.0	CHEMBL2553	Homo sapiens	Activity	%	55.0
	22820579	CHEMBL4716291	Inhibition of recombinant full length N-terminal His6-tagged human RSK1 expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	3.0	CHEMBL2553	Homo sapiens	Activity	%	3.0
	22826347	CHEMBL4717532	Inhibition of recombinant full length N-terminal His6-tagged human RSK1 expressed in Sf21 insect cells at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL2553	Homo sapiens	INH	%	60.0
	22843211	CHEMBL4720238	Inhibition of RSK1 (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	nM	10000.0
	22843212	CHEMBL4720238	Inhibition of RSK1 (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	IC50	nM	10000.0	CHEMBL2553	Homo sapiens	IC50	nM	10000.0
	22843578	CHEMBL4720564	Inhibition of human RSK1 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.126	CHEMBL2553	Homo sapiens	IC50	10^-10M	1.26
	22843921	CHEMBL4720907	Inhibition of human RSK1 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.67	CHEMBL2553	Homo sapiens	Activity	%	95.67
	22844857	CHEMBL4721532	Inhibition of wild-type human partial length N-terminal RSK1 kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	87.12	CHEMBL2553	Homo sapiens	Activity	%	87.12
	22849805	CHEMBL4723236	Binding affinity to wild-type human partial length RSK1 expressed in bacterial expression system assessed as inhibition of probe binding at 3 uM by Kinomescan method	B	CC(C)Oc1cc(NC(=O)N2CCCc3cc(CN4CCCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4764394	=	Inhibition	%	68.0	CHEMBL2553	Homo sapiens	INH	%	68.0
	22950619	CHEMBL4766186	Inhibition of human full length recombinant RSK1 using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	559.0	CHEMBL2553	Homo sapiens	IC50	uM	0.5589999999999999
	22952988	CHEMBL4766925	Inhibition of recombinant full length human Rsk1 assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	56.0	CHEMBL2553	Homo sapiens	Activity	%	56.0
	23120998	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	3300.0	CHEMBL2553	Homo sapiens	IC50	uM	3.3
	23120999	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	13300.0	CHEMBL2553	Homo sapiens	IC50	uM	13.3
	23121000	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	15800.0	CHEMBL2553	Homo sapiens	IC50	uM	15.8
	23121001	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	5400.0	CHEMBL2553	Homo sapiens	IC50	uM	5.4
	23121002	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	59900.0	CHEMBL2553	Homo sapiens	IC50	uM	59.9
	23121003	CHEMBL4804486	Inhibition of RSK1 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	24000.0	CHEMBL2553	Homo sapiens	IC50	uM	24.0
	23121016	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-7700.0	CHEMBL2553	Homo sapiens	IC50	uM	-7.7
	23121017	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	3800.0	CHEMBL2553	Homo sapiens	IC50	uM	3.8
	23121018	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-1400.0	CHEMBL2553	Homo sapiens	IC50	uM	-1.4
	23121019	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	11000.0	CHEMBL2553	Homo sapiens	IC50	uM	11.0
	23121020	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-700.0	CHEMBL2553	Homo sapiens	IC50	uM	-0.7
	23121021	CHEMBL4804489	Inhibition of RSK1 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	1000.0	CHEMBL2553	Homo sapiens	IC50	uM	1.0
	23122037	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122038	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122039	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122040	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122041	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	<=	Inhibition	%	75.0	CHEMBL2553	Homo sapiens	INH	%	75.0
	23122042	CHEMBL4804668	Inhibition of RSK1 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	<=	Inhibition	%	75.0	CHEMBL2553	Homo sapiens	INH	%	75.0
	23122055	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122056	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122057	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122058	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122059	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122060	CHEMBL4804671	Inhibition of RSK1 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2553	Homo sapiens	INH	%	0.0
	23122803	CHEMBL4805154	Inhibition of human N-terminal RSK1 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	91.0	CHEMBL2553	Homo sapiens	Activity	%	91.0
	23122804	CHEMBL4805155	Inhibition of human C-terminal RSK1 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	97.0	CHEMBL2553	Homo sapiens	Activity	%	97.0
	23123498	CHEMBL4805742	Inhibition of human N-terminal RSK1 kinase domain 1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	93.0	CHEMBL2553	Homo sapiens	Activity	%	93.0
	23123499	CHEMBL4805743	Inhibition of human C-terminal RSK1 kinase domain 2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	23123953	CHEMBL4806197	Inhibition of DNA-tagged human N-terminal RSK1 kinase domain 1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	23123954	CHEMBL4806198	Inhibition of DNA-tagged human C-terminal RSK1 kinase domain 2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	84.0	CHEMBL2553	Homo sapiens	Activity	%	84.0
	23125086	CHEMBL4806759	Inhibition of human N-terminal RSK1 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL2553	Homo sapiens	Activity	%	98.0
	23125087	CHEMBL4806759	Inhibition of human N-terminal RSK1 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL2553	Homo sapiens	Activity	%	96.0
	23125088	CHEMBL4806760	Inhibition of human C-terminal RSK1 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2553	Homo sapiens	Activity	%	100.0
	23125089	CHEMBL4806760	Inhibition of human C-terminal RSK1 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL2553	Homo sapiens	Activity	%	86.0
	23128542	CHEMBL4807989	Inhibition of RPS6KA1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2553	Homo sapiens	Activity	%	75.0
	23128543	CHEMBL4807989	Inhibition of RPS6KA1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2553	Homo sapiens	Activity	%	75.0
	23128544	CHEMBL4807989	Inhibition of RPS6KA1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2553	Homo sapiens	Activity	%	75.0
	23213441	CHEMBL4822975	Inhibition of human recombinant RSK1 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	6.0	CHEMBL2553	Homo sapiens	INH	%	6.0
	23216109	CHEMBL4823624	Inhibition of recombinant full length human Rsk1 using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL2553	Homo sapiens	IC50	nM	1000.0
	23239302	CHEMBL4828827	Inhibition of ADP(ATP)-biotin probe binding to RSK1 domain 1 in human Kelly cells at 1 uM incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	Inhibition	%	35.4	CHEMBL2553	Homo sapiens	INH	%	35.4
	23246348	CHEMBL4830040	Inhibition of RSK1 (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	=	IC50	nM	756.0	CHEMBL2553	Homo sapiens	IC50	nM	756.0
	23297880	CHEMBL4841338	Inhibition of full length recombinant His-tagged human RSK1 expressed in baculovirus expression system using biotin-labelled AGAGRSRHSSYPAGT-OH as substrate in presence of ATP	B	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		CHEMBL3604793	=	IC50	nM	6.0	CHEMBL2553	Homo sapiens	IC50	nM	6.0
	23297881	CHEMBL4841338	Inhibition of full length recombinant His-tagged human RSK1 expressed in baculovirus expression system using biotin-labelled AGAGRSRHSSYPAGT-OH as substrate in presence of ATP	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	IC50	nM	5.0	CHEMBL2553	Homo sapiens	IC50	nM	5.0
Not Active	23297915	CHEMBL4841347	Inhibition of RSK1 in human TE-10 cells assessed as suppression of EIF4B phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
Not Active	23297916	CHEMBL4841348	Inhibition of RSK1 in human TE-10 cells assessed as suppression of P27KIP1 phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL2553	Homo sapiens	INH		
	23297923	CHEMBL4841355	Inhibition of RSK1 (unknown origin) at 100 nM relative to control	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762	>	Inhibition	%	90.0	CHEMBL2553	Homo sapiens	INH	%	90.0
Not Active	23317639	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23317640	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23318107	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL2553	Homo sapiens	% Control	%	96.0
Not Active	23318108	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23318773	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	89.0	CHEMBL2553	Homo sapiens	% Control	%	89.0
Not Active	23318774	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23319257	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	72.0	CHEMBL2553	Homo sapiens	% Control	%	72.0
Not Active	23319258	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23319894	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	97.7	CHEMBL2553	Homo sapiens	% Control	%	97.7
Not Active	23319895	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23320369	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	91.3	CHEMBL2553	Homo sapiens	% Control	%	91.3
Not Active	23320370	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	75.7	CHEMBL2553	Homo sapiens	% Control	%	75.7
Not Active	23321047	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23321048	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23321515	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23321516	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23322145	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	87.0	CHEMBL2553	Homo sapiens	% Control	%	87.0
Not Active	23322146	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	74.0	CHEMBL2553	Homo sapiens	% Control	%	74.0
Not Active	23322613	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23322614	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	77.0	CHEMBL2553	Homo sapiens	% Control	%	77.0
Not Active	23323302	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	98.0	CHEMBL2553	Homo sapiens	% Control	%	98.0
Not Active	23323303	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	85.0	CHEMBL2553	Homo sapiens	% Control	%	85.0
Not Active	23323770	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23323771	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23324125	CHEMBL4880744	Rsk1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	46.0	CHEMBL2553	Homo sapiens	% inhibition	%	46.0
Not Active	23324624	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	91.2	CHEMBL2553	Homo sapiens	% Control	%	91.2
Not Active	23324625	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23325259	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	90.0	CHEMBL2553	Homo sapiens	% Control	%	90.0
Not Active	23325260	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	95.0	CHEMBL2553	Homo sapiens	% Control	%	95.0
Not Active	23325727	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23325728	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL2553	Homo sapiens	% Control	%	92.0
Not Active	23326374	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL2553	Homo sapiens	% Control	%	91.0
Not Active	23326375	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	75.0	CHEMBL2553	Homo sapiens	% Control	%	75.0
Not Active	23326842	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	98.0	CHEMBL2553	Homo sapiens	% Control	%	98.0
Not Active	23326843	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23327542	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23327543	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23328010	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	89.0	CHEMBL2553	Homo sapiens	% Control	%	89.0
Not Active	23328011	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23328597	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23328598	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	78.0	CHEMBL2553	Homo sapiens	% Control	%	78.0
Not Active	23329065	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23329066	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23329515	CHEMBL4881222	Rsk1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	121.0	CHEMBL2553	Homo sapiens	% residual kinase activity	%	121.0
Not Active	23330011	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23330012	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23330479	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23330480	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23331235	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23331236	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23331703	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	87.0	CHEMBL2553	Homo sapiens	% Control	%	87.0
Not Active	23331704	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23332290	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	97.0	CHEMBL2553	Homo sapiens	% Control	%	97.0
Not Active	23332291	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23332756	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	91.7	CHEMBL2553	Homo sapiens	% Control	%	91.7
Not Active	23332757	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23333474	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23333475	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	91.5	CHEMBL2553	Homo sapiens	% Control	%	91.5
Not Active	23334113	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	76.0	CHEMBL2553	Homo sapiens	% Control	%	76.0
Not Active	23334114	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23334581	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23334582	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23334958	CHEMBL4881578	Rsk1 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	72.0	CHEMBL2553	Homo sapiens	% inhibition	%	72.0
Not Active	23335560	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	91.0	CHEMBL2553	Homo sapiens	% Control	%	91.0
Not Active	23335561	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23336028	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	86.0	CHEMBL2553	Homo sapiens	% Control	%	86.0
Not Active	23336029	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23336655	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	94.0	CHEMBL2553	Homo sapiens	% Control	%	94.0
Not Active	23336656	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	83.0	CHEMBL2553	Homo sapiens	% Control	%	83.0
Not Active	23337123	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	98.0	CHEMBL2553	Homo sapiens	% Control	%	98.0
Not Active	23337124	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	96.0	CHEMBL2553	Homo sapiens	% Control	%	96.0
Not Active	23337762	CHEMBL4882133	RPS6KA1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.0	CHEMBL2553	Homo sapiens	% Ctrl	%	96.0
Not Active	23338204	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23338205	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23338672	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23338673	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23339284	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23339285	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	87.0	CHEMBL2553	Homo sapiens	% Control	%	87.0
Not Active	23339752	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Active	23339753	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	0.0	CHEMBL2553	Homo sapiens	% Control	%	0.0
Not Active	23340389	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	77.0	CHEMBL2553	Homo sapiens	% Control	%	77.0
Not Active	23340390	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	79.0	CHEMBL2553	Homo sapiens	% Control	%	79.0
Not Active	23340857	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23340858	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23341514	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23341515	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23341982	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23341983	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23342598	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23342599	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23343066	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23343067	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23343696	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL2553	Homo sapiens	% Control	%	97.0
Not Active	23343697	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	84.0	CHEMBL2553	Homo sapiens	% Control	%	84.0
Not Active	23344164	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23344165	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL2553	Homo sapiens	% Control	%	95.0
Not Active	23344802	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23344803	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23345375	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	74.0	CHEMBL2553	Homo sapiens	% Control	%	74.0
Not Active	23345376	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23345843	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23345844	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	82.0	CHEMBL2553	Homo sapiens	% Control	%	82.0
Not Active	23346420	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23346421	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23346888	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	91.2	CHEMBL2553	Homo sapiens	% Control	%	91.2
Not Active	23346889	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23347488	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.9	CHEMBL2553	Homo sapiens	% Control	%	89.9
Not Active	23347489	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23347980	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	90.3	CHEMBL2553	Homo sapiens	% Control	%	90.3
Not Active	23347981	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23348559	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23348560	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23349027	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23349028	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	88.0	CHEMBL2553	Homo sapiens	% Control	%	88.0
Not Active	23349614	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	90.0	CHEMBL2553	Homo sapiens	% Control	%	90.0
Not Active	23349615	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23350232	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	81.0	CHEMBL2553	Homo sapiens	% Control	%	81.0
Not Active	23350233	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23350700	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	82.0	CHEMBL2553	Homo sapiens	% Control	%	82.0
Not Active	23350701	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	95.0	CHEMBL2553	Homo sapiens	% Control	%	95.0
Not Active	23351305	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23351306	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23351773	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	91.0	CHEMBL2553	Homo sapiens	% Control	%	91.0
Not Active	23351774	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23352214	CHEMBL4882903	RPS6KA1 (RSK1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.657	CHEMBL2553	Homo sapiens	% Inhibition	%	8.6568
Not Active	23352797	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	97.0	CHEMBL2553	Homo sapiens	% Control	%	97.0
Not Active	23352798	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23353265	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23353266	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23354147	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23354148	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23354615	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23354616	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23355347	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23355348	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23355815	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23355816	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23356451	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23356452	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23356919	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23356920	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23357528	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23357529	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23358175	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23358176	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23358643	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23358644	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	92.0	CHEMBL2553	Homo sapiens	% Control	%	92.0
Not Active	23359229	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23359230	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23359827	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23359828	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	97.0	CHEMBL2553	Homo sapiens	% Control	%	97.0
Not Active	23360295	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23360296	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23360880	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
Not Active	23360881	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	96.0	CHEMBL2553	Homo sapiens	% Control	%	96.0
Not Active	23361348	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23361349	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23361921	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23361922	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	91.0	CHEMBL2553	Homo sapiens	% Control	%	91.0
Not Active	23362457	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23362458	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23362925	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	79.0	CHEMBL2553	Homo sapiens	% Control	%	79.0
Not Active	23362926	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23364567	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	69.0	CHEMBL2553	Homo sapiens	% Control	%	69.0
Not Active	23364568	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	73.0	CHEMBL2553	Homo sapiens	% Control	%	73.0
Not Active	23365035	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	95.0	CHEMBL2553	Homo sapiens	% Control	%	95.0
Not Active	23365036	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23365774	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	81.0	CHEMBL2553	Homo sapiens	% Control	%	81.0
Not Active	23365775	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23366317	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23366318	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	96.0	CHEMBL2553	Homo sapiens	% Control	%	96.0
Not Active	23366907	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23366908	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	92.0	CHEMBL2553	Homo sapiens	% Control	%	92.0
Not Active	23367375	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23367376	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23367733	CHEMBL4884086	RPS6KA1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL2553	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23368253	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	71.0	CHEMBL2553	Homo sapiens	% Control	%	71.0
Not Active	23368254	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	76.0	CHEMBL2553	Homo sapiens	% Control	%	76.0
Not Active	23368721	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	79.0	CHEMBL2553	Homo sapiens	% Control	%	79.0
Not Active	23368722	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	92.0	CHEMBL2553	Homo sapiens	% Control	%	92.0
Not Active	23369320	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23369321	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	82.0	CHEMBL2553	Homo sapiens	% Control	%	82.0
Not Active	23369788	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23369789	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	98.0	CHEMBL2553	Homo sapiens	% Control	%	98.0
Not Active	23370229	CHEMBL4884471	Rsk1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	7.0	CHEMBL2553	Homo sapiens	% residual kinase activity	%	7.0
	23370230	CHEMBL4884471	Rsk1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	9.0	CHEMBL2553	Homo sapiens	IC50	nM	9.0
Active	23370345	CHEMBL4884206	Eurofins kinase panel (RPS6KA1)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	9.1	CHEMBL2553	Homo sapiens	IC50	nM	9.1
Active	23370756	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	1.8	CHEMBL2553	Homo sapiens	% Control	%	1.8
Not Active	23370757	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23371224	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23371225	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23372033	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	74.0	CHEMBL2553	Homo sapiens	% Control	%	74.0
Not Active	23372034	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	92.0	CHEMBL2553	Homo sapiens	% Control	%	92.0
Not Active	23372501	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23372502	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
	23372883	CHEMBL4884848	RSK1 [p90RSK(R6A2CGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2553	Homo sapiens	pIC50		6.0
	23373292	CHEMBL4885139	RSK1 [p90RSK(R6A2CGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2553	Homo sapiens	pIC50		6.0
	23373648	CHEMBL4885425	RSK1 [p90RSK(R6A2CGE1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2553	Homo sapiens	pIC50		6.0
Not Active	23375091	CHEMBL4886079	RSK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	7.5	CHEMBL2553	Homo sapiens	% Inhibition	%	7.5
Not Active	23375369	CHEMBL4886351	ribosomal protein S6 kinase, 90kDa, polypeptide 1  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	9.0	CHEMBL2553	Homo sapiens	% inhibition	%	9.0
Not Active	23375928	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23375929	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23376396	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL2553	Homo sapiens	% Control	%	93.0
Not Active	23376397	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23376973	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23376974	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23377441	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23377442	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23378301	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	86.0	CHEMBL2553	Homo sapiens	% Control	%	86.0
Not Active	23378302	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL2553	Homo sapiens	% Control	%	88.0
Not Active	23378769	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	96.0	CHEMBL2553	Homo sapiens	% Control	%	96.0
Not Active	23378770	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23379936	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL2553	Homo sapiens	% Control	%	94.0
Not Active	23379937	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23380404	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23380405	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	79.0	CHEMBL2553	Homo sapiens	% Control	%	79.0
Not Active	23381098	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23381099	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23381746	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23381747	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23382214	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23382215	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23382838	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23382839	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	71.0	CHEMBL2553	Homo sapiens	% Control	%	71.0
Not Active	23383306	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL2553	Homo sapiens	% Control	%	100.0
Not Active	23383307	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	68.0	CHEMBL2553	Homo sapiens	% Control	%	68.0
Not Active	23383975	CHEMBL4887579	RPS6KA1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL2553	Homo sapiens	% Ctrl	%	94.0
Not Active	23384045	CHEMBL4887643	MAPKAPK1A DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	77.5	CHEMBL2553	Homo sapiens	% Ctrl	%	77.5
Not Active	23384452	CHEMBL4888047	Rsk1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-6.03	CHEMBL2553	Homo sapiens	% inhibition	%	-6.03
Not Active	23384708	CHEMBL4888234	RPS6KA1 (RSK1) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	12.0	CHEMBL2553	Homo sapiens	% Inhibition	%	12.0
Not Active	23385221	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	71.0	CHEMBL2553	Homo sapiens	% Control	%	71.0
Not Active	23385222	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL2553	Homo sapiens	% Control	%	91.0
Not Active	23385688	CHEMBL4879945	KinomeScan assay: inhibition of RSK1(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	65.0	CHEMBL2553	Homo sapiens	% Control	%	65.0
Not Active	23385689	CHEMBL4879946	KinomeScan assay: inhibition of RSK1(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	99.0	CHEMBL2553	Homo sapiens	% Control	%	99.0
